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In heart failure, the presence of functional mitral r%#gitation secondary to a 
myocardial infarction (MI) is known to double mortality. While the mechanism of 
functional mitral regurgitation has been extensively studied, the mechanism of a 
concomitant functional tricuspid regurgitation has been neglected. We hypothesized that 
MI alters not only the geometry of the left ventricle but also of the right ventricle leading 
to both ischemic mitral and tricuspid regurgitation (IMR & ITR). We also hypothesized 
that these geometric alterations modulate mechanical stresses resulting in molecular 
changes. To answer these hypotheses, the following Aims were designed: 1) complete an 
anatomy study of the normal tricuspid valve following the established principles applied 
to the mitral valve; 2) perform an in vivo sonometric study of the functional anatomy of 
the atrioventricular valves in order to clarify their relationships; 3) compare in sheep the 
data obtained with transthoracic echocardiography (TTE) with those acquired with 
sonomicrometry. Evaluation of the reliability of the echo geometric data is essential 
given its value because of its non-invasiveness. 4) develop a reproducible animal model 
of IMR and ITR and analyze the resulting geometrical changes 5) search for variations in 
eNOS and nNOS expression at increasing distance from the MI as an indicator of 
cardiomyocyte stretch.
Results 1) An original terminology of the tricuspid valve useful to surgeons and 
cardiologists was developed; 2) we showed how the mitral and tricuspid valves are linked 
by the septum; 3) TTE in sheep provides precise information needed for the non invasive 
follow up of the LV remodeling; 4) an original animal model of IMR and ITR was 
developed with the percutaneous selective injection of ethanol. Specific geometrical 
distortions of both ventricles that resulted in IMR and ITR were found; 5) we showed that 
the expression of eNOS was correlated with the distance from the MI and thus the 
amount of stress.
Conclusion: This data suggest that IMR and ITR are caused by a geometrical distortion 
of both atrioventricular valves and that this macroscopic remodeling was associated with 
an up-regulation of eNOS that may be correlated with an adapatative process of the 
stretched cardiomyocytes.
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Introduction
The clinical symptoms of heart failure are due to inadequate performance of the 
heart. Heart failure develops gradually following a myocardial infarction, as the 
myocardium is progressively remodeled [1]. The degree of myocardial remodeling 
determines the alterations in ventricular size, shape and function [2]. Left ventricular 
remodeling may be associated with the presence of a functional mitral regurgitation that 
following an ischemic event is known to double mortality [3]. While functional mitral 
regurgitation has been extensively studied the presence of a concomitant functional 
tricuspid regurgitation has been generally ignored. In a retrospective study of patients 
with functional mitral regurgitation from ischemic origin, we observed a concomitant 
functional tricuspid regurgitation in 30% of the cases. The mechanisms at the origin of 
functional ischemic tricuspid regurgitation remain unknown.
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Background
1: Ischemic Heart Failure with Mitral and Tricuspid Regurgitation 
1-1: Heart Failure: A Major Health Problem.
The clinical syndrome of heart failure is a major health problem in the western 
countries. It is estimated that 4.6 million Americans are currently treated for heart failure 
and that 550,000 new cases are diagnosed each year [4]. Heart failure is the reason for at 
least 20 percent of all hospitalizations among persons older than 65. The rate of 
hospitalizations for heart failure has increased by 159 percent during the nineties. An 
estimated $5,501 was spent for every hospital discharge diagnosis of heart failure, and 
another $1,742 per month was required to care for each patient after discharge [2]. In 
France, 85 to 93% of the economic cost of heart failure is attributable to hospitalizations, 
most of them avoidable [5]. Substantial efforts have been made to identify and treat the 
factors that predict recurrent hospitalizations.
Mortality associated with heart failure remains high in spite of advances in 
therapy. Symptomatic heart failure continues to confer a worse prognosis than the 
majority of cancer, with one-year mortality of approximately 45 percent [6,7]. Senni et al. 
reported, in a community-based survey, 76 percent and 35 percent survival rates at one- 
year and five-years, respectively [8]. Large epidemiologic surveys have not documented 
any meaningful change in overall death rates.
Heart failure is clinical syndrome of signs and symptoms caused by inadequate 
performance of the heart. Currently, complex blends of structural, functional, and 
biologic alterations are evoked to account for the progressive nature of heart failure. Only
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
the combination of several animal models of heart failure can explain more fully the 
cascade of mechanisms: the hemodynamic model is focused on the altered load of the 
ventricle while the neurohumoral model recognizes the importance of the renin- 
angiotensin-aldosterone axis and the sympathetic nervous system in the progression of 
cardiac dysfunction. Some studies have scrutinized myocytes from failing hearts in an 
attempt to detect abnormal signaling, gene expression, or contractile protein structure.
Microbiologie changes and increased levels of circulating neurohormones are 
only part of the response seen after initial insult to the myocardium. Jessup et al. defined 
the left ventricular remodeling as the process by which mechanical, neurohormonal and 
possibly genetic factors alter ventricular size, shape and function [2]. Remodeling occurs 
after several clinical conditions such as myocardial infarction, cardiomyopathy, 
hypertension, and valvular heart disease. Its hallmarks include loss of myocytes, 
hypertrophy and increased interstitial fibrosis [9,10].
1-2: Ischemic Heart Failure
The effect of the underlying cause of heart failure on survival is unclear. In 
general, patients with heart failure due to left ventricular dysfunction are classified 
broadly in two groups: those with cardiomyopathy due to ischemic causes and those with 
cardiomyopathy due to non-ischemic causes. Misclassification of causes of heart failure 
may result when cardiomyopathy is diagnosed clinically because one-third of patients 
with cardiomyopathy due to non-ischemic causes have clinical angina [4]. In France, one 
in two hospitalized patients with heart failure is classified as an ischemic cardiomyopathy 
[11]. In an analysis of 3,787 patients with left ventricular dysfunction who underwent
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
coronary angiography, an underlying cause of ischemia was a significant independent 
predictor of mortality [12]. Five-year survival for patients with ischemic heart disease 
was 59 percent.
Ischemic heart failure is mostly due to coronary atherosclerosis. During the 
1980s, the age-adjusted mortality due to coronary artery disease decreased considerably 
in the United States [13] and in other countries [14]. This favorable trend was due partly 
to a decrease in the rate of fatal myocardial infarction and also to the decline of risk 
factors for coronary disease [13], which strongly influence the severity of atherosclerosis. 
Severity of atherosclerosis is a major predictor of survival in patients with coronary 
artery disease [15]. Death seems to have been delayed and occurs a longer time after a 
myocardial infarction [2]. However Enriquez-Sarano et al. showed that the prevalence of 
atherosclerosis remained the same from 1980 to 1989 [16]. These findings likely explain 
the increased prevalence of patients with heart failure symptoms from ischemic 
cardiomyopathy.
1-3: Ischemic Mitral Regurgitation 
1-3-1: Significance of Isehemic Mitral Regurgitation
Mitral regurgitation (MR) in heart failure can be organic or functional. Organic 
implies a disease of the mitral valve itself and functional implies a “normal” mitral valve. 
For example, after a myocardial infarction, a rupture of one of the papillary muscle can 
occur resulting in an organic mitral regurgitation and in acute massive heart failure. 
Functional means that the mitral valve is normal on macroscopic appearance and MR 
may be due to annular dilatation (type 1 in Carpentier’s functional classification of MR)
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or alternatively to restricted motion of the leaflets (type 111b in Carpentier’s functional 
classification of MR) [17]).
The incidence of functional ischemic mitral regurgitation (IMR) after acute 
myocardial infarction (Ml) has been reported to be between 13% [18] and 39% [19]. 
Barzilai et al. reported a one-year mortality of 36% compared with 15% in patients 
without MR [20]. Lehmana reported a one-year mortality of 18.2 % for patient with mild 
MR and 60% for those with moderate or severe MR [18]. In a retrospective analysis of 
11,848 patients with significant coronary disease (>75% stenosis of one or more coronary 
arteries), ejection fraction, age, and number of diseased vessels were also predictors of 
poor outcome but less significantly compared to presence of mitral regurgitation. An 
inverse relationship exists between degree of mitral regurgitation and prognosis [21]. In a 
study of 303 patients, Grigioni et al. showed that the presence of MR doubles the long­
term (5-years) mortality [3]. These findings are the same even in cases with mild or 
moderate regurgitation [22]. Therefore, presence of functional MR is an independent 
predictor of poor prognosis in ischemic heart failure.
1-3-2: Mitral Regurgitation and Localization of the Ischemic Event
Lehman et al. [18] reported a significant difference (p<0.01) in the presence of 
MR following an ML Mitral regurgitation was present in 21% of patients after anterior 
Ml (20/96 patients) compared with 6% of patients after inferior Ml (6/106 patients). 
However, Barzilai et al. [19] reported a MR with 46% of the anterior Ml patients (11/24 
patients) and 35% with the inferior Ml patients (12 of 34 patients).
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Localization of Ml is not the only parameter that determines the presence of MR. 
Kumanohoso et al. showed that global LV dilatation and dysfunction were significantly 
less pronounced in 43 patients with inferior Ml compared to 61 patients with anterior ML 
However, the percentage of MR was very significant in inferior Ml patients compared to 
those with anterior Ml patients (p<0.0001) [23]. Kono et al. reported that the left 
ventricular shape was the primary determinant of functional MR in heart failure [24]. 
Change of ventricular shape, size and function or “remodeling” after myocardial 
infarction is associated with functional mitral regurgitation.
1-3-3: Mechanisms of Ischemic Mitral Regurgitation
The mechanism responsible for functional ischemic mitral regurgitation (IMR) 
remains uncertain, although specific anatomic abnormalities of the left ventricle (LV) 
have been proposed. They are mitral annulus dilatation, chamber enlargement, 
dysfunction of the papillary muscle and associated dysfunction of the ventricular wall 
[25]. Coexistence of these characteristics in the failing heart makes the identification of 
the precise abnormality responsible for the IMR difficult.
- Dilatation of the mitral annulus
Experimental models of acute ischemic MR, using sonomicrometry array 
localization [26], myocardial marker technology or three-dimensional echocardiography 
[27,28], showed distortions in the geometry of the mitral annulus, just after myocardial 
infarction. In an animal model of chronic ischemic MR using sonomicrometry array 
localization, Gorman et al. showed that the end systolic annular area increased from
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647±44 mm^ to 1,094±173 mm^ (p=0.01). The annular dilatation oecurred equally along 
the anterior (47±5.6 mm to 60.2±4.9 mm, p=0.001) and posterior (53.8±3.1 mm to 
68.5±8.4, p=0.005) portions of the annulus [29]. Using radiopaque marker technology in 
the same ovine model of chronic ischemic MR, Tibayan et al. obtained the same results. 
Mitral annular diameter, septo-lateral and commissure-commissure dimensions increased 
significantly with the severity of the IMR at seven weeks [30](Figure 1). They also 
demonstrated the flattening of mitral annulus, which is normally a saddle shaped 
structure. These experimental results are comparable to what has been observed in the 
human. In a prospective analysis of the degree of functional IMR in 128 patients with 
systolic LV dysfunction, the mitral annulus from these patients were compared with 21 
normal controls by echocardiography. Diastolic and systolic mitral annular areas were 
significantly larger than in control group (9.5±L7 mm and 7.7±1.8 mm versus 
6.9±0.8mm and 4.4±0.7 mm, respectively) [31]. In an analysis of geometric alterations of 
the mitral apparatus with magnetic resonance imaging, Yu et al. showed that there was a 
significant difference (p=0.008) in the antero-posterior diameter between patients with a 
remodeled LV after myocardial infarction without MR (28.7±4.5mm) and patients with 
IMR (45.6±13.4 mm) [32]. The consequence of annular dilatation is shortening of the 
coaptation plane of both the anterior and posterior leaflets. At most, it can result in lack 
of coaptation and a central leak (type 1, Carpentier’s ftmctional mitral regurgitation 
classification) [17].
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Figure 1 : Mitral Annulus dilatation in IMR.
The dilatation occurred in antero-posterior and septo-lateral directions.
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- Chamber enlargement
Dilatation of the heart after an isehemie event is the first eharaeteristie of 
myocardial remodeling. The cardio-thoracic index is always increased in heart failure on 
a chest X-ray. All experimental studies and human observations of IMR showed an 
increased volume of the LV. Patients without any IMR can also present with LV 
enlargement. However, enlargement of the LV seems to be more prevalent in eases in 
which patients present with an IMR. In a comparative analysis of patients after an 
ischemic event, LV end-diastolic (LVED) and LV end-systolic (LVES) volumes were 
significantly larger for patients with IMR than patients without IMR (239±84 ml and 
148±65 ml versus 202±68 ml and 120±47 ml; p<0.001) [25]. This more pronounced LV 
enlargement, which is demonstrated in other human [31-33] and animal [34,35] studies, 
is also associated with a greater index of sphericity (the heart appeared more spherical) 
[25]. This sphericity of the heart may explain the worsened clinical symptoms and poorer 
prognosis of these patients according to Torrent-Guasp [36] who described the helical 
heart as a muscular band scrolled on itself. In case of dilatation of the heart, the 
longitudinal orientation of the scrolled muscular band becomes more transversal 
decreasing its twisting during the contraction and thus, the ejection of the blood [36].
- Tethering effect
The greater volume of the heart is associated with increased longitudinal and 
transverse measurements of the heart. LVED and LVES diameters and inter papillary 
muscle distances are reported increased in human and animal studies [28,30-32,34,35]. 
The increased longitudinal diameter also can be measured by the distance between the tip
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
of the posterior papillary muscle and the anterior part of the mitral annulus. This distance 
is called the “tethering distance”. The inferoposterior wall bulges outward, displacing the 
attached posterior papillary muscle outward and apically [27].
During the enlargement of the LV, in the case of IMR, the distance between the 
tip of the posterior papillary muscle and the mitral annulus increases. Because of the low 
elasticity of the fibrous tissue of the chords and the mitral leaflet, the chords and more 
particularly the basal chords, tether the leaflets. Therefore, the enlargement of the heart is 
responsible for a tethering effect on both mitral leaflets. Leaflets motion is restricted and 
because of the movement of the coaptation point toward the apex, a central MR results 
[37](Figure2).
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Figure 2: Tethering effect on the anterior leaflet observed on an ischemic MR patient in 
systole.
The anterior leaflet shape mimics a tent. The coaptation point of both leaflets is 
apically displaced. The association of annular dilatation and tethering effect result in 
massive MR.
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- Dysfunction of the papillary muscles and associated dysfunction of the ventricular wall:
Damaging the posterior papillary muscle was an early method to produce an 
experimental model of IMR and study the function of the papillary muscle [38]. In 
previous human case reports, IMR murmur following myocardial infarction was 
associated with development of heart failure. Autopsy of two patients showed non­
ruptured papillary muscles and chordae. In one case, extensive scars were found in the 
ventricle wall at the base of the papillary muscle. In the other case, the papillary muscle 
was infareted [39]. In the most popular chronic IMR animal model of Llaneras et ah, MR 
appears after infarction of the posterior papillary muscle and the relative left ventricle 
wall [35]. Messas et al., using an acute ovine model of IMR, showed that inferior 
ischemia, which did not involve the posterior papillary muscle, was associated with IMR. 
In their experiment, the ischemia and therefore the dysfunction of the papillary muscle 
even decreased the amount of MR [28]. The amount of IMR varies with loading 
conditions [37]. The dynamic variability of IMR is enhanced by the report of Pierard and 
Lancelloti [40], who described IMR as being responsible for pulmonary edema. A 
comparative study of patients with left ventricular dysfunction, trivial MR and acute 
pulmonary edema or non history of acute pulmonary edema showed significant 
association between exereise-induced ehanges in the effeetive regurgitant orifice area and 
pulmonary edema.
1-4: Functional Tricuspid Regurgitation in Cases of Ischemic Heart Failure
Functional tricuspid regurgitation (TR) has the same definition as funetional MR. 
The valve is leaking, but appears macroscopically normal.
12
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1-4-1: Significance of Functional Tricuspid Regurgitation:
The tricuspid valve is the right-sided atrioventricular valve and its study has 
always lagged behind those of other cardiac valves. Ineidence of tricuspid insufficiency is 
higher than expected and surgical management does not have the expected clinical results 
[41]. Patients with severe left ventricular dysfunction who developed functional MR are 
associated with poor prognosis [18,21,25]. In these patients, right ventricular dysfunction 
and presence of TR have been shown to be an independent predictor of mortality [42-44].
Greater LV enlargement and higher prevalence of echocardiographic functional 
MR were associated with functional TR in a comparative study of 117 patients in heart 
failure. In the same study, estimated I-year event-free (cardiae transplantation or death) 
survival was 68% in patients without TR and 30% in patient with TR (p-0.0002). 
Presence of TR was also a marker of right ventricle (RV) systolic dysfunction, RV 
dilatation and RV hypokinesia [42]. These criteria were defined as indicators of a poor 
prognosis in congestive heart failure associated with coronary artery disease by Polak et 
al. [45].
1-4-2: Mechanism of Functional Tricuspid Regurgitation:
The mechanism of functional TR was never studied with the same aecuracy as 
was applied to study the mechanism of functional MR. Functional TR is the most 
frequent cause of tricuspid disease. In a retrospective study of 80 patients who presented 
a hemodynamically significant tricuspid regurgitation, etiology of TR was functional in 
85.5% (68) of patients. The most common functional cause was pulmonary artery 
hypertension (80%) while ischemic (25%) and non-ischemic cardiomyopathy (8%) were
13
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also common [46]. In a postmortem study of patients with pure TR, Waller et al reported 
that 47 % of all cases of TR were functional [47].
The suspected mechanism of functional TR is right ventricular enlargement and 
abnormal leaflet coaptation. The tricuspid annulus, which is mostly muscular, follows the 
dilatation of the right cavities. The causes of RV enlargement are ischemic or non­
ischemic cardiomyopathy and pulmonary hypertension leading to chronic right 
ventricular hypertension. Causes of pulmonary hypertension are divided into primary 
pulmonary hypertension (precapillary) or secondary pulmonary hypertension. Of these 
causes left-sided valvular disease are common [46]. In the case of IMR, LV pressure 
filling may develop secondary to pulmonary hypertension [44]. The total perimeter of the 
tricuspid annulus is 100-120 mm. This annulus circumference can reach 150-I70 mm in 
the case of ftmctional TR [47,48]. Annulus dilatation is not homogeneous. In a 
postmortem study, Deloche et al. showed that the posterior and anterior portions of the 
annulus dilated far more than the septal portion [49] (Figure 3). Annulus dilatation results 
in lack of coaptation of the leaflets and therefore regurgitation.
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Figure 3: Dilatation of the tricuspid annulus in the case of functional tricuspid 
regurgitation (Modified from Deloche et al. [49]).
Dilatation affects mainly posterior and anterior annulus. Numbers indicate the change of 
length in percentage found by Deloche et al [49].
+ 46 %
Dilated tricuspid annulus
+ 30 %
+ 50 %Anterior Posterior
+ 3 7 % Septal
+15 % 
Normal tricuspid annulus
+ 46 %
15
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
1-4-3: Alternative meehanisms
Besides the annulus dilatation, another mechanism was cited by Carpentier et al.: 
“Excessive dilatation o f the right ventricle maintains an abnormal tension o f  the 
chordae, impairing the free motion and therefore perfect coaptation o f the leaflets” [50]. 
Anterior displacement of the tricuspid leaflet tips was described 10 years later by Mikami 
et al. [51]. However, in a study of eleven patients. Come and Riley showed that in 5 
patients with failure of systolic leaflet coaptation, tricuspid annular dilatation appeared to 
play a major role [52]. Severity of tricuspid regurgitation was correlated with the degree 
of apical displacement of the leaflets in an extensive echocardiography study of Sagie et 
al [53]. In summary, mechanisms of functional regurgitation in the case of ischemic TR 
(ITR) remain unclear. Right ventricular enlargement, tricuspid annulus dilatation and 
restrictive motion of the leaflets as in IMR are three possible origins.
1-5: Surgical Approach of Ischemic Heart Failure
1-5-1: Repair of Ischemic MR
The optimal management of moderate IMR remains controversial. Some authors 
argue that revascularization alone without any mitral maneuvers is adequate therapy. 
Potential reversibility of ischemic MR following revascularization alone may not justify 
longer surgery mixing mitral repair or replacement and revascularization [54].
While functional IMR is related to the location and extent of the infarct, 
successful reperfusion alone does not reduce mortality, nor does it reliably restore 
valvular competence [33] [55].
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- Annuloplasty
Mitral annuloplasty is performed in nearly 80% of patients with ischemic mitral 
regurgitation [56]. Undersizing the mitral ring is the technique of choice in cases of IMR 
(type IIIB dysfunction, restricted leaflet motion in systole only) [54]. Authors who 
worked on an ovine model advocated a complete and undersized ring as a prosthetic 
annuloplasty. The dilatation of the mitral annulus occurs in all the annulus, therefore the 
ring has to be complete and sizing the ring on the dilated intertrigonal distance may result 
in selecting a ring that is too large [29,30]. The insertion of an undersized ring on a 
dilated annulus may lead to ring dehiscence because of excessive tension on the sutures. 
Multiple overlaping sutures around the annulus can reinforce the sutures and prevent this 
complication [57].
However, mitral annuloplasty is sometimes inadequate. In 30% of patients 
recurrent MR occurs following annuloplasty for IMR. In a retrospective study of 585 
patients who underwent annuloplasty alone for repair of IMR, 28% of patients had 3+ or 
4+ MR 6 months after the operation. In this study the use of a Peri-Guard armuloplasty 
ring, higher grade preoperative MR, jet direction or complex and more severe 
preoperative LV dysfunction were associated with a higher risk of recurrence of high 
grade MR than Cosgrove bands and Carpentier rings [58]. In a retrospective study of 100 
patients who underwent mitral annuloplasty and revascularizations for ischemic MR, the 
incidence of recurrent MR was 29% [59]. From 48 patients who underwent 
revascularization and ring annuloplasty for IMR and left the operating room with <1+ 
MR, Matsunaga et al. reported 15 patients who had recurrent IMR. In these patients, LV 
dysfunction and enlargement and papillary muscle displacement were greater than in the
17
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other 33 patients who did not have any recurrent IMR [60]. In a retrospective analysis of 
126 patients who underwent mitral annuloplasty in case of IMR, analysis showed no clear 
survival benefit conferred by the surgery [61].
All these studies showed that annuloplasty alone in cases of ischemic MR seemed 
to be insufficient. One of the reasons was that the annulus prosthesis addressed only the 
mitral annulus dilatation, but did not influence the other mechanisms responsible for 
ischemic MR. Other procedures, which involve the sub-valvular mitral apparatus, have 
been described.
- Chordal cutting
In cases of functional IMR, the laterally displaced postero-lateral papillary muscle 
[27] tethers the anterior mitral leaflet (Figure 1) through the stay chords. The anterior 
mitral leaflet has a characteristic tent-shape and this angulated bend limits its ability to 
coapt effectively. Messas et al. reported experimentation on sheep with reduction of the 
amount of IMR by chordal cutting compared with controls [62]. Several patients were 
operated on with this procedure (personal observation of cases in Paris, France), however 
no human studies have been published. Only two cases with no follow-up were reported 
in 2004 in a Japanese journal [63]. Experimentation on sheep showed the importance of 
these chords as essential for the valvular-LV geometry. Rodriguez et al. showed that 
cutting second order chords did not prevent acute IMR and resulted in LV systolic 
dysfunction in sheep [64] [65]. Goetz et al. showed that the anterior mitral stay chords, 
which connect the papillary muscle to the fibrous trigones, suspend the aorto-mitral
18
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angle. Transection of these chords increased the papillary muscles -  fibrous trigones 
distances and narrowed the aorto-mitral angle in systole and diastole by 5 degrees [66].
The true function of the anterior mitral basal “stay” chords is not yet known. 
Collagen fiber orientation of anterior mitral leaflet suggests that local stress be directed 
from papillary muscles over these chords and to fibrous trigone [67,68]. It seems that the 
stay chords are like pillars that support the anterior mitral leaflet as a vault. Therefore 
cutting these chords could be dangerous.
- Surgical relocation of the papillary muscle
Kron et al., aware of mitral annuloplasty failure in ischemic mitral regurgitation, 
reported 18 patients with previous inferior myocardial infarction who underwent 
posterior papillary muscle relocation associated with revascularization and armuloplasty. 
This new technique consisted of adding a suture between the left trigone and the postero­
lateral papillary muscle associated with an armuloplasty. This suture brings the papillary 
muscle tip closer to the annulus and therefore allows coaptation of the mitral leaflets.
This surgical procedure is performed in patients whose LV end-systolic diameter is 
moderately dilated (<6 cm) [56]. In case of larger dilatation (>6 cm end-systolic LV 
diameter), surgical relocation of the posterior papillary muscle can be done with a Dor 
procedure. A Dor procedure consists of a surgical resection of the ventricular wall at the 
level of the infarction. A suture is placed on the collar of the myomectomy, which 
reduces the neck of the scars and an endoventricular patch is secured inside the ventricle. 
This procedure is designed to re-shape the LV and relocate the posterior papillary muscle 
by giving a more ellipsoid shape to the heart [69,70]. Hvass et al. reported 10 patients
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with ischemic mitral regurgitation who underwent a “sling procedure” associated with a 
mitral annuloplasty. The sling procedure consisted of a Gore-tex tube placed around the 
two papillary muscles through the trabeculations of the heart. The tube was tightened 
until the papillary muscles were in close contact. Results showed significant 
improvement in echocardiography and clinical data [71]. All these surgical relocations of 
the displaced papillary muscle are associated with an annuloplasty. The results involve 
only small numbers of patients and further clinical studies have to be reported to draw 
conclusions.
- Mitral Valve Replacement
In a comparative review of 223 patients, short-term outcome showed that 
mortality rate was doubled for patients who underwent mitral valve replacement versus 
repair (30 days mortality 20% versus 10%). Five-year complication-free survivals were 
64% for repair and 47% for replacement. However, the statistical analysis suggested an 
outcome linked primarily to the NYHA functional class and independent from the type of 
surgery. The authors concluded in this study that replacement and repair were both 
possible choices and could be left up to the surgeon, the acuteness of the presentation and 
the pathophysiology involved. In cases where the predominant presentation was a large 
annulus dilatation, annuloplasty and mitral valve reconstruction had excellent results
[72]. Gillinov et al. studied, retrospectively, 482 patients who underwent mitral valve 
replacement (n=85) or mitral valve repair (n=397) during a 12-year period. Their findings 
were similar to the results of Grossi et al. in that most patients benefited from mitral 
valve repair. For the sickest patients, survival after repair and replacement were similar
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[73]. According to Miller, a role remains for mitral valve replacement using a 
bioprosthesis in cases of complex and long predictable repair and for surgeons who do 
not often do repair procedures and that mechanical valves, given the limited life 
expectancy of these patients, would not provide any benefit [74].
1-5-2: Repair of functional TR: Critical annulus diameter:
Repair of functional TR is based on the idea that the cause of regurgitation is the 
lack of leaflet coaptation due to annulus dilatation. Therefore the search for a “critical 
annulus diameter” beyond which the tricuspid regurgitation should not be ignored by the 
surgeon is very important. In 1983, Ubago et al. used a right ventriculogram to quantify 
TR. They showed that the indexed mean maximum diameter for the tricuspid annulus 
was 21 mm/m^ among patients without regurgitation, 31 mm/m^ among patients with 
mild regurgitation and 37 mm/m^ among patients with moderate or severe TR. The 
authors concluded that the critical annulus diameter was 27 mm/m^ [48]. In a 
transthoracic echocardiography study of 11 patients with functional TR, Come et al. 
reported a mean diastolic aimulus diameter of 51 mm in the four-chamber view and 54 
mm in the short axis view. Fifteen control patients had a mean annulus diameter of 34 
mm in the four-chamber view and 33 mm in the short axis view [52]. Using 
intraoperative transeosophageal echocardiography, Goldman et al. measured the largest 
tricuspid annulus diameter from the base of the septal leaflet to the insertion of the 
anterior leaflet in the free right ventricular wall. When TR was 0-2+, annulus diameter 
was 26 mm in 36 patients. When TR was 2-4+, annulus length was 39 mm [75].
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Therefore, 30 mm appears to be the critical length for these authors who did not describe 
differences in systolic and diastolic diameter.
Differentiation between organic and functional disease can be done pre- 
operatively by echocardiography. Analysis of leaflet thickness, irregularities, doming and 
the presence of a transvalvular gradient is a clear indication of organic disease. Annulus 
dilatation, present in both organic and functional disease is more pronounced in 
functional TR. In a postmortem study. Waller et al. showed that patients with functional 
TR had a much larger annulus than patients with organic disease [47]. However, no 
hemodynamic and angiographic differences were found between organic and functional 
disease [57].
-Tricuspid annuloplasty
Surgical techniques for functional TR are based on reduction of the tricuspid 
armulus. To reduce the tricuspid annulus allows the coaptation of the three leaflets. An 
early method of plicature of the posterior annulus was described by Kay [76]. This 
method was abandoned because of the difficulty in determining the amount of plicature 
necessary. The remaining annulus was also not supported and could dilate later. A partial 
suture which encircled and narrowed the annulus was described by De Vega [57] and 
Cabrol [77]. However, this technique is rarely used today because of the late recurrence 
of tricuspid regurgitation resulting from the suture cutting through or breaking [57]. Total 
flexible prosthetic rings can correct dilatation and deformation of the annulus. These 
rings are sized and shaped and give optimal orifice area and the annulus can be reduced 
selectively at the point of excessive dilatation [50,78]. Surgical techniques for implanting
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a tricuspid annuloplasty ring are very similar for all types of rings. The dangerous part of 
this surgery is the proximity of the atrio-ventricular node along the septal leaflet. In a 
retrospective study of 790 patients with functional TR, McCarthy et al. [79] showed that 
tricuspid valve armuloplasty did not consistently eliminate functional TR. Four 
techniques of armuloplasty were used and regurgitation severity remained stable with 
Carpentier-Edwards ring (p=0.7), increased with the Cosgrove-Edwards band (p=0.05) 
and remained unstable with the De Vega (p=0.002) and Peri-Guard (p=0.0009) 
procedures during the follow-up. Risk factors for TR recurrence included higher 
preoperative regurgitation grade, poor LV function, permanent pacemaker and repair type 
different from armuloplasty. At one-month postoperatively, prevalence of 3+ or 4+ TR 
was 15% for each of the different procedures and the size of ring was not a factor in the 
failure.
- Tricuspid valve replacement in case of functional tricuspid regurgitation
Presence of functional TR is not an indication for tricuspid valve replacement 
[57]. Tricuspid valve replacement is a high-risk procedure. McCarthy [79] reported a 
37% mortality rate in cases of reoperation for functional TR. However, patients were 
referred late to the surgeon with hepatic and renal dysfunction. Poveda et al. reported a 
39% hospital mortality rate in patients with rheumatic disease between 1974 and 1993 
[80]. If the replacement is performed after a subsequent open-heart procedure, Hornick 
et al reported a mortality of 50% for patients operated between 1985 and 1993 [81]. 
Tricuspid armuloplasty has a better prognosis than tricuspid valve replacement. However,
23
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
failure of annuloplasty in a number of patients questions whether this technique is 
appropriate or not.
2: Ultrastructure of the Myocardium
2-1: The Sarcomere
The myocardium is composed of fibers arranged in parallel. The fiber is made up 
of longitudinally arranged cardiomyocytes, which are the contractile cells of the heart. 
The cardiomyocytes are made up of hundreds of myofibrils, which contain many 
mitochondria and an elongated centrally located nucleus. Cardiomyocyte size varies from 
10 to 20 pm in diameter and from 50 to 100 pm in length. The longitudinally oriented 
myofibrils are formed by interdigitating myosin and actin filaments, which are the 
contractile elements of the cell. The repeating units of contractile elements, the sarcomere 
(from 1.5 to 2.2 pm in length), produces a regular pattern of dark and light areas. The 
dark Z bands are localized at the extremities of the sarcomere and support the attachment 
of the actin filaments. In the middle of the sarcomere are the thick myosin filaments. The 
interdigitating intersections produce dark and light zones within the sarcomere under 
microscopy (Figure 4). They contain an intricate sarcotubular system of tubules, vesicles 
and cisternae. The sarcoplasmic reticulum (SR) is a plexiform labyrinth of vesicles that 
tend to be oriented parallel to the myofibrils, which they surround. The periodic 
invagination of the sarcolemma by transversely oriented tubules constitutes the T-tubules. 
At the level of Z band, both T-tubules and SR present dilatation -the cisternae of the SR- 
creating a triadic junction. The sarcotubular system plays an important role in both 
electrical impulse conduction and electromechanical coupling [82].
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Figure 4: Electron microscopy of human cardiomyocyte (freeze fracture of the SR 
surrounding the myofibrils, x 26,000).
The sarcomere between two Z bands (Z) presents two light I bands (I) constituted by 
thin actin filaments attached to Z bands. The A band (A) is the dark area between two 1 
bands that contains both actin and myosin filaments. In the center of the A band is the 
lighter H zone constituted of myosin filament only. The M line (M) constituted by 
excrescence of the myosin forms the dark thin line in the middle of the A band. SR: 
sarcoplasmic reticulum (Modified from Nicholas J. Severs, The cardiac muscle cells 
BioEssays 22:188-199)
&
I Z I
MM—
,-i r z
25
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2-2: Myocardial Excitation-contraction Coupling
The calcium ion (Ca^^) plays a central role in the action potential generated along the 
surface of the myocyte to initiate contraction in the cardiomyocyte. The initiation of the 
action potential corresponds to the opening of sodium (Na^ channels that initiates a very 
rapid influx of Na^, which produces the electrical spike during phase zero of the action 
potential. During the plateau phase of the action potential, there is a slow inward flux of 
Ca^^ through Ca^^-channels in the sarcolemma (myocardial cell membrane) into the 
intracellular fluid (sarcoplasm). The action potential spreads from the sarcolemma down 
the T-tubules, which allows the entire activation of the myocyte. At the level of the 
triadic junction, the calcium release channels of the SR or ryanodine receptors are opened 
by the Câ "̂  that enters through voltage gated L-type calcium channels in the sarcolemma. 
The SR releases a large amount of Ca^  ̂in the sarcoplasm. These Ca^  ̂ions binds to 
troponin C (protein in the actin filament that inhibits the interaction between actin and 
myosin) and allows the interaction between actin and myosin, permitting the sarcomere 
to contract. Relaxation occurs when the rise in sarcoplasmic Ca^  ̂increases the uptake of 
Ca^^ into the SR by the calcium pump known as the Sarco-Endoplasmic Reticulum 
Calcium ATPase (SERCA) located mainly along longitudinal tubules of the SR. The 
strength and velocity of tension developed by the sarcomere are directly related to the 
amount of Ca^^ available to induce contraction. Stimulation of sarcolemmal P-adrenergic 
receptors increases the intracellular concentration of cyclic AMP (cAMP), which 
augments contractility by increasing Ca^  ̂entry through calcium chaimel and also 
facilitates relaxation by phosphorylation of Troponin 1 (reduces Ca^^ affinity) and of
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phospholamban. This protein when phosphorylated increases the rate of Ca^^ uptake into 
the SR [83].
2-3: Sarcomere Stretch and Cardiac Function
The preload, the afterload, the contractility, the compliance and the heart rate 
regulate the contraction of the heart. The preload corresponds to the Frank-Starling law of 
the heart; the mechanism by which any increase in diastolic volume causes an increase in 
systolic performance. It establishes the initial muscle length of the cardiac fibers prior to 
contraction. The afterload is the sum of all the loads against which the myocardial fibers 
must shorten during systole. The contractility corresponds to the speed and shortening 
capacity of the heart. The compliance corresponds to the capacity of the heart to fill at 
any diastolic pressure and the heart rate is the frequency of contraction. These five factors 
are interrelated and determine the myofibril stretch or length, a principal determinant of 
cardiac performance [83]. Changes in muscle length not only change the number of actin- 
myosin bridges that can be formed to develop force but also affect the amount of force 
produced by the same amount of Ca^  ̂activation [84]. Lengthening the sarcomere 
promotes enhanced Ca^^ binding to troponin C and an increase in contractile force in 
response to the release of Ca^  ̂from the SR. Length or stretch of the sarcomere modulates 
the contraction via the excitement Câ "̂  release process [85]. The Anrep effect or 
homeometric autoregulation corresponds to the adaptation of the cardiomyocyte to an 
abrupt change in length. This change of length in vivo or in vitro increases the Ca^  ̂
concentration in the sarcoplasm and in parallel the development of contractile force [84]. 
At normal filling pressures, a myocardial sarcomere length of the LV varies from 2.07
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pm at end-diastole to 1.8 pm at end-systole [86]. The resting tension of the sarcomere 
increases markedly between 2.0 and 2.2 pm and the actin and myosin myofilaments are 
optimally overlapped to provide maximal forces when the myocardial sarcomere 
measures 2.2 pm after fixation. When the sarcomere is stretched beyond 2.2 pm, the 
myocardium become very stiff and resting tensions rise greatly while developed tension 
starts to decline [83]. A number of stimuli such as pressure and volume overload and MI 
are responsible for the stretch of cardiomyocytes, thus the sarcomeres. Following 
myocyte loss, a portion of the ventricle is disabled resulting in failure to eject a normal 
quantity of blood. There is an increase in intraventricular end-systolic volume that is 
added to the blood entering the ventricle during the diastole. This overload volume 
creates an increased mechanical stress that stretches the myocardium [83]. The sarcomere 
lengths increase ultimately to 2.2 pm in endocardial, midwall and epicardial areas, where 
at this point, further increases in diastolic volume produces a very large increase in 
diastolic pressure. This limits acute ventricular dilatation and there does not appear to be 
any overstretch (beyond 2.2 pm) of the sarcomeres. Excessive stretch of the 
cardiomyocyte may lead to myocyte damage and even death [87]. The adaptations of the 
heart (or ventricular remodeling) to chronic distending forces are an increase in myofibril 
length with addition of new sarcomeres in series (hypertrophy) as well as a ventricular 
dilatation to maintain the cardiac output [88]. The Laplace relationship (T=(P x r)/2h 
where T=ventricle wall tension, P=LV pressure, r=radius and h=wall thickness) describes 
the increased workload created by the increased volume for the heart. Wilson et al. [89] 
showed that, eight weeks after induction of an anterior MI, the ventricle wall stretch 
measured by the percentage of lengthening of wall segments was heterogeneous. The
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lengthening of the wall segments in a remodeled ventricle was directionally greater 
within the MI region: Further from the Ml, less stretch applied on the cardiomyocytes. 
Following a MI, the mechanical stress exerted by the overload volume associated with 
ventricle geometrical alterations does not stretch the myocardium homogeneously. The 
fall of cardiac output that follows the loss of myocytes is also compensated by a variety 
of physiological mechanisms [2]. These adjustment mechanisms try to preserve the 
cardiac function within physiological range to maintain the patient symptomatic or 
minimally symptomatic after the initial event. Heart failure may then develop 
progressively and at some point the patient will develop symptoms [90]. The activation of 
the adrenergic nervous and salt -and water- retaining systems preserve pressure and 
cardiac output, and the activation of vasodilatory molecules, such as natriuretic peptides, 
prostaglandins and nitric oxide, counteract the systemic vasoconstriction resulting from 
excessive activation of the renin angiotensin aldosterone and adrenergic systems [91]. 
These compensatory mechanisms may also participate in the remodeling process and the 
development of contractile dysfunction [1,2,91,92].
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Aim of the Study
The presence of functional mitral regurgitation secondary to an ischemic event is 
frequent and known to double mortality. While its mechanism has been extensively 
studied and its surgical treatment standardized the presence, importance and mechanism 
of a concomitant functional tricuspid regurgitation has been generally neglected. The 
interest and therefore knowledge of the tricuspid valve has always lagged behind the 
mitral valve. Because of the paucity of clinical signs when diseased and the imprecision 
of available diagnostic tools, the tricuspid valve has been generally ignored by 
cardiologists and surgeons. In a previous retrospective study of patients with mitral 
regurgitation from ischemic origin, we observed the presence of a concomitant and 
significant functional TR in 30% of cases. Based on this finding, we hypothesized that 
infarction alters not only the geometry of the LV, but also of the RV, leading to both 
IMR and ITR. These geometric alterations also modulate mechanical stresses 
resulting in molecular ehanges. To test these hypotheses, the following 
experimentations were performed.
Before analyzing the geometrical dimensions of both ventricles in heart failure, it 
was necessary to complete three experiments in normal hearts in order to understand the 
common elements of both atrioventricular valves. The tricuspid valve presents many 
variable anatomical characteristics [93] compared to the mitral valve. Therefore, to 
analyze the constant anatomical characteristics of the tricuspid valve, we performed an 
anatomical study of the tricuspid valve (including an original terminology) (Experiment 
1). Secondly, to clarify the geometrical changes and the relationship of the normal mitral
30
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
and tricuspid valves during the cardiac cycle, we performed an in vivo study of the 
functional anatomy of both valves using invasive sonomicrometry technology 
(Experiment 2). Thirdly, following a MI, heart failure develops progressively and 
repetitive analysis of the ventricle measurement is needed to understand the geometrical 
changes of the ventricles. The use of the non-invasive trans-thoracic echocardiography 
seemed more appropriate than the invasive sonomicrometry technology on a chronic 
heart failure animal model. Therefore, given the lack of published information of trans­
thoracic echocardiography in sheep, we compared the trans-thoracic echocardiographic 
data with the sonomicrometric data (Experiment 3) to assess the reliability of the trans- 
thoracic echocardiography in sheep. Then, we developed a reproducible animal model of 
ischemic heart failure leading to IMR and ITR and analyzed the geometrical changes of 
both atrioventricular valves using trans-thoracic echocardiography (Experiment 4). 
Lastly, recent advance in molecular physiology of the cardiomyocyte showed that 
endothelial and neuronal nitric oxide synthase (eNOS & nNOS) contribute to sustain 
normal excitation/contraction coupling and to response to stretch [94]. The mechanical 
stress that stretches the cardiomyocyte has a direct impact on the excitation/contraction 
coupling of the cell as previously seen. Therefore, to analyze the molecular change 
associated with the geometrical alterations, we searched for regional variations in eNOS 
and nNOS expressions at increasing distance from the Ml given the fact that the further 
from the MI the less stretch is applied to the cardiomyocytes [89] (Experiment 5).
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Normal Heart Experiments
Experiment 1: A Unified Functional Terminology for the Mitral and Tricuspid 
Valves
The tricuspid valve has been traditionally described as formed by three leaflets 
and three or more papillary muscles [49] [50] [95], although a recent anatomical study 
describes it as a bicuspid valve with endless variations in leaflet scallops, chords, and 
papillary muscles [93]. A precise nomenclature has been developed for the mitral valve, 
however, no such terminology is available for the tricuspid valve. To understand the 
tricuspid anatomy and develop a tricuspid valve terminology similar to the existing mitral 
valve nomenclature, we studied 50 porcine hearts. The use of porcine heart was justified 
by its availability and the fact that in all higher vertebrates, the morphogenetic programs 
in the heart are the basically similar [96]. The study was designed as a search for 
parameters common to both atrioventricular valves that would lead to a unified 
terminology easy to apply in clinical practice.
Experiment 2: Geometrical Changes of the Mitral and Tricuspid Valves during the 
Cardiac Cycle.
A simultaneous study of both valves and ventricles in an ovine model allows the 
understanding of the close anatomic and physiologic relationships between the LV and 
RV.
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Experiment 3: Echocardiography Data versus Sonomicrometrics Data.
Reliability of the use of transthoracic echocardiography (TTE) for the 
measurement of distances between intracardiac structures was shown by the comparison 
of sonomicrometric measurements and TTE measurements in normal sheep.
Heart Failure Experiments
Experiment 4: Induction of a Postero-lateral Infarct by Percutaneous Injection of 
100% Ethanol and Analysis of LV and RV Geometrical Changes.
We developed an original percutaneous method of inducing Ml consisting of the 
selective injection of pure ethanol in branches of the circumflex artery leading to a 
posterior-lateral Ml that by ± 8 weeks resulted in significant IMR and ITR and analyzed 
the geometrical change of both ventricles by TTE.
Experiment 5: Change in eNOS and nNOS Expression with the Distance from the 
Infarct in an Ovine Ischemic Heart Failure Model
The changes of molecular expression and localization of eNOS and nNOS were 
measured at increasing distances from the postero-lateral Ml. A correlation between these 
changes and the distance from the myocardial infarction was analyzed.
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EXPERIMENTS
Experiment 1: A Unified Functional Terminology for the Mitral and 
Tricuspid Valves 
1: Background: Anatomy of the Human Mitral and Tricuspid Valves
1-1: Mitral valve anatomy
The mitral valvular apparatus derived its name from the bishop’s mitre. It is 
located between the left atrium and the left ventricle (LV) and allows the blood to flow 
from the left atrium to the left ventricle. The mitral annulus, the leaflets, the chordae 
tendinae and the papillary muscles are the four elements that constitute the mitral valve.
1-1-1: The mitral annulus
The mitral annulus forms the junction between the left atrium and the left 
ventricle, and is the insertion of the anterior and posterior mitral leaflets. More an area 
than a true anatomically identifiable fibrous structure between the left atrium and the left 
ventricle, the mitral annulus can be defined by its function. It is described by Kumar et al. 
as “part o f  the circular area that surrounds the base o f the left ventricle and encompasses 
the inlet, inflow or mitral orifice separated from the outflow orifice by the aortic curtain, 
which stretches between the two fibrous trigones o f the heart ” [97]. These two fibrous 
structures, the right and left trigones, collagenous thickening of the fibrous skeleton of 
the heart, can be consistently isolated in hearts. The right trigone (Tl) is a fibrous
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junctional area between the membranous septum, the mitral, the aortic and the tricuspid 
valves and was considered by Zimmerman et al. as the central body of the heart [98]. The 
left trigone (T2) is situated between the mitral valve and the left coronary cusp leaflet of 
the aortic valve. The shape and size of the mitral annulus varies continuously during the 
cardiac cycle as it was shown in dogs [99] and later in the human by Ormiston et al., who 
showed that the mitral annular area increases gradually during diastole and then decreases 
until midsystole. The mitral area starts to increase again during late systole [100]. 
Sonomicrometry array localization, marker angiography and three dimensional 
echocardiography were also used to confirm its dynamic changes during the cardiac cycle 
and to assess the saddle configuration of the mitral annulus with the commissures located 
at the low point of the saddle [26,101,102]. The hyperbolic paraboloid shape of the 
saddle configuration decreases the stress on leaflets during systole [101].
1-1-2: The leaflets
Anterior and posterior leaflets constitute the tissue portion of the valve (Figure 5). 
The anterior leaflet has a semicircular shape and is attached to two-fifths of the 
circumference of the mitral annulus. The free edge is not indented and there is continuity 
between the left coronary and non-coronary cusps of the aortic valve and the anterior 
mitral leaflet between the two trigones (Figure 6). The posterior leaflet is quadrangular 
and attached to three fifths of the mitral annulus. In an anatomical post-mortem study of 
50 mitral valves, Ranganathan et al showed that the division of the mitral leaflets into 
anterior and posterior leaflets was possible in 98% of the cases by identifying the 
commissural areas. The posterior leaflet was tri-scalloped in 92% of the hearts with one
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middle scallop more prominent in 84% of cases [67]. The posterior leaflet height is half 
that of the anterior leaflet height. However, the tissue area of both leaflets is the same and 
is twice the size of the orifice area delimited by the mitral annulus. These leaflets are 
separated one from the other by the commissures. The commissures are posteromedial 
and anterolateral according to their anatomical position in the body. Some leaflet tissue is 
delimited at the level of the commissures and can be called commisural leaflets. Distinct 
ridges that define the leaflet closure area (or coaptation surface) exist on the atrial side of 
the leaflets [67].
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Figure 5: The mitral leaflets o f a pig heart.
Atrial face after section of the ventricle through the posterior wall. 
Anterior leaflet: A,
Posterior leaflet: P
I
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1-1-3: The chordae tendineae:
The connection between the papillary muscles and the leaflets, the chordae 
tendinae are classified according to the site of insertion between the free margin and the 
base of the leaflets. Tandler et al divided the chords in three orders and Lam et al. 
subdivided the three orders by describing the commissural, strut and basal chordae [68]. 
Marginal chordae (primary chordae) are inserted into the free margin of the leaflets. They 
are made up of the commissural chordae, branches of cleft chordae of the posterior leaflet 
and the rough zone chordae of the posterior and anterior leaflets.
Intermediate chordae (secondary chordae) are inserted beyond the free margin of the 
leaflets. They are made up of those that arise from each papillary muscle and insert into 
the ventricular aspect on the rough zone of the anterior and posterior mitral leaflet and by 
the main stems of the elefl ehordae of the posterior leaflet. Lam et al. described among 
them two particularly strong and thick, tendon-like chordae that insert into the 
undersurface of the body of the anterior leaflet and stretch toward the anterior mitral 
annulus and called them strut chordae [68]. Leonardo Da Vinci wrote, on his anatomical 
drawing of the heart, “prima” in front of these presumably chordae (Leonardo da Vinci, 
Anatomic Drawings, Windsor Collection, Windsor, United Kingdom). These stay 
chordae remain under the same pressure during the entire cardiac cycle [103] (Figure 6). 
Basal chordae are limited to the posterior leaflet. They are attached to the leaflet base 
connecting it to the mitral annulus and the myocardial tissue of the posterior leaflet.
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Figure 6: The stay chords.
The strut or stay chords (A & B) and their insertion on the anterior mitral leaflet 
(ventrieular view). C shows the continuity between the left coronary and non-coronary 
cusps of the aortic valve and the anterior mitral leaflet between the two trigones.
i a
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1-1-4: The papillary muscles:
Two papillary muscles arise from the LV wall approximately one-third the length 
of the LV from the apex. They are anterolateral and posteromedial, aeeording to their 
anatomical position. They connect the mitral leaflet to the ventricle wall through the 
ehordae tendinae. They are anchored in the LV wall among the trabeculae cameae of the 
myocardium. Each papillary muscle provides chordae to half of the eorresponding mitral 
leaflet and eommissure (Figure 3). The morphology of these papillary muscles is very 
variable and difficult to describe. Ranganathan et al. described three different types, 
according to their insertion in the LV wall [104].
-Finger-like: One third of the muscle arises in the LV cavity and there are no 
trabeculation.
-Tethered: The papillary muscle is hardly seen and only its tip arises in the LV
eavity.
-Mixed: The papillary muscle presents both previous eharacteristics.
This classification was modified in 1996 by Rhamsheyi et al. who described 4 types of 
papillary muscles from 65 human hearts [105]:
-Type 1= Finger-like: Papillary muscles well individualized and non-subdivided 
corresponded to 63% of the antero-lateral and 41% of the postero-medial.
-Type 11: Papillary muscle is divided longitudinally in two parts. The chordae to 
the posterior leaflet are on one head and the chordae for the commissural and the anterior 
leaflet are on the other head (7% of the anterolateral and 39% of the posteromedial 
papillary muscles).
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-Type III: Papillary muscle divided into several heads. One head supports all the 
chordae for the commissural area (15% of the anterolateral and 7% of posteromedial 
papillary muscle).
-Type IV: Papillary muscle divided in several complex heads with several 
insertion bases. One thin muscular band supports very short commissural chordae (15% 
anterolateral and 13% posteromedial papillary muscles).
The vasculature of the papillary muscles is also variable. The anterolateral 
papillary muscle is vascularized by branches of the left anterior deseending artery. The 
posteromedial papillary muscle is vascularized by branches of the right coronary or of the 
obtuse marginal artery. This is independent of the dominance of the right or left coronary 
[106]. Ranganathan et al. described in 10 human hearts the micro-vascularization of the 
papillary muscles. One or more of long penetrating vessels that originate from the artery 
on the epicardial surface of the heart supplied each papillary muscle. During their course 
through the wall, these vessels branched and anastomosed with adjacent arteries. A 
central artery supplies the free portion of the papillary muscle. In case of many trabecular 
attachments, the long penetrating intramyoeardial vessels were eoursing through them 
[104].
1-1-5: Anatomical and surgical classification
Indentations and scallops of the posterior leaflets associated with relationship with 
chords and papillary muscles are used to classify the areas of the mitral valve.
Two different anatomical nomenclatures are used to analyze the segmental valve (Figure 
3 and Table 1). The Carpentier classification delimits both leaflets in three eorresponding
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areas according to the main scallops of the posterior leaflet and recognizes two 
commisural areas or leaflets. The Duran classification delimits the anterior leaflet in two 
parts and the posterior leaflet in four parts and two commissural areas according to their 
attachment to the papillary muscles [97].
Table 1 : Correspondence of Carpentier and Duran nomenclatures of the mitral valve. 
A: anterior leaflet, P & PM; posterior leaflet, C: commissural leaflet
Carpentier Duran
Anterior leaflet A1 A1
A2
A3 A2
Posterior leaflet PI PI
P2 PM1,PM2
P3 P2
Commissural leaflets Cl
C2
Cl
C2
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Figure 7: Classifications of the mitral valve. Black: Duran’s and Grey: Carpentier’s
Carpentier (gray) and Duran classification (black) are represented together. The black 
lines delimit the chordae repartition while the gray lines delimit the scalloped 
segmentation of the leaflets.
PM1 PI C1 /M I A2 C2 pM2
Joudinaud 2005
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1-2: Tricuspid valve anatomy
The tricuspid valvular apparatus was named from the predominant presence of 
three leaflets. It is located between the right atrium and the right ventricle and allows the 
blood flow to go from the right atrium to the right ventricle. It is, like the mitral valve, 
constituted of four elements: the tricuspid annulus, the leaflets, the chordae tendinae and 
the papillary muscles.
1-2-1: The tricuspid annulus
The tricuspid annulus is more an area where the leaflets are attached to the 
myocardium between the right atrium and the right ventricle than an actual fibrous ring. 
The absence of an encircling fibrous structure may explain the change in geometry during 
the cardiac cycle. The geometry changes were demonstrated in a sheep study by Hiro et 
al [41]. The annulus expanded almost homogeneously during the cardiac cycle from 
4.8±0.8 em^ to 6.1 ±0.9 cm .̂ The septal part of the annulus expanded by 10 %, the 
anterior by 13% and the posterior by 14%. These findings were also seen in the human by 
Tei et al. using echocardiography [107]. The tricuspid annulus was described as pear- 
shaped with its narrower end close to the antero-septal commissure and its wider end 
corresponding to the midpoint of the posterior leaflet in pressurized post mortem human 
[108] and sheep hearts [41]. In-vivo, the sheep model of Hiro et al. showed the opposite 
with the narrow end at the level of the postero-septal commissure. Like the mitral 
annulus, the tricuspid annulus is a three-dimensional structure with its three highest 
points at the level of the mid-posterior and mid-anterior annulus and the anteroseptal 
commissure (Figure 8). Three minimal points were found at the antero-posterior and
44
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
postero-septal commissures and the midpoint of the septal leaflet [41]. This complicated
3-D structure of hyperbolic paraboloid-like for the saddle shape of the tricuspid valve 
may reduce the stress exerted on the leaflets [101].
Figure 8: The saddle shape of the tricuspid annulus.
The three lowest points are the anteroposterior commissure (AP), the posteroseptal 
commissure (PS), and the mid of the insertion of the septal leaflet on the annulus (S). A 
and P: mid points of the anterior and posterior leaflets on the annulus. AS anteroseptal 
commissure. (From CMG Duran in Surgery of the chest, pl337 [57])
PS AP
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1-2-2: The leaflets:
Commonly, the tricuspid valve is described with three leaflets separated by three 
commissures (the anterior, the septal and the posterior leaflets separated by the 
anteroseptal, anteromedial and posteromedial commissures). The leaflets are named 
according to the level of their insertion on the annulus. At the level of the commissures 
that don’t reach the annulus, can be found small commissural leaflets [57]. The anterior 
leaflet is the largest, followed by the posterior leaflet with the septal leaflet being the 
smallest (figure 9 A & B). However, the number of leaflets of the tricuspid valve is 
highly variable [93]. In a study of 100 normal human hearts, Victor et al. showed 
numbers of subdivisions for the anterior and posterior leaflets attached to the free right 
ventricle wall. They described six main different types with a minimum of one and a 
maximum of five scallops dividing the anterior and posterior leaflets:
-Type A: No division between anterior and posterior leaflets (one scallop) (1%)
-Type B: Division in posterior and anterior leaflets (31%)
-Type C: Type B -f antero-posterior commissural scallop (three scallops) (40%)
-Type D: Type C -i- Presence of a posterocommissural scallop (four scallops) (17%) 
-Type E: Type D -t- Presence of an anterocommissural scallop (five scallops) (10%)
-Type F: Absence of tissue at the antero septal junction. (1%)
The septal leaflet remains constant and is always described by anatomist [93] [50] [57]. 
However, the anterior and posterior cusps are dominant in tricuspid valve function [109]. 
Higashidate et al. showed in dogs that resection of the septal leaflet did not result in TR 
and that the two remaining valves were sufficient for closure of the tricuspid orifice 
[110].
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Figure 9: The Tricuspid valve in a pig heart.
A: Atrial face of the tricuspid valve viewed after section of the anterior wall of the right 
ventricle. Septal (s), Anterior (a) and posterior (p) leaflets.
B: Tricuspid valve viewed from the atrium.
C: Detail of the finger-papillary muscle and of the marginal chordae tendinae.
;
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1-2-3: The chordae tendinae and papillary muscles
In most cases, three tricuspid papillary muscles can be found and identified as 
anterior, posterior and septal. Anterior and posterior muscles are practically always 
present, however, the septal muscle might be absent in 20% of patients. The anterior 
papillary muscle is the longest and sustains the highest number of chordae [57]. In their 
anatomical work on 100 human hearts, Viktor et al. found that the papillary muscles 
exhibited endless variations in number, size, shape, fusion and location (Figure 9C)[93]. 
Marginal and basal chords connect the papillary muscles to the leaflets. Marginal chords 
are inserted on the free edge of the leaflets and basal chords are inserted into the 
ventricular surface of the leaflets. The role of the basal chords in the right ventricle is 
probably the same as in the left ventricle in maintaining the valve and ventricular 
geometry [57].
The interest and therefore knowledge of the tricuspid valve has always lagged 
behind the mitral valve. Because of the paucity of clinical signs when diseased and the 
imprecision of available diagnostic tools, the tricuspid valve has been generally ignored 
by cardiologists and surgeons. In the case of the mitral valve, more precise nomenclatures 
have been developed to fit the demands of complex repair maneuvers; however, no such 
terminology is available for the tricuspid valve.
2: Materials and Methods
Fifty pig hearts collected from a local abattoir (Hamilton Packing Inc., Hamilton, 
Montana, United States) were studied. The pulmonary artery was incised longitudinally. 
The incision was extended apically between the anterior and right pulmonary cusps and
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across the free wall of the right ventricle to ensure that no papillary muscle, muscle band, 
or chordae was divided. After sectioning the ventricular muscle band, the anterior leaflet 
was cut from its free edge to the annulus. The tricuspid valve and right ventricle were 
then fully opened.
To design a terminology for the tricuspid valve, all observations were based on 
the traditional understanding that the tricuspid valve has three main leaflets and three 
papillary muscles. Recognizing the high variability of all its structures, an attempt was 
made to use this classic assumption because it is familiar to surgeons and cardiologists.
The leaflets were classified according to their heights (free edge to base) and 
their chordal insertions. The three main leaflets were defined as having the largest heights 
and being supported by chords from two different groups of papillary muscles. They were 
identified with the classic terms of septal (S), anterior (A), and posterior (P). The 
remaining leaflets were defined as “commissural” if they had smaller heights and were 
supported by chords arising from a single papillary muscle group.
The papillary muscles were grouped according to their chordal distribution to a 
single commissure and two contiguous main leaflets. The group corresponding to the 
anteroseptal commissure was termed “anteroseptal,” the group corresponding to the 
anteroposterior commissure was termed “anteroposterior,” and that corresponding to the 
posteroseptal commissure was called “posteroseptal”. The shape of the papillary muscle 
within the same group was described as “finger-like” if one-third of the muscle protruded 
into the ventricular cavity, as “tethered” if the body of the papillary muscle was 
embedded within the ventricular wall and only its tip could be identified [104], and as 
“vestigial” when the chords arose directly from the ventricular wall (Figure 10).
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Maximum distances between the lateral aspects of the papillary muscles furthest 
apart within the same group were measured. According to this distance, each papillary 
muscle group was classified as “small” (1 to 2 cm), “medium” (2 to 3 cm), or “large” (> 3 
cm).
The right ventricular band was defined as “atrophic” (< 2 mm width), “medium” 
(2 to 4 mm), or “large” (> 4 mm).
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Figure 10: The three different types of papillary muscles.
F: finger-like; T: tethered; V: vestigial.
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3: Results
3-1: The Leaflets and Their Commissures
In all hearts, the tricuspid valve had three main leaflets. As commonly accepted, 
they were termed septal, anterior, or posterior according to their base attachment to the 
annulus. Between each main leaflet, one or more commissural leaflets were commonly 
present. These commissural leaflets did not reach the annulus with more than 5 mm of 
tissue between its free edge and the annulus. These commissural leaflets were mostly 
found between the anterior and the posterior leaflet (1.02 per heart, range 0-3) and 
between the posterior and the septal leaflet (0.98 per heart, range 0-2). The presence of a 
commissural leaflet between the septal and the anterior leaflet occurred in only eight 
hearts (0.16 per heart, range 0-1). Every heart studied had at least one commissural 
leaflet. In one heart, one anteroposterior and one posteroseptal commissural leaflet had 
the same height as the main leaflet. The number of commissural leaflets present at the 
anteroposterior, posteroseptal, and anteroseptal commissure is shown in Table 2.
Table 2: Number of commissural leaflets at each commissure.
Commissures
Number of commissural leaflets per 
commissure
Anteroposterior Posteroseptal Anteroseptal
1 8 8 42
2 35 35 8
3 6 7 0
4 1 0 0
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3-2: The Papillary Muscles and Chordae Tendinae
Three groups of papillary muscles were found in every heart studied. The three 
groups were defined according to the distribution of their chords to the two adjacent half- 
main leaflets and their corresponding commissure. The number of separate papillary 
muscles per group is reported in Table 3.
In the anteroseptal group, a separate conus papillary muscle was always 
identified. The other muscles were constantly attached to the ventricular septum below 
the conus. The shapes of these 89 muscles were finger-like in nine cases, tethered to the 
wall in 12 cases, and vestigial in 68 cases. The overall width or maximal distance 
between muscles of the same group was small (< 2 cm) in 22 groups, medium (between 2 
and 3 cm) in seven groups, and large (> 3 cm) in three groups.
The anteroposterior group of papillary muscles was better defined than the other 
groups. In 48 of 50 hearts, it consisted of a single papillary muscle located in the free 
wall. This finger-like papillary muscle had one head in 25 hearts, two heads in 20 hearts, 
and was multi-headed in three hearts. The other two hearts presented an anterior group 
formed by two finger-like papillary muscles in one case and by four in the other. In both 
cases, the distance between the lateral aspects of the papillary muscles was medium 
(between 2 and 3 cm).
The posteroseptal papillary muscle group had the highest variability in shape, 
size, number, and location of the three groups. This posteroseptal group was always 
attached to the septum, except in one case. In this heart, there was one finger-like 
papillary muscle attached to the posterior free wall with the remaining papillary muscles 
anchored to the posterior septum. In all specimens, at least one papillary muscle was
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found on the septal wall close to the corner with the free wall. The shapes of the 115 
papillary muscles that constituted this group were fmger-like in 60 cases (with a single 
head in 73.3%, double head in 11.6%, and multi-headed in 15.1%). Of the remaining 
papillary muscles, 50 were tethered to the wall; in five, the papillary muscle was vestigial 
with the chords inserted directly onto the ventricular wall. The width or maximum 
distance between papillary muscles in that group was < 2 cm in 10 hearts, between 2 and 
3 cm in 22 hearts, and > 3 cm in 12 hearts.
A right ventricular band was always present. Its thickness or diameter was 
atrophic (< 2 mm) in 14 hearts, medium (2 to 4 mm) in 19 hearts, and thick (> 4 mm) in 
17 hearts. In all specimens, this band linked the base of the anterior papillary muscle to 
the base of the conus papillary muscle.
In two hearts, it was difficult to determine the appurtenance of a single vestigial 
papillary muscle located on the septal wall between the anteroseptal and posteroseptal 
groups. Their chordae tendinae were inserted into the midpoint of the free edge of the 
septal leaflet.
Table 3: Number of separate papillary muscles per papillary muscle group.
Papillary muscle groups
Number of separate papillary 
muscles per papillary muscle group
Anteroseptal Anteroposterior Posteroseptal
1 18 48 6
2 26 1 22
3 5 0 18
4 1 1 3
5 0 0 1
Average number per group 1.78 T08 2.42
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3-3: Proposed Terminology and Classification
Careful analysis of the literature and of our findings revealed that the more 
preeise the description of the leaflets, the more confusing and useless it was for the 
surgeon. Like Kumar et al. [97], who focused on the anatomical elements that are 
observed by the surgeon through the atriotomy, we divided the struetures into three 
elements: the papillary muscles, the leaflets, and the chords. The three groups of papillary 
muscles were then defined by the numerals 1 for the anteroseptal; 2 for the posteroseptal, 
and 3 for the anteroposterior.
Each leaflet was divided in two areas that were named according to both the 
traditional leaflet’s names (S, A, P) and the papillary musele origin of the chords inserted 
on it (1, 2, 3). Figure 11 shows the suggested tricuspid valve terminology and Figure 12 
shows the combined mitral and tricuspid valve nomenclatures.
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Figure 11 : Tricuspid valve terminology.
The valve has been opened with a vertical section through the middle of the anterior 
leaflet. A1 & A3: anterior leaflet; P2 & P3: posterior leaflet; SI & S2: septal leaflet; C l, 
C2, & C3: commissural leaflets.
SI . « A1
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Figure 12: Diagram of the mitral and tricuspid valves as seen by the surgeon through left 
and right atriotomies.
Circles represent the papillary muscles and straight lines represent the division of the 
leaflets according to their chordal insertion into the papillary muscles. The shape of both 
annuli is based on sonomicrometric information.
For the mitral valve: A1& A2: anterior leaflet, PI, FMI, PM2 & P2: posterior leaflet. 
Cl & C2: commissural leaflets, 1 & 2: papillary muscles.
For the tricuspid valve: A1 & A3: anterior leaflet; P2 & P3: posterior leaflet; SI & 82: 
septal leaflet; C l, C2, & C3: commissural leaflets, 1, 2 & 3: papillary muscles.
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4: Discussion
4-1: A New Nomenclature for the Tricuspid Valve
Semantics has always been the main stumbling block to progress. A lack of 
precise definitions results in subjective meanings, variable interpretations, and 
subsequent confusion. This problem is particularly apparent in heart valve surgery, where 
more precise anatomic knowledge is required as new techniques are developed. The old 
terminology soon becomes insufficient to describe pathologic findings, surgical 
maneuvers undertaken, and evaluation of the results. Also, new surgical procedures 
demand a common set of anatomical definitions for the reporting of precise pre- and 
postoperative echocardiographic information between the echocardiologist and surgeon. 
This situation, which has been largely improved in the case of the mitral valve, is still 
missing for the tricuspid valve. To clarify this issue, we took the same familiar 
parameters used by surgeons and echocardiographers for the mitral valve as guidelines 
and applied them to the tricuspid valve. The aim of the present study was not a strict 
anatomical description, but a search for parameters common to all atrioventricular valves 
so that a unified terminology could be applied in clinical practice. Due to the variability 
in the number of leaflet scallops and number of chords present in the normal valve, we 
based both terminologies on the papillary muscles. Although the number of papillary 
muscle heads is also variable (particularly in the tricuspid valve), it was always possible 
to identify two groups in the mitral valve and three groups in the tricuspid valve. The 
Duran mitral valve classification was based on the fact that the mitral valve consists of 
two symmetrical structures supported by two papillary muscles (Figure 3). All elements 
supported by the anterior papillary muscle (situated to the left of the surgeon) were
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identified with the numeral 1 ; those supported by the posterior papillary muscle (situated 
to the right of the surgeon) were identified with the numeral 2. Therefore, the papillary 
muscles were identified as Ml & M2, the trigones were identified as T1 & T2, the 
commissures were identified as Cl & C2, the anterior leaflets were identified as A1 & 
A2, the lateral posterior scallops were identified as PI & P2, and the mid scallop was 
identified as PMl or PM2 according to whether its chords arose from M l or M2 [97].
The earlier classification described by Carpentier [111] was probably based on the fact 
that the most fiequent surgical maneuvers are applied to the posterior leaflet, so he 
defined its three scallops as PI, P2, and P3 and defined the anterior leaflet into the 
corresponding opposite A l, A2, and A3. This classification does not encompass the 
commissures, trigones, and papillary muscles, which must be identified with the old 
terminology based on anterior/posterior and lateral/medial terms.
The tricuspid valve is more complex than the mitral valve, not only because it is a 
trileaflet valve but, more importantly, because of its high variability. Traditionally, the 
tricuspid valve has been described as formed by three very thin leaflets attached to the 
annulus at their base and to the papillary muscles through the chordae tendinae[49,95]. 
Although the number of tricuspid leaflets varies according to author [93], it is commonly 
accepted that the tricuspid valve consists of three leaflets (septal, anterior, and posterior) 
that are separated by three clefts or commissures [112]. These commissures do not reach 
the annulus but delineate small commissural leaflets. By defining the main leaflets as 
tissue receiving chords from two different groups of papillary muscles, we always found 
three main leaflets associated with a variable number and size of commissural leaflets 
(interpreted as additional scallops by other authors [93]). Since our focus was on the
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surgical classification of the tricuspid valve and not on a precise anatomical report, we 
did not fully size all leaflets and commissures. The septal leaflet was present in all of the 
hearts studied, which is always described by others [50,93,112].
As previously reported [93], we found endless variations in the number, size, 
shape, fusion, and location of the papillary muscles. However, when observing the 
insertion of the chords into the three leaflets, we were able to identify three different 
groups of papillary muscles corresponding to the anteroseptal, anteroposterior, and 
posteroseptal commissures. The anteroposterior muscle was the longest and sustained the 
highest number of chordae. It was single in 96% of our hearts. The posteroseptal 
papillary muscle group, although most variable, was always present in our series. 
Although the anteroseptal muscle has been reported as absent in 20% of patients [112], if 
we classified it as an anteroseptal group giving rise to chords to the septal and anterior 
leaflets, we constantly found one papillary muscle on the conus.
The three papillary muscle groups were always present in 1) the middle of the free 
wall; 2) on the septum close to the corner between the posterior wall and the free wall; 
and 3) at the level of the conus. Although the main papillary muscle variations were 
always present on the septal wall, these aberrant muscle heads could always be classified 
into the posteroseptal or the anteroseptal groups according to the distribution of their 
chords. It was difficult to classify two septal papillary muscles into either the anteroseptal 
or the posteroseptal group in only two cases; their chords were inserted exactly in the 
middle of the septal leaflet.
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4-2: Clinical Relevance and Limitations of the Study
The present anatomical study was conducted on pig tricuspid valves, which 
probably differ from human tricuspid valves. However, the goal of this study was not to 
provide an exact anatomical description of the porcine tricuspid valve, but rather to 
attempt to unify the nomenclatures of both atrioventricular valves and find a simple 
method for surgeons and echocardiologists to describe and record pathologic findings and 
repair techniques employed. The porcine model was used to determine whether a 
classification of the different structures of the valve was possible despite the variability 
between individual hearts. Although tricuspid valve replacement and simple ring 
armuloplasty do not require detailed knowledge of the valve, newer surgical techniques 
demand a terminology that identifies the exact location of the pathologic findings and 
surgery performed. Clear examples of this need include commissurotomy of rheumatic 
lesions [112], leaflet resection of advanced myxomatous lesions [113], excision of 
infective vegetations [114], transfer and rotation of leaflet segments in traumatic [115] 
and bioptome-induced [116] ruptures, and autotransplantation into the mitral valve of 
whole commissures carrying their corresponding leaflets and papillary muscle [117,118]. 
In all of these organic lesions, a clear terminology is absolutely required to (at a 
minimum) record the surgery performed. More recently, the awareness of the high 
incidence of functional ischemic tricuspid regurgitation [60] and the poor results obtained 
from standard aimuloplasties [79] are promoting studies on its physiopathology and 
possible new, more complex surgical techniques. Again, precise anatomic definitions 
become imperative.
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The tricuspid valve has been generally ignored by cardiologists and surgeons 
because of the paucity of clinical signs when diseased and the imprecision of available 
diagnostic tools. The tricuspid valve has been traditionally described as formed by three 
leaflets and three or more papillary muscles [49] [50] [95], although a recent anatomical 
study describes it as a bicuspid valve with endless variations in leaflet scallops, chords, 
and papillary muscles. This complicated anatomy has resulted in the absence of a 
systematic classification of the valve. To standardize the description of both 
atrioventricular valves, we studied the tricuspid valve from 50 pig hearts and described a 
new terminology for this valve based on the same principles previously applied to the 
mitral valve. We found that the tricuspid valve may be divided into three elements: three 
groups of papillary muscles, the chords and the main leaflets. The three groups of 
papillary muscles were defined by the numerals 1 for the anteroseptal; 2 for the 
posteroseptal, and 3 for the anteroposterior. Each main leaflet was divided in two areas 
that were named according to both the traditional leaflet’s names (S, A, P) and the 
papillary muscle origin of the chords inserted on it (1, 2, 3). Without expecting rapid and 
universal acceptance of this nomenclature, it is hoped that this attempt will constitute a 
step toward the goal of more precise data collection, both for particular groups and also 
between different surgical centers.
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Animal Welfare and Anesthesia Protocol for Experiment 2 to 5:
Animal Welfare
All animals were cared for in accordance with the “Principles of Laboratory 
Animal Care” formulated by the National Society of Medical Research and the “Guide 
for the Care and Use of Laboratory Animals” prepared by the Institute of Animal 
Resources, National Research Council, and published by the National Academy Press, 
revised 1996. The protocol for the use of the animals for this project was also reviewed 
and approved by the Institutional Animal Care and Use Committee (lACUC) of The 
University of Montana.
Anesthesia protocol:
Tar ghee sheep (weight range 50 to 80 kg) had a left jugular catheter placed and 
were premedicated with intravenous (i.v.) administration of ketamine 1.0 mg/kg, atropine 
0.03 mg/kg, and propofol 4.0 mg/kg. Artificial ventilation was maintained with a volume 
regulated respirator (North American Drager, Telford, PA, USA) supplemented with 
oxygen at 2-4 L/min. Anesthesia was maintained with intermittent propofol and 
continuous isoflurane (1.5% to 2.5%). A Swan-Ganz catheter was introduced through the 
left external jugular vein into the pulmonary artery. At baseline, three consecutive sets of 
measurements of cardiac output and right ventricular (RV) and pulmonary artery (PA) 
pressures were taken.
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Experiment 2; Geometrical Changes of the Mitral and Tricuspid Valves 
during the Cardiac Cycle 
1: Introduction
The following elements constitute both atrioventricular valves: the annulus, 
leaflets, chordae tendinae and papillary muscles [95]. These elements work together with 
the ventricles to maintain the competence of the valves. Studies on cadavers showed the 
remarkable geometry of the valves. Functional studies in animals showed the geometrical 
changes of the mitral [119,120] and the tricuspid [41] valves. The dynamic interactions 
between the mitral annulus and the aortic valve were shown Lansac et al. [121]. To 
understand the relationship of the normal mitral and tricuspid valves, it was necessary to 
study the normal geometry and dynamic interactions of the tricuspid and mitral valves in 
the same animal. Therefore, we undertook the following experiment.
2: Materials and Methods
2-1: Definition of the Different Phases of the Cardiac Cycle
The different phases of the cardiac cycle were defined from the LV and aortic 
(Ao) pressure curve. End-diastole or beginning of systole (isovolumic contraction or 
JVC) was defined as the beginning of an increase in LV pressure (dP/dt>0). Lnd- 
isovolumic contraction was defined as the beginning of ejection (Lj) at the point where 
the LYP curves crosses the aortic pressure curve (gradient AoP/LVP=0). The dichrotic 
notch on the aortic pressure curve defined end-ejection and the beginning of isovolumic 
relaxation (IVR). The end of lYR was defined by the lowest pressure point of the LY
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pressure curve (D). Mid-diastole point (midD) was defined by the middle-time point 
between the D and the beginning of systole.
2-2: Digital Sonomicrometry
Originally developed by Smith and Vesely [122], the digital sonomicrometer is 
available from Sonometrics Corporation (London, Ontario, Canada). Sonomicrometry is 
the measurement of distances in an aqueous medium within soft tissue by using sound 
energy. Small piezoelectric crystals are utilized as both transmitters and receivers of short 
pulses of ultrasound energy. The time for a transmitted pulse signal from a transmitter 
crystal to be received by a receiver crystal is measured. The computer converts this time 
to distance by using the Doppler formula. When a transmitting crystal is activated, all 
digital distance counters are reset to zero. The instant that a receiving crystal receives a 
burst of transmitted ultrasound, its respective digital counter is halted and the resulting 
numbers are transferred directly to the RAM buffer of the computer. There is no analog 
conversion process involved in these distance measurements, therefore eliminating the 
need to calibrate the system.
The circuitry in the digital sonomicrometer (Sonometrics Corporation, London, 
ON, Canada) allows for up to 32 simultaneous distance measurements to be performed. 
The range of measurement is software limited from 0 mm to 196 mm. The typical range 
is from 10 mm to 120 mm. The smallest measurable change in distance is 0.024 pm.
In addition to the digital sonomicrometer readings, a circuit board interfacing 
directly with the PC-AT bus inside the computer performs the function of digitizing up to 
16 external analog signals. The conversion of each analog signal to digital is performed
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simultaneously with virtually no phase shift and occurs once per block of 
sonomicrometry measurements. Analog signal allows the recording of LV and aortic 
pressures and distances between the crystals during the same time period. The user can 
select the active transmitters, receivers and analog channels. These parameters including 
the time and date of data acquisition, are stored along with the raw data.
2-3: Data Acquisition
Sonometrics Digital Ultrasonic Measurement System TRX Series 16 and 1 and 2 
mm transmitter/receiver crystals were used to measure displacements. A post-processing 
program (Sonometrics Corporation, London, Ontario, Canada) was used to examine each 
individual length tracing between crystals. Data sampling rate was 200 Hz. A filter 
algorithm eliminates possible signal corruption by analyzing the pattern of both the true 
distance and the corrupted data. Millar pressure transducer eontrol units TCB 600 and 
MIKRO-TIP pressure transducers (Millar Instruments, Inc. Houston, TX, USA) were 
used to obtain the LV and Ao pressures. To ensure stability, the micromanometer 
catheters were immersed in saline for a minimum of 2 hours before use then placed into a 
water bath warmed to 37°C and zeroed in the dark. All distances and pressures were 
displayed and recorded simultaneously on the same screen by the Sonomicrometrics 
system. This ensures that all data are synchronized and recorded during the same 
timeline.
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2-4: Surgical Preparation
The animals underwent implantation of 19 ultrasonic crystals on the mitral and 
tricuspid valves using cardiopulmonary bypass. The animal was placed in the right lateral 
decubitus position on the operating table. The heart was exposed through a T-shaped 
incision of the pericardium by a standard left thoracotomy into the 4* intercostal space. 
The heart was then suspended in a pericardial cradle. Heparin at a dose of 300 U/kg i.v. 
was injected as a bolus in preparation for cardiopulmonary bypass with a target ACT of 
480 seconds or more. The ascending aorta was cannulated with a #16 Fr Medtronic 
arterial cannula. A #32 Fr single venous cannula was inserted into the inferior vena cava 
and a #24 Fr into the superior vena cava. Cardiopulmonary bypass (CPB) was then 
instituted. Two cotton umbilical tapes were placed around the superior vena cava and the 
inferior vena cava. A LV vent line was inserted into the LV apex. The ascending aorta 
was cross-clamped followed by the infusion of cold crystalloid cardioplegia into the 
aortic root.
2-4-1: Surgical Implantation of Crystals for the Mitral Valve Study
Ten ultrasonic crystals were used to study the mitral valve complex. The 
following 2-mm ultrasonic crystals were placed and secured with a 5/0 polypropylene 
suture on the mitral valve through a left atriotomy. Six crystals were placed on the 
annulus to delineate the longitudinal (PI, P2) and antero-posterior (AM, PM) diameter, 
and the intertrigonal distance trigone (Tl, T2); 1 crystal on the tip of each papillary 
muscle at the insertion of the anterior leaflet’s basal chordae (Ml, M2); 1 crystal on the 
anterior wall of the LV at the level of the papillary muscle (ALV); 1 crystal on the apex
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of the LV. The crystal electrodes were exteriorized through the ventricular wall for M l, 
M2 and ALV and through the left atriotomy for the annulus crystals. One high fidelity 
catheter-tipped pressure transducer (model 510, Millar Instruments, Houston, TX) was 
placed within the lumen of the proximal ascending aorta and one within the LV cavity 
through the apex (Figure 13).
2-4-2: Surgical Implantation of Crystals for the Tricuspid Valve Study
Nine 2-mm ultrasonic crystals (Sonometrics Corp, London, Ontario, Canada) 
were implanted and secured with a 5/0 polypropylene suture through a right atriotomy to 
study the tricuspid valve complex. Six crystals were located along the tricuspid annulus: 
at the anteroseptal (AS), the posteroseptal (PS) and the anteroposterior (AP) 
commissures, and at the relative mid point of the base of the septal (S), anterior (A), and 
posterior (P) leaflets. Three crystals were located inside the RV on the tips of the septal 
(Spm), anterior (Apm) and posterior (Ppm) papillary muscles. The crystal sutured at the 
apex of the LV was used as a reference crystal. The electrodes of crystals inside the RV 
were exteriorized through the right ventricular wall and the electrodes of the tricuspid 
annulus were exteriorized through the right atriotomy.
High fidelity, catheter tipped pressure transducers (model 510; Millar Instruments, 
Houston, TX, USA) were placed within the lumen of the pulmonary artery and in the RV.
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Figure 13: Surgical implantation of the sonomicrometry crystals.
The posterior part of the heart is in front.
AM: Anterior mitral annulus
PM: Posterior mitral annulus
Tl and T2: Left and right trigone
PI and P2: Left and right lateral mitral annulus
M l and M2: Anterior and posterior papillary muscles in the LV. ALV: crystal on the LV 
wall at the level of M l and M2.
Spm, Apm and Ppm: Septal, anterior and posterior papillary muscles in the RV.
S, AS and PS: Septal, anteroseptal and postero septal tricuspid annulus 
A, AP and P: Anterior, anteroposterior and posterior tricuspid aimulus.
AMTl AS
AP
PM PS
SpmALV
Apm
M l M2
Ppm
Apex
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After discontinuing the eardio-pulmonary bypass, and after the animal was 
hemodynamieally stable for at least 15 min, crystal distances on the mitral valve and the 
left ventricle were recorded along with left ventricular and aortic pressures. Then, crystal 
distances on the tricuspid valve and the RV were recorded along with right ventricular 
and pulmonary trunk pressures. Epicardial two-dimensional echocardiography with color 
Doppler was used to assess the competence and anatomy of the tricuspid valve. At the 
end of experiment the heart was arrested by lethal injection of potassium chloride and 
explanted from the body cavity. The correct positions of the crystals were checked.
2-5: Definition of Anatomical Regions
The mitral and tricuspid valve complexes were divided in 3 planes: the annulus, 
the annulo-papillary, and the papillary muscle plane. Several lengths and areas defined 
each plane. Heron’s formula was used to calculate the area of a triangle with lengths a, b 
and c as follows: S = !4(a+b+c) and Area = V[S (S-a)(S-b)(S-c)].
- Annulus:
The distance changes defined by the intertrigonal distance (T1-T2), the 
anteroposterior (AM-PM), commissural-commissural (P1-P2) diameters and by the 
distance between each consecutive crystals sutured on the mitral annulus defined the 
deformation of the mitral annulus. The distance changes defined by the S-A, the S-AP 
and the S-P lengths (the short axis diameters), by P-AS, P-A and A-PS (the long axis 
diameters) and by the distance between consecutive crystals sutured on the tricuspid 
annulus defined the deformation of the tricuspid annulus. The motion of both annuli was 
analyzed at the five time points by computing the changes of both annulus areas and
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diameters at the same time. The respective mitral and tricuspid areas were calculated with 
Heron’s formula using four triangles that characterized the mitral and tricuspid annulus 
planes.
Annulo-papillary muscle plane:
The variations of distances between each papillary muscle and the mitral annulus 
were explored (Ml-Mitral annulus crystals and M2-Mitral annulus crystals). The 
distances between the apex and the papillary muscle tips (apex-Ml and apex-M2) and 
between the apex and the crystals of the mitral annulus were analyzed. The change of the 
average of the distances between the apex and each crystal of the mitral annulus defined 
the average change of the LV (apex-annulus). Apex-aimulus changes were compared 
with the Apex-M2 and Apex-M2 changes. The annulo-papillary muscle plane of the 
mitral valve was divided into two functional units: the anterior annulo-papillary apparatus 
defined by each length of the quadrilateral T1-T2-M1-M2 and the posterior annulo- 
papillary apparatus defined by each length of the quadrilateral P1-P2-M1-M2. Variations 
and relationships between these distances were described. The variations of distances 
between each papillary muscle and the crystals of the tricuspid annulus were explored 
(Spm-trieuspid aimulus, Apm-tricuspid annulus and Ppm-trieuspid annulus). The annulo- 
papillary muscle plane of the tricuspid annulus was divided into three fiinetional units: 
the septo-annulo-papillary apparatus defined by each length of the quadrilateral AS-PS-P- 
S, the anterior-annulo-papillary apparatus defined by each length of the quadrilateral AS­
AP-A-S and the posterior annulo-papillary muscle apparatus defined by each length of 
the quadrilateral AP-PS-P-A. Variations and relationships between these distances were 
described.
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- Papillary muscle plane:
One area (M l-M2-ALV) using Heron’s formula and one length (M l-M2) defined the 
papillary muscle plane of the mitral valve. In addition, one area (Spm-Apm-Ppm) using 
Heron’s formula and three lengths (Spm-Apm, Spm P-pm and Ppm-Apm) defined the 
papillary muscle plane of the tricuspid annulus. The distance between the crystal at the 
apex and crystals placed on the papillary muscles and both annuli were also studied.
2-6: Measurement and Statistical Analysis Methods
After examination of the data, three consecutive heartbeats that contained the least 
amount of noise were chosen for analysis for each animal. Once these calculations were 
complete, summary statistics were reported for each location as mean ± 1 S.D. Between 
the five time points of the cardiac cycle, the percentages of change were calculated for 
each sheep and reported as mean ± S.D. The distance changes during the cardiac cycle 
were analyzed with repeated measures analysis of variance (ANOVA) and distance 
changes between two time-points of the cardiac cycle were analyzed with 
Bonferoni/Dunn test. The unpaired student t-test was used to compare the relative change 
between different distances. A value of p<0.05 was considered significant.
3; Results
Seven Targhee sheep (72 ± 21 kg) underwent implantation of crystals on the 
mitral valve and the triscuspid valve. Average cardiopulmonary bypass time was 136 ± 9 
minutes and average cross-clamp time was 88 ± 6 minutes. The following hemodynamic 
characteristics were recorded: Arterial pressure 67/40 ± 2/3 mmHg, cardiac output 2.9 ±
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0.4 L/min, pulmonary artery pressure 20/11±1/1 mmHg. At the time of recording, there 
was no mitral or tricuspid regurgitation on epicardial echocardiography. At necropsy all 
crystals in the mitral and tricuspid annuli, RV and LV were verified to be in the correct 
position.
3-1: Geometrical changes in Tricuspid and Mitral annuli
3-1-1: Mitral annulus
The main contraction of the mitral annulus occurred during the systole and was 
mainly dependent of the contraction of the anteroposterior (AM-PM) and the septolateral 
(P1-P2) diameters. These distances presented the major changes during the cardiac cycle 
(AM-PM: 15.9 ± 10%, p=0.01, ANOVA and P1-P2: 13.1 ± 4% of change, p=0.013, 
ANOVA). T1-T2 presented a change of 10.5 ± 5%, but was not significant during the 
cardiac cycle (p=0.2, ANOVA). The changes of these diameters were different through 
time. During JVC, AM-PM presented a 4 ± 4% decreased (p=0.17) while T1-T2 and Pl- 
P2 slightly expanded (+2 ± 3% and +2 ± 4%, p=0.3). During the time of ejection AM-PM 
and T1-T2 increased (+3 ± 5%, p=0.14 and +4 ± 8%, respectively) and P1-P2 
significantly decreased (-10 ± 6%, p=0.0012). During IVR, AM-PM and P1-P2 expanded 
(+9 ± 5 %, p=0.2 and +6 ± 1%, p=0.019, respectively) while T1-T2 decreased (-3 ± 2%). 
Between end of IVR and midD, PI-P2 and AM-PM decreased (-1 ± 3 %, p=0.8 and -3 ± 
2%, p=0.3, respectively) while T1-T2 expanded (-2 ± 5%). A significant change for AM- 
PM was observed between the beginning of IVR and midD (p=0.0033, Bonferoni/Dunn). 
Figure 14 reports the variations of TI-T2, P1-P2 and AM-PM during the cardiac cycle.
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Figure 14: Heterogeneous variations of the intertrigonal (T1-T2), P1-P2 and antero­
posterior diameter (AM-PM) of the mitral annulus through the phases of the cardiac 
cycle in one sheep.
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole, Ao: Aorte, LV: Left ventricle
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During the cardiae eycle, Tl-AM and AM-T2 (anterior segments of the annulus) 
presented 11 ± 7% and 12 ± 7% of change, respectively (p<0.05). PI-PM and P2-PM 
(posterior segments) presented 12.6 ± 4% and 14.3 ± 3.5% of change, respectively 
(p<0.05). P l-T l and P2-T2 (lateral segments) presented 10.7 ± 6.5% and 16 ± 6% of 
change, respectively (p<0.05). The motions of the different segments of the mitral 
annulus were not homogenous over time (Figure 15). Posterior segment and lateral 
segment lengths decreased during systole while anterior segment lengths increased. 
During diastole, posterior and lateral segment lengths increased while Tl-AM and AM- 
T2 lengths decreased.
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Figure 15: Variations o f the segments of the mitral annulus during the phases o f the
cardiac cycle in one sheep.
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole, Ao: Aorte, LV: Left ventricle 
AM & PM: Anterior and posterior annulus 
Tl & T2: trigones 
PI & P2: lateral annulus
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3-1-2: Tricuspid Annulus
The antero-posterior (A-P: 13.4 ± 7%, p=0.017, ANOVA), the postero-septal (S- 
P: 21.6 ± 8.4 %, p=0.001, ANOVA) and anteroseptal-posterior (AS-P: 15.8 ± 5%, 
p=0.0013, ANOVA) diameters of the tricuspid annulus had significant and major changes 
throughout the cardiac cycle. The septal-anteroposterior (S-AP) and the septo-anterior (S- 
A) diameters presented minor non-significant variations during the cardiac cycle (11.1 ± 
4.5%, p=0.25 and 11 ± 5%, p=0.2, respectively, ANOVA). The antero-posteroseptal (A- 
PS) presented the least variation during the cardiac cycle (7 ± 3%, p=0.6, ANOVA). The 
changes of the tricuspid diameters are reported in Figure 16. The short axis diameters (S- 
AP, S-A and SP) and A-PS (one of the long axis diameter) had the smallest change and 
presented the same kind of variation during the cardiac cycle. During IVC, the segments 
S-AP, S-A, A-PS and S-P trend to decrease (-1 ± 4%, -0.5 ± 4% and -0.5 ± 5% and -4 ± 
5%, respectively with for S-P, p<0.05 Bonferoni/Dunn). During most of ejection time, 
these distances decreased and just before beginning of IVR increased again (percentages 
of change were respectively: -2 ± 4%, -3 ± 5%, +3 ± 3% and +11 ± 6%, respectively with 
for S-P, p<0.05, Bonferoni/Dunn). During IVR, these diameters slightly expanded (+2 ± 
2, +2 ± 1, +1 ± 2% and +2 ± 4%, respectively). Between end of IVR and the end of 
diastole, these diameters decreased, reaching their smallest length for S-A and S-AP 
before midD (S-AP: -3 ± 5%, SA: -4 ± 7%, A-PS -4  ± 5% and SP: -10 ± 5%, 
respectively with for S-P, p=0.006, Bonferoni/Dunn). Then between midD and beginning 
of IVC, S-A, S-AP and S-P increased while A-PS decreased (+5 ± 2 %, +3 ± 4%, +1 ± 
4% and -1 ± 4%, respectively). The main contraction of the tricuspid annulus occurred
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between IVC and end of ejection. The contraction was mainly due to the decrease of the 
segments between P and the anteroseptal (A, AS and S) part of the annulus.
Figure 16: Variations of the diameters (A-PS, P-AS and A-PS) of the tricuspid annulus 
during the phases of the cardiac cycle in one sheep.
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole, PA: Pulmonary artery, RV: right ventricle.
A, AS & PS: Anterior, anteroseptal & postero septal tricuspid annulus 
A, AP & P: Anterior, anteroposterior & posterior tricuspid annulus.
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Dimensions of the antero-septal segments of the annulus (S-AS and A-AS) did 
not present significant variations during the cardiac cycle (19 ± 13% and 11 ± 7 %, 
respectively, p>0.05 ANOVA). These distances decreased between IVC and D and then 
increased during the last part of the diastole. The changes of the antero-posterior part of 
the annulus (A-AP and P-AP) were not significant during the cardiac cycle (17 ± 10% 
and 16.6 ± 10 %, respectively, p>0.05 ANOVA). The distances increased between Ej and 
D before contracting again between the last part of diastole and the IVC. The postero­
septal part of the annulus did not contract homogeneously; The P-PS segment (20.5 
±12%, p>0.05 ANOVA) decreased between end of diastole (D) to IVR and increased 
between IVR and D. The S-PS (20 ± 10% of change, p<0.05 ANOVA) segment 
followed the motion of P-AP. For S-PS, Bonferroni/Dunn test showed significant 
expansions between Ej and IVR and between IVR and significant diminution between D 
and MD (p<0.01). During the cardiac cycle, the different segment changes of the 
tricuspid annulus were homogenous in proportions, but did not happen at the same time 
(Figure 17).
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Figure 17: Variations o f the segment lengths of the tricuspid annulus during the phases of
the cardiac cycle in one sheep
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole, PA: Pulmonary artery, RV : right ventricle 
A, AS & PS: Anterior, anteroseptal & postero septal tricuspid annulus 
A, AP & P: Anterior, anteroposterior & posterior tricuspid annulus.
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3-1-3: Motion of the Mitral and Tricuspid Annuli
Expansion of mitral and tricuspid annulus areas did not occur at the same time. 
The mitral annulus area expanded significantly from 5.5 ± 0.9 cm^ in IVR to 6.08 ± 1 cm^ 
at the end of diastole (+ 10%) and the tricuspid annulus area expanded significantly from 
6 ± 1.4 cm^ in Ej to 6.8 ±1.4 cm^ (+14%) in midD. Tricuspid annulus area was maximal 
while mitral annulus area was minimal. Antero-posterior diameter (AM-PM) of the mitral 
annulus and long axis diameters (P-AS and P-A) of the tricuspid annulus had the same 
trend during the cardiac cycle except during the ejection period. P1-P2 changes of the 
mitral annulus and short axis diameters (S-A, S-AP and S-P) of the tricuspid annulus 
presented also the same trends during late diastole, IVC and the early ejection period. 
During the end of ejection and diastole, tricuspid short axis diameters seemed to expand 
earlier than P1-P2. Both contracted between D and midD and expanded in late diastole 
(Figure 18). The lengths of the different segments of both annuli are reported in Table 4. 
Motions of the septal segments of both annuli were the same in change and timing (S-AS: 
19 ± 13%, and T2-P2: 16 ± 6%, maximal contraction in IVR and maximal expansion in 
end-diastole). Figure 19 shows a reconstruction of both annuli at end-diastole and end- 
systole.
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Figure 18: Motion of the mitral and tricuspid annuli.
Variations of the mitral and tricuspid annulus areas, of the antero-posterior (AM-PM) and 
commissure-commissure diameters of the mitral annulus and long axis (P-AS) and short 
axis (S-AP) diameters of the tricuspid annulus. The earlier expansion of the long axis 
diameter of the tricuspid aimulus compared to AM-PM is well represented. Thick 
tracings correspond to the mitral valve and thin tracing to the tricuspid.
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole, Ao: Aorte, LV: Left ventricle
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Table 4: Average measurement of the segments of both aimuli during the different phases 
of the cardiac cycle.
p<0.05 repeated measurement ANOVA. **Bonferroni/Dunn test showed a significant 
difference between IVC and IVR and between Ej and D (p<0.01).
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole,
S,AS & PS: Septal, anteroseptal and posteroseptal tricuspid annulus,
A, AP & P: Anterior, Anteroposterior, posterior tricuspid annulus
Tl & T2: Trigones, AM & PM: Anterior & posterior mitral annulus, PI & P2: lateral
mitral annulus
Tricuspid S-AS AS-A A-AP AP-P* ** P-PS PS-S* **
IVC 20.57±6.54 15.12±4.54 12.73=4:2.09 18.56±5.59 16.32=1=5.78 34.4U8.85
Ej 20.39±6.04 14.85±5.35 12.43=4=1.69 18.10±5.69 17.50=4:5.37 34.22=1=8.46
IVR 19.84±6.57 14.73±5.58 12.97=1=2.88 19.60=1=6.35 17.65=1=5.47 35.4U9.22
D 19.92±6.96 14.55±5.57 13.03=t2.54 20.2U6.71 17.25=^6.27 35.76=^9.88
midD 20.44±6.50 14.70^=4.86 12.85±1.63 18.63=1=5.42 16.57=4=6.72 34.67=1=9.19
Mitral PM-P1* ** P1-T1* ** 11-AM AM-T2 T2-P2* ** P2-PM* **
IVC 20.32±3.65 13.33=t2.82 11.81±2.27 13.90=t3.94 20.54=1=4.20 14.32=4=2.17
Ej 19.23±3.86 13.13=t2.69 12.39=t2.51 14.28=1=3.81 20.5U4.26 14.03=1=2.07
IVR 18.65±3.53 12.94±2.37 12.36=t2.39 14.96=t4.09 20.15=1=4.82 13.54=11.64
D 19.80±3.83 13.63=t3.34 11.84=4=2.42 13.88=1=3.62 21.22=1=4.91 14.82=1=1.86
midD 19.92±3.41 13.55=4:3.34 11.6U2.21 13.48^=3.85 20.25=1=4.36 14.55=4=2.07
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Figure 19: Reconstruction of the mitral valve annulus (left) and of the tricuspid annulus 
(right).
Variations of segments of both annuli between end-diastole (black) and end-systole 
(gray). AM: Anterior mitral annulus, PM: Posterior mitral annulus 
Tl and T2: Left and right trigone 
PI and P2: Left and right lateral mitral annulus
S, AS and PS: Septal, anteroseptal and postero septal tricuspid annulus 
A, AP and P: Anterior, anteroposterior and posterior tricuspid annulus.
\T 2
PI
[AP
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3-2; Geometrical Changes in Tricuspid and Mitral Annulo-papillary Muscle Planes 
3-2-1: Annulo-papillary Muscle Apparatus of the Mitral Valve
The variations of distances between Ml-Mitral annulus and M2-Mitral annulus 
are reported in Table 5. There was no significant distance change for M l-Tl (3.5 ± 2% of 
change, p=0.9, ANOVA), M l-Pl (5 ± 2% of change, p=0.07, ANOVA) and M l-PM (5 ± 
3% of change, p=0.4, ANOVA) during the cardiac cycle. Significant changes in distances 
between M1-T2 (11.7 ± 3% of change, p<0.005, ANOVA), M1-P2 (23 ± 6% of change, 
p<0.005, ANOVA) and Ml-AM (6 ± 3% of change, p<0.005, ANOVA) were observed. 
These significant changes occurred mostly between IVC and D for M1-T2 and M1-P2 (- 
10 ± 4%, p=0.0008 and -20 ± 5%, p=0.002, Bonferroni/Dunn test, respectively) and 
between IVR and midD (+6.4 ± 4%, p=0.0007 and 15.5 ± 8%, p=0.004, Bonferroni/Dunn 
test, respectively). The distance changes for M2-T2 (2.7 ± 2% of change, p=0.24, 
ANOVA), M2-P2 (6.1 ± 3% of change, p=0.07, ANOVA) and M2-AM (4.2 ± 3 % of 
change, p=0.63, ANOVA) were not significant. However, significant changes in distance 
for M2-T1 (8+3%, p=0.04, ANOVA), M2-P1 (10.5 ± 6%, p=0.031, ANOVA) and M2- 
PM (12.6 ± 8%, p<0.005, ANOVA) were observed. These significant changes occurred 
mostly between beginning of IVC and end of ejection for M2-T1, M2-PI and M2-PM (-6 
± 5%, p=0.003; -10 ± 6%, p=0.004 and +9 ± 5%, p=0.002, Bonferroni/Dunn test 
respectively). During the cardiac cycle, Apex-Ml presented 12.9+1% (p=0.021,
ANOVA) and Apex-M2 10.5+1% (p<0.005, ANOVA) of change. The averaged distances 
between the apex and the crystals of the mitral annulus also presented significant changes 
during the cardiac cycle (8.3 + 1%, p<0.001, ANOVA). The distance changes for apex- 
papillary muscle tips and apex mitral annulus crystals are reported in Table 6.
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Table 5: Variations in distance between Ml-Mitral annulas and M2-Mitral annulas 
during the phases of the cardiac cycle.
* = p<0.05 (repeated-measures ANOYA). Significant Bonferroni/Dunn test with p<0.05, 
** = IVC versus IVR, ***= lYC versus D, f=  ejection versus isovolumic relaxation, %= 
Ejection versus D, j=Isovolumic relaxation versus mid diastole. 
lYC: Isovolumic contraction, Ej: Ejection, lYR: Isovolumic relaxation, midD & D: 
Diastole, M l & M2: Papillary muscles of the LY, XI & T2: Trigones, AM & PM: 
Anterior & posterior mitral annulas, P1& P2: lateral mitral annulas
IVC Ej IVR D MidD
M1-P1 26.21±1.39 26.86+1.81 26.94±1.79 27.22+2.16 26.35±1.58
M1-T1 28.60±3.09 28.45+2.71 28.58±2.44 28.62±3.16 28.68±3.21
M1-AM* 32.90±1.40** 33.01+1.21$ 32.06±0.88 3164+159 32.68±1.45
M1-T2* 36.94+2.46** *** 36.51±1.94tî 33.58+1.12f 34.06±2.69 35.88+3.26
M1-P2* 37.68±4.05** 36.96±4.21 32.10±7.05 34.71±5.71 37.86±5.31
M1-PM 33.14±2.01 34.27±1.68 33.39±0.63 32.85±1.63 33.1811.84
M2-PM* 31.89±2.79** 34.61±3.33 35.04±3.05 33.40±3.55 31.8014.03
M2-P1* 39.75±2.06** 39.34±1.89 36.24±0.52 38.81+1.08 38.8412.85
M2-T1* 43.08±0.87** 41.06±1.55 39.98±2.42 40.49+1.62 41.2010.92
M2-AM 38.04±2.00 37.78±2.67 38.25±2.35 37.98+2.35 37.5011.52
M2-T2 29.72±2.65 30.08±2.63 30.20±2.35 29.81±2.50 29.68l2.58
M2-P2 26.37+2.77 27.29+2.79 28.03±2.52 26.81+2.60 26.51l2.92
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Table 6: Changes through the cardiac cycle of average distances Apex-Annulus, Apex- 
M1 and Apex-M2
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole, M l & M2: Papillary muscles of the LV, T1 & T2: Trigones, AM & PM: 
Anterior & posterior mitral annulus, P1& P2: lateral mitral annulus
Apex-Annulus Average change Bonferoni/Dunn
test
IVC 88.50+4.33 IVC versus Ej 5.2±1% P=0.0001
Ej 92.46±4.02 Ej versus IVR -8.3+2% P=0.0001
IVR 86.19i5.66 IVR versus D 1.5±1% P=0.035
D 85.21+5.95 D versus 
midD
-09+0.6% P=0.096
MidD 87.12+5.28 MidD versus 
IVC
2.1±1% P=0.93
Apex-M1
IVC 46.13±3.21 IVC versus Ej 1+4% P=0.81
Ej 47.06±3.52 Ej versus IVR -7+5% P=0.0011
IVR 43.20±2 IVR versus D 1±3% P=0 6
D 41.32±3.7 D versus 
midD
4±3% P=0.035
MidD 44.13±4.01 MidD versus 
IVC
2±1% P=0 12
Apex-M2
IVC 33.82±3.85 IVC versus Ej 0.8±2% P=0.001
Ej 35.28±3.48 Ej versus IVR -8±2% P=0.002
IVR 32.79+3.29 IVR versus D 1±3% P=0.007
D 3101+4 03 D versus 
midD
7+6% P=0.0012
MidD 33.84+2.5 MidD versus 
iVC
2±0.5% P=0.91
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Apex-annulus changes were significantly different from Apex-Ml (p=0.002, 
unpaired t-test) and Apex-M2 (p=0.017, unpaired t-test) changes during the cardiac cycle. 
During IVC, Apex-Annulus, Apex-Ml and Apex-M2 increased (table 6), however 
percentages of expansion were significantly different (Apex-annulus: 5.2 ± 1%, Apex- 
M l: 1 ± 4% and Apex-M2: 0.8 ± 2%, p=0.01 for apex-annulus versus Apex-Ml and for 
apex-annulus versus Apex-M2). During the ejection period, Apex-annulus reached its 
maximum value and started to decrease until the IVR period during which it reached its 
minimum value. Apex-Ml and Apex-M2 followed the same pattern. During these periods 
of the cardiac cycle, no significant differences were found for the percentages of change 
between Apex-annulus and Apex-Ml or Apex-M2. Figure 20 shows the variations of the 
distances between the apex, both papillary muscles and the mitral annulus during the 
cardiac cycle. The flat curves of the distances between papillary muscles and mitral 
annulus show that there are almost no variations in distance. Variations of the distances 
between apex and papillary muscle tips or apex-mitral annulus are also represented.
88
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 20: In one sheep, variations through the phases of the cardiac cycle of the 
distances apex-Mitral annulus, Apex-Ml, Apex-M2, Ml-Mitral annulus (PM, PI, T l, 
AM) and M2- Mitral annulus (PM, P2, T2, AM).
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole, M l & M2: Papillary muscles of the LV, TI & T2: Trigones, AM & PM: 
Anterior & posterior mitral annulus, P1& P2: lateral mitral annulus, Ao & LV: Aorta and 
Left ventricle
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3-2-2: Annulo-papillary Muscle Units of the Mitral Valve
Between IVC and IVR, the lengths of the quadrilateral T1-T2-M1-M2 that 
defined the anterior annulo-papillary apparatus and the ones of the quadrilateral P1-P2- 
M1-M2 that defined the posterior annulo-papillary apparatus remained the same, except 
for the distance between M1-M2. M l-Tl was almost equal to M2-T2 and that of M l-PI 
was almost equal to M2-P2 (Table 7). The ratios between the lengths of the quadrilateral 
were close to one (Table 8). Because of these consistent lengths and the relationship close 
to one in systole and diastole, these two quadrilaterals stayed trapezoid-like during 
systole and diastole.
Table 7: Lengths of the two functional unit and their variations between IVC and IVR
IVC IVR % change
P1-P2 32.08±6.5 30.57±6.9 5%
M1-P1 27.68±4.1 28.83±3.9 -4%
M2-P2 26.61±4.9 28 57+4 1 -7%
M1-M2 28.11 ±6.1 21.29±5 32%
T1-T2 25.84±2.15 26.8±3.8 -2%
M1-T1 28.43±3.3 28.56±3 0.5%
M2-T2 31.66±2.9 30.65+4.6 3%
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Table 8: Relationship between segment of the quadrilaterals of anterior and posterior 
functional unit.
IVR IVC
Anterior functional unit
T1-T2/M1-M2 0.9±0.1 1.2±0.2
T1-T2/T1-M1 0.9±0.2 0.9±0.1
T1-T2/T2-M2 0.8+0.1 0.9+0.1
T1-T2/P1-P2 0.8±0.1 0.9±0.1
Posterior functionai unit
M1-M2/P1-P2 0.9+0.1 0.7±0.1
P1-P2/P1-M1 1.3±0.2 1.2±0.2
P1-P2/P2-M2 1.2±0.2 1.1±0.2
3-2-3: Annulo-papillary Muscle Apparatus of the Trieuspid Valve
The distances between each papillary muscle and the crystals of the tricuspid 
annulus and the percentage of change through the cardiac cycle were analyzed and 
reported in Table 9. No significant change were observed by repeated measures ANOVA 
(p<0.05) for the segment lengths between each papillary muscle and its corresponding 
commissural crystals of the tricuspid annulus. Bonferroni/Dunn test was used to evaluate 
significant differences found by ANOVA resulting in significant differences for IVC 
versus IVR and IVR versus MD with p<0.01.
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Table 9: Distance between the three papillary muscles of the tricuspid valve and the 
tricuspid annulus.
* = p<0.05 (repeated-measures ANOVA).
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole, Spm, Apm & Ppm: Papillary muscles of the RV,
S, AS, PS: Septal, anteroseptal and posteroseptal tricuspid annulus,
AP, P and PS: Anteroposterior, posterior and posteroseptal annulus
Spm-S Spm-AS Spm-A Spm-AP Spm-P Spm-PS
IVC 26.58+1.68 20.62±5.08 26.11 ±7.22 28.48±5.43 36.24±2.54 38.05±4.06
Ej 25.88+2.83 20.99+5.47 28.26±6.13 29.84±3.81 35.74±1.38 37.28±3.38
IVR 25.76+2.79 20.65±4.55 28.47±5.42 31.53±2.74 39.34±1.94 39.85±2.89
D 26.41±2.06 19.90±4.16 27.04±4.83 30.11 ±4.37 39.18±2.65 40.43±4.21
midD 26.76±1.53 19.73+4.25 24.63±7.39 27.51±5.17 36.78±2.51 38.45±3.77
% change 7.00±4.70 5.00±3.80 14.00±8.20* 16.00±9.30* 14.90±4.00* 10.10±1.40*
Apm-S Apm-AS Apm-A Apm-AP Apm-P Apm-PS
IVC 38.25±3.31 35.85±6.35 28.14±2.73 21.22±3.97 28.10±6.84 39.33±4.42
Ej 37.06±4.88 34.75+6.68 28.52±2.91 21.31±3.85 27.70±6.02 38.76±4.59
IVR 33.67±4.92 33.04+6.28 28.00±3.29 21.32±3.64 27.27±6.66 36.69±4.96
D 36.08±3.31 34.04±5.51 27.86±3.00 21.40±3.62 27.73±7.52 38.33±4.74
midD 38.38±3.19 35.48±6.46 28.18±3.26 21.2U3.55 28.23±7.03 39.8U4.96
% change 11.70±7.90* 8.60±2.40* 4.50±2.10 3.90±1.60 5.10±1.90 8.20±2.40*
Ppm-S Ppm-AS Ppm-A Ppm-AP Ppm-P Ppm PS
IVC 28.41±2.75 41.61±5.41 43.26±5.78 33.32±5.99 25.3U2.42 19.82±2.95
Ej 28.04+2.53 41.08+3.79 43.47±4.54 33.89±4.56 26.48±3.93 19.99±4.08
IVR 27.60±2.59 41.34±4.16 44.30±4.47 34.89±3.93 27.08±4.16 19.90±3.82
D 28.00+2.32 41.19+4.96 44.29±5.24 34.88±4.77 26.44±2.70 19.64±2.85
midD 28.66±3.03 40.50±6.04 42.11±6.52 32.68±6.16 24.18±2.23 19.75±2.89
% change 7.9±2.7 7.9±2.6 9±5.1* 11 ±6.9* 13.5±7.2* 5.4±3
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The distances between the septal papillary muscle and the crystals of the annulus 
expanded between Ej and D and decreased during the end of diastole and the end of 
isovolumic contraction. The distance between the anterior papillary muscle and the 
crystals of the annulus increased between IVR and the end of diastole and decreased 
between IVC and the end of ejection. The distance between the posterior papillary muscle 
and the annulus followed the same trend as the one of the anterior papillary muscle.
Figure 21 shows the variations through the cardiac cycle of the distances between each 
papillary muscle tips and their corresponding commissural crystal, of Spm-P, Apm-S and 
Ppm-A.
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Figure 21 : In one sheep, variations through the phases of the cardiac cycle of the
distances between the PM tips and the corresponding commissures.
The flat line between the PM tips and their corresponding commissure showed no 
variations during the cardiac cycle.
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, Spm, Apm & Ppm: Papillary muscles of the RV
S, AS, PS: Septal, anteroseptal and posteroseptal tricuspid annulus
AP, P and PS: Anteroposterior, posterior and posteroseptal annulus
PA & RV : Pulmonary artery and right ventricle
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3-2-4: Annulo-papillary Units of the Tricuspid Valve
During the different times of the cardiac cycle, the relationships of the lengths of 
the quadrilateral AS-AP-A-S that defined the anterior annulo-papillary apparatus, the 
quadrilateral AS-PS-P-S that defined the septal annulo-papillary apparatus and the 
quadrilateral AP-PS-P-A that defined the posterior annulo-papillary muscle apparatus are 
in Table 10. Each ratio remained consistent during the cardiac cycle. The ratios that 
involved a segment of the annulus and the segment between the two corresponding 
papillary muscles and the ratios that involved two distances between the tip of a papillary 
muscle and its corresponding commissural crystal were close to one. However, they were 
different from one when the ratios involved a segment of the armulus and the distance 
between the tip of the papillary muscle and the corresponding crystal for the septal and 
posterior annulo-papillary apparatus. These last ratios were also close to one for the 
anterior annulo-papillary unit. These consistent ratios showed the same percentage of 
change of lengths for the different segments during the cardiac cycle. Therefore, as for 
the mitral papillary unit, these three quadrilaterals stayed trapezoid-like during the 
cardiac cycle.
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Table 10: Relationships between the segments of the septal, anterior and posterior 
papillary muscle apparatus.
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D:
Diastole, Spm, Apm & Ppm: Papillary muscles of the RV
S, AS, PS: Septal, anteroseptal and posteroseptal tricuspid armulus
AP, P and PS: Anteroposterior, posterior and posteroseptal annulus
Anterior Annuio-Papiliary apparatus
AS-PA/Spm-Apm AS-PA/Spm-AS AS-PA/Apm-PA AS-Spm/PA-Apm
IVC 0.901 0.992 0.974 1.019
Ej 0.887 0.969 0.945 1.026
IVR 0.853 1.030 0.979 1.052
D 0.842 1.054 0.963 1.095
midD 0.878 0.997 0.940 1.062
Septal Annulo-Papillary apparatus
AS-PS/Spm-Ppm AS-PS/AS-Spm AS-PS/PS-Apm AS-Spm/PS-Apm
IVC 0.940 1.652 1.764 0.937
Ej 0.961 1.648 1.711 0.963
IVR 0.947 1.748 1.815 0.963
D 0.949 1.829 1.864 0.981
midD 0.928 1.706 1.747 0.976
Posterior Annulo-Papillary apparatus
PA-PS/Apm-Ppm PA-PS/PA-Apm PA-PS/PS-Spm PA-Apm/PS-Spm
IVC 0.930 1.418 1.542 0.919
Ej 0.973 1.432 1.526 0.939
IVR 0.993 1.438 1.571 0.915
D 0.977 1.463 1.632 0.896
midD 0.946 1.429 1.553 0.920
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3-3: Geometrical Changes in the Mitral and Trieuspid Papillary Musele Planes 
3-3-1: Papillary Museles of the Mitral Valve
M1-M2-ALV presented a 72% decrease from 2.15 ± 0.45 cm^ to 1.24 ± 0.34 cm^ 
between IVC and IVR. The inter-papillary muscle distance M l-M2 decreased from 29.8 
± 6 mm to 23.8 ± 7 mm (-32%) between IVC and IVR. Distance between M l and ALV 
decreased from 23.14±5.4-mm to 15.7 ± 3.5 mm (-47%) between IVC and IVR. Distance 
between M2 and ALV decreased from 19.1 ± 4.2 mm to 15.5 ± 3.6 mm between IVC and 
IVR. Table 11 shows the significant variations of the mitral papillary muscle plane during 
the cardiac cycle. Figure 22 shows the variation through the cardiac cycle of the distances 
of the papillary muscle plane of the mitral valve.
Table 11 : Variations of distances through the cardiac cycle for the papillary muscle plane 
of the mitral valve.
* = p<0.05 (repeated-measures ANOVA). Significant Bonferroni/Dunn test with p<0.05, 
** = IVC versus IV R , ***= IVC versus D, f=  ejection versus IVR, J= ejection versus D, 
]= Isovolumic relaxation versus midD, IVC: Isovolumic contraction, Ej: Ejection, IVR: 
Isovolumic relaxation, midD & D: Diastole,
M l-M2: Papillary muscles of the LV, ALV: Crystal on the LV wall at the level of the 
papillary muscles.
M1-M2 (mm) Ml-ALV (mm) M2-ALV (mm) M1-M2-ALV 
Area (cm*)
IVC 29.8+6.1****** 21.65±4.79* ** *** 21.39+4.95* ***** 2.1+0.45* ** ***
Ej 28.7±5.52n 20.77±4.43t 21.08±4.73tt 2.02±0.41tt
IVR 23.8±7 15.80±2.81f 17.28±4.27[ 1.24±0.34f
D 25.13±6.2 18.41±4.63 18.52±4.84 1.28±0.35
MD 27.97±6.16 21.22+4.62 20.19+5.41 1.7±0.39
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Figure 22: Variations of M l-M2, Ml-ALV, M2-ALV through the phases of the eardiac 
cycle.
Contraction of the ventricle during the systole is shown by the diminution of the 
interpapillary muscle plane distance.
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole, M l-M2: Papillary muscles of the LV, ALV: Crystal on the LV wall at the level 
of the papillary muscles. Ao & LV: Aorta and Left ventricle
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3-3-2: Papillary Muscles of the Tricuspid Valve
The area defined by the septal (Spm), anterior (Apm) and posterior (Ppm) 
papillary muscles crystals contracted by 22 ± 14% (p>0.05, ANOVA) between IVC and 
IVR. The three segment motions (Spm-Apm, Spm-Ppm and Ppm-Apm) were 
homogeneous during the cardiac cycle in distance and time. Spm-Apm presented a total 
change of 15 ± 12% (p>0.05, ANOVA), Apm-Ppm, of, 12 ± 5% (p>0.05, ANOVA) and 
Spm-Ppm of 10 ± 4% (p>0.05, ANOVA). These lengths decreased during the systole and 
increased during the diastole (Table 12 & Figure 23).
Table 12: Variation of the inter-papillary muscle distance of the tricuspid valve during 
the phases of the cardiac cycle.
Spm, Apm & Ppm: Septal, anterior and posterior papillary muscles of the RV 
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole,
Spm-Apm (mm) Apm-Ppm (mm) Spm-Ppm (mm) Area (cm^)
IVC 31.51±5.33 32.36±4.80 36.59±5.37 3.8+1.5
Ej 31.48+3.25 31.38±5.21 35.62±4.12 3.6±1.1
IVR 29.55+4.20 30.86±5.98 35.38+3.26 3.3±1.1
D 29.88+6.10 32.04+5.57 37.68±3.71 3.4+1.3
midD 31.11±5.31 32.02+4.53 36.72±4.65 3.6+1.4
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Figure 23: Variations of the interpapillary musele distances of the tricuspid valve during 
the phases of the cardiac cycle.
Spm, Apm & Ppm; Septal, anterior and posterior papillary muscles of the RV 
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole, PA & RV : Pulmonary artery and right ventricle
45
Spm-Ppm
40
pm-Apm
3040
mmHg
30
25Apm- Ppm
RV pressure
20
20
PA pressure
IVR midDD IVC Ej
mm
100
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3-3-3: Motion of Both Papillary Muscle Planes:
Both papillary muscle plane areas decreased during systole from IVC to IVR (see 
table 11 & 12 for values). During the contraction of the ventricles. M l-M2, Spm-Apm 
and Apm-Ppm decreased by 32%, 15 ± 12% and 12 ± 5% respectively; however, Spm- 
Ppm (10 ± 4% of change) decreased during the IVC, but increased during the ejection 
period. Figure 24 represents the variation of the interpapillary musele distance at the 5 
time points of the eardiac cycle.
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Figure 24: Variations of the papillary-muscles distances of both atrioventricular valves 
during the cardiac cycle.
Ml & M2: papillary muscle of the LV
Spm, Apm & Ppm: Septal, anterior and posterior papillary muscles of the RV 
IVC: Isovolumic contraction, Ej: Ejection, IVR: Isovolumic relaxation, midD & D: 
Diastole,
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4: Discussion
4-1: Mitral and Tricuspid Valve Annuli
It was first shown in dogs that the shape and size of the mitral and tricuspid annuli 
varied continuously during the cardiac cycle [99,123]. Other studies with 
sonomicrometry array localization, marker angiography and three dimensional 
echocardiography confirmed their dynamic changes during the cardiac cycle 
[26,41,101,102]. Our findings on the diameter and segment length changes of both annuli 
resulting in shape and area variations during the cardiac cycle are consistent with 
previous reports of different groups who studied separately the mitral and the tricuspid 
annuli. In our experiment, the mitral annulus decreased in size during systole with the 
contraction of the antero-posterior (AM-PM: 15.9 ± 10 %) and commissure-commissural 
(PI-P2: 13.1 ± 4%) diameters of the annulus. These results are different from the findings 
of Gorman et al. who studied the mitral valve in sheep using sonomicrometry and 
reported an expansion of the AM-PM diameter of the annulus during the IVC and an 
expansion of P1-P2 during ejection [119], while we found in our experiment a 
contraction (figure 14). These differences may depend on the variability between sheep 
breeds. The time variations of AM-PM and PI-P2 diameters were associated with the 
motion of the posterior (PM-Pl : 12.6 ± 4% and PM-P2: 14.3 ± 3.5%) and lateral 
segments (TI-Pl; 10.7 ± 6.5% and T2-P2: 16 ± 6%) of the annulus during the cardiac 
cycle. The intertrigonal distance that was previously considered to remain constant or to 
change minimally during the cardiac cycle was actually found to expand during ejection 
along with the expansion of the aortic root. The expansion of the intertrigonal distance 
(T1-T2 10.5 ± 5%, p>0.05) during the cardiac cycle was associated with significant
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expansion of the anterior segment lengths of the annulus (Tl-AM: 11 ± 7%, AM-T2: 12 
± 7%) and corresponded to the dynamic balance of the aorto-mitral junction [121]. Mitral 
annulus deformation is closely related to aortic root dynamics. The intertrigonal distance 
expands during systole and allows for aortic root expansion, probably to maximize 
ejection.
For the tricuspid valve, the long axis diameter centered on the posterior part of the 
annulus (P-S: 21.6 ± 8.4 %, P-AS: 15.8 ± 5 % and P-A: 13.4 ± 7%) and the short axis 
diameters, septum-anteroposterior free wall (S-A: 11 ± 5 % and S-AP: 11.1 ± 4.5%) 
presented the major changes during the cardiac cycle. The minimal change corresponded 
to the segment A-PS (7 ± 3%). Thus the deformation of the annulus was associated with 
the motion of the posterior part of the annulus. According to Hiro et al. [41], the 
posteroseptal commissure in Tar ghee sheep corresponds to the tail of the pear shape of 
the tricuspid annulus. In humans, the change of the tricuspid valve depends on the 
expansion of the free wall segment of the narrow tail of the pear shaped annulus or the 
anteroseptal portion of the annulus [108]. We found the same relative distance changes 
(15-20%) between each segment defined by the six crystals of the annulus as Hiro et al 
[41] showed an homogenous change (12%) of the insertion of the three leaflets. The 
motion of these annulus segments was, however, not homogeneous in time. The 
anteroposterior segments (A-AP and P-AP) of the free wall and the postero-septal (S-PS) 
part of the annulus were increasing during ejection while the anteroseptal annulus (S-AS 
and A-AS) and the posterior segment P-PS were contracting. Thus the lateral annulus 
motion was following the septal annulus motion and the anterior annulus motion was 
following the posterior free wall motion.
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According to our knowledge, there was no previous report describing the motion 
of both annuli during the cardiac cycle. We described the variations of the annulus shapes 
by their diameter changes. The mitral annulus had more significant changes in the axis 
parallel to the septum than in the free wall-septum axis AM-PM: 15.9 ± 10 % versus P l- 
P2: 13.1 ± 4%, which correspond to the findings of Gorman et al. [119]. The long axis 
(P-AS) of the tricuspid annulus expanded during ejection while the short axis (S-AP) was 
decreasing, following the motion of the diameters of the mitral valve. The tricuspid 
annulus long axis increase was associated with an early expansion of the tricuspid area 
during ejection. The contraction of the LV and the mitral annulus may create a dynamic 
balance of the atrioventricular valve septal junction. Our finding about the area of the 
mitral valve corresponds to that of Ormiston et al. who showed that the mitral annular 
area was increasing gradually during diastole and then was decreasing until midsystole. 
The mitral area started to increase again during late systole [100]. By using the Heron 
formula, we added triangles that were not on the same plane and respected the saddle 
shape of the annulus.
4-2: Annulo-papillary Muscle Apparatus of Mitral and Tricuspid Valves
In cadaveric hearts, the distances between the tip of both papillary muscles and 
the trigones or the point between the middle and lateral or septal scallops of the posterior 
leaflets were measured and found to be equal [124]. It has been shown in dogs that the 
orthogonal distance between the plane of the mitral annulus and the tips of both papillary 
muscles had a variation of less than 1-mm during the cardiac cycle with different heart 
rates and preload conditions [120]. In our study, the distance between each papillary
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muscle tip and the hemicorresponding mitral annulus remained the same during the entire 
cardiac cycle. We studied the Apex-PM tip changes during the cardiac cycle and 
observed an elongation followed by a shortening of the distance during systole. Komeda 
et al. reported the same variations of the papillary muscle lengths [120]. We compared 
Apex-PM tip changes to the variations of the averaged distances between the apex and 
the mitral annulus crystals, which correspond to an average of the LV wall variations. We 
found a significant difference for the average change during the cardiac cycle (Apex-Ml 
versus Apex-annulus, p=0.002 and Apex-M2 versus Apex-annulus, p=0.017) and for the 
relative expansion during the IVC (Apex-Ml versus Apex annulus, p=0.01 and Apex-M2 
versus Apex-annulus, p=0.01). The constant distance between the papillary muscles tips 
and the differences in changes between the apex-annulus distance and apex-papillary 
muscle distances suggest that both papillary muscles do not present the same changes as 
the ventricular wall during the phases of the cardiac cycle. The papillary muscles seem to 
be functionally different from the LV wall. The papillary muscles have variable 
morphology [104,105] and were always described as part of the LV in the conventional 
anatomy textbooks. Their muscular fibers of the body and base were understood to be in 
direct continuity with the myocardium of the LV. However, using x-ray multidetector CT 
with interactive 3-D images. Axel [125] has shown that the base of the human papillary 
muscles is not in continuity with the LV wall but through trabeculae carneae with clear 
demarcation spaces between both structures. These facts suggest that anatomically, the 
papillary muscles are different from the LV wall. Therefore, the papillary muscles, 
functionally and anatomically different from the LV wall, may function as independent 
structures that serve to maintain a constant distance between the annulus and their tip.
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This continuity between the mitral valve armulus and the papillary muscles has to be 
preserved for LV performance and prevents postoperative mid-ventricle rupture in cases 
of mitral valve replacement [126].
For the tricuspid valve, our results also showed a remarkable geometry of the 
annulus-papillary muscle complex. According to our knowledge, no one previously 
reported that each papillary muscle of the tricuspid valve remained at a constant distance 
from its corresponding commissure. Traditionally, in the RV, three tricuspid papillary 
muscles are described and identified as anterior, posterior and septal. In their anatomical 
work on 100 human hearts, Viktor et al. found that the papillary muscles of the tricuspid 
valve exhibited endless variations in number, size, shape, fusion and location [93]. We 
showed that a single anterior muscle constituted the tricuspid valve predominantly and 
that numerous muscles among the septum constituted the posteroseptal and anteroseptal 
groups (Experiment 1). Among these muscles, a posteroseptal one at the comer between 
the septum and the free wall and the conus PM were always present at the level of the 
anteroseptal and posteroseptal commissures. These muscles corresponded to the 
placement of the crystals during the experiment. L. Axel also studied the RV papillary 
muscles and found also that they were not attached to the RV wall but to the trabeculae 
tendinae [125] and that they were anatomically distinct from the RV wall. In the case of 
the RV, the papillary muscles may also correspond to independent structures that 
maintain a constant distance between their tips and the annulus.
We studied the relationships between the segments of the quadrilateral constituted 
by two PM tips and the intertigonal or the latero-lateral mitral annulus and by two 
papillary muscles and their corresponding commissures in the tricuspid valve. For the
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mitral valve our results showed a constant ratio close to one in each calculation. For the 
tricuspid valve, our results showed a constant ratio (different from one) during the phases 
of the cardiac cycle between interpapillary muscle and commissure-commissure distances 
and equal to one between papillary muscle -commissure distances. The mitral and 
tricuspid valves may be described as two (for the mitral) and three (for the tricuspid) 
annulo-papillary units constituted by two papillary muscles and the corresponding 
annulus with the leaflet base in between.
4-3: Papillary Muscle Motion
During systole, with the contraction of the ventricles, the interpapillary muscle 
distance in the LV decreased by 32% while the Apm-Ppm and Apm-Spm decreased by 
15% and 12%, respectively. However, the distance between Spm and Ppm, the papillary 
muscles inserted on the septum in the RV increased by 10%. We demonstrated that the 
long axis diameter (P-AS) and the septal segment (S-PS) of the tricuspid annulus 
expanded during ejection (figure 16 & 17) while the septum was contracting. At the level 
of the papillary muscles, the PM tip motion seemed to reproduce the motion of the 
tricuspid annulus. The contraction of the LV may create, not only at the armulus level but 
also at the papillary muscle level, a dynamic balance with the sub-valvular apparatus of 
the tricuspid valve during ejection. One explanation for this finding may be a physiologic 
bulging of the septum during contraction. According to the anatomical concept of 
Torrent-Guasp, a muscular band wrapped upon itself forms the heart [36]. The RV is 
formed by horizontal fibers wrapped on the helical bands that constitute the LV. During 
systole the successive contractions of the basal and apical loop of the LV band make the
108
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
muscle thicker and more spherical [127]. The septum may become prominent inside the 
RV during ejection, while the pressure inside the LV is increased, and thus the distance 
between the Spm and Ppm increases.
In conclusion, we studied the motion of both atrioventricular valves in vivo in 
normal ovine hearts with sonomicrometry array localization. Both annuli were linked by 
the septum and presented the same directional change during the cardiac cycle. The 
subvalvular apparatus of both valves was associated with the annuli in a remarkable 
geometrical pattern. The LV papillary muscles remained at a constant distance from the 
hemi-correponding mitral valve and the RV papillary muscles remained at constant 
distance from their corresponding commissures. The papillary muscles within each 
ventricle were associated with the each other to form with the trigones and the lateral 
mitral annulus or with their corresponding commissure areas on the tricuspid armulus a 
trapezoid-like quadrilateral. These quadrilateral sides presented constant ratios during the 
cardiac cycle.
Although sonomicrometry has an outstanding spatial and temporal resolution 
[119], differences in surgical placement and anatomic variations of the animals may 
explain deviations in measurements between research groups or even within the same 
group. To minimize this problem, the same surgeon performed all surgeries. This 
experiment was also conducted as an acute, open chest, open pericardium study on an 
anesthetized animal. This associated with the deleterious effect of cardio-pulmonary 
bypass and ischemia could have resulted in abnormal valve behavior.
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Experiment 3: Comparison of Sonomicrometry and TTE Data in Sheep 
1: Trans-thoracic echocardiography in sheep
The traditional long axis (aortic root to apex), short axis (perpendicular to long 
axis) and four chambers (traversing both ventricles and atria through mitral and tricuspid 
valves) views [128] of trans-thoracic echocardiography in sheep are obviously different 
from human patients. The TTE in human patients has been described as iterative and 
dependent on anatomical characteristics of the patient and manipulation of the operator 
[129]. The three dimensional structures are sliced in two-dimensional images and allow 
the measurements of intracardiac structures. To recognize precisely the structures that are 
measured by TTE in sheep where no references are available, comparisons between TTE 
data and sonomicrometry data were undertaken.
2: Materials and Methods
2-1: Echo data acquisition
Tar ghee sheep (n=6) were anesthetized and a trans-thoracic echocardiography 
was performed (HP, 5500) by the same operator. The sheep was positioned on its right 
side on the operating table. A short-axis view was acquired through the 5* left intercostal 
space about 4 cm above the sternum. A long-axis view was acquired trough the 4* left 
intercostal space 4 cm above the sternum. The short axis view allowed seeing the LV and 
its papillary muscles but did not allow any measurements on the RV. Only the long axis 
view allowed the analysis of both annuli and both ventricles because of the anatomical 
conformation of the sheep.
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Left ventricular and RV measurements were performed. For the LV: on short-axis 
view, maximum and minimum inter-papillary muscle distances (M l-M2) at the level of 
the head of papillary muscles were measured. On long-axis view, maximum and 
minimum M2-posterior annulus dimension and M2-anterior annulus (tethering distance) 
were measured. On the same view, maximum and minimum antero-posterior mitral 
annulus diameters were measured. Only the long-axis view was used for the 
measurements in the RV. The annulus diameter, the distance between the apex and the 
septal part of the annulus and the distance between the apex and the free wall part of the 
annulus were measured in systole and diastole. The distance between the tip of the free 
wall papillary muscle and the free wall annulus and the distance between the free wall 
PM and the septal annulus were acquired in systole and diastole. The distance between 
the septal papillary muscles and the septal annulus and the distance between the septal 
papillary muscle and the free wall annulus were also measured in systole and diastole.
2-2: Surgical experiment
Sonomicrometry data from crystals implanted in the sheep described above in the 
LV, RV, mitral and tricuspid annuli were used in this experiment. Three beats were 
selected from the filtered sono data, using Sonometric’s software (SonoSOFT Version 
3.1.4, Sonometrics Corp, London, Ontario, Canada). Maximum and minimum distances 
between the following crystals were found for each beat and were used for comparisons. 
For the LV dimension; The interpapillary muscle distances measured on TTE were 
compared with the inter-papillary muscle distance using the crystals implanted on the 
head of both papillary muscles (M l-M2).
I l l
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For the mitral and tricuspid annuli: The TTE a mitral annulus diameter was compared 
with the antero-posterior distances of the mitral annulus defined by the following 
crystals: AM-PM, T l-P l, T2-P2, Tl-PM, T2-PM, AM-Pl and AM-P2. The TTE 
tricuspid annulus diameter was compared with the distance defining the septo-lateral 
diameter (S-A, S-AP or S-P).
For the LV: M2-posterior annulus distances from TTE were compared with the distance 
between the head of the postero-medial papillary muscle and the posterior annulus M2- 
P l, M2-PM and M2-P2. The tethering distance (M2-anterior annulus) from TTE was 
compared with the distance between M2-AM, M2-T1 and M2-T2.
For the RV: The distance between free wall PM and the septal annulus from TTE were 
compared with Apm-PS, Apm-S and Apm-AS. The distance between free wall PM and 
the free wall annulus from TTE were compared with the Apm-A, Apm-AP and Apm-P.
2-3: Statistical analysis:
Samples of sheep were drawn randomly from a population of Targhee sheep with 
an assumed normal distribution. Because of the small number of our samples and to 
allow the use of parametric tests, normal distribution of our numbers was checked by a 
normal-probability-plot. Statistical analysis was performed using the unpaired t-test with 
p<0.05 significance.
3: Results 
3-1: Data Comparison
The validity of the comparison of the sono and TTE groups was determined by 
matching the weight and hemodynamic characteristics of the two groups. The weight of
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the TTE group was not significantly different from the weight of the sono group (57.6 ± 6 
kg versus 72 ± 21kg respectively, p= 0.2). Comparison of cardiac output (CO) and aortic 
systolic pressure were not significant (3.3 ± 0.4L/min versus 2.9±0.4 L/min, p=0.24 and 
72 ± 5 mmHg versus 67 ± 2 mmHg, p=0.26, respectively).
In short axis view, the interpapillary muscle distance (M l-M2) measured in TTE 
was 27.7 ±6.1 mm in ED and 26.4 ± 5.8 in ES. These measurements were not different 
from 29.8 ±6.1 mm in ED (unpaired t-test, p=0.24) and from 23.8 ± 7 mm in ES 
(unpaired t-test, p=0.12).
In long axis view, the TTE measurements for the mitral and tricuspid annulus 
diameters are reported in table 13. The TTE diameter of the mitral annulus was not 
significantly different from AM-PM and from AM-Pl in ED and ES and from Tl-PM  in 
ED. The TTE measurement of the tricuspid annulus was not significantly different from
S-AP, S-P and AP-AS in ED and ES. Altogether, the 2-D picture acquired by TTE 
corresponded to a slice of the heart through the mitral annulus at the level of the segments 
AM-Tl and PM-P2 and through the tricuspid annulus at the level of the segments S-AS 
and AP-P (Figure 25).
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Table 13; Comparison of TTE long axis view and sonomicrometry measurements (in 
mm) of the two groups for the LV and the mitral valve.
ED; end diastole. ES: end systole.
AM & PM: anterior & posterior mitral annulus
T1 & T2: trigones
PI & P2: Lateral mitral aimulus
S, AS & PS: septal, anteroseptal & posteroseptal tricuspid annulus
Echo N=10 Sonomicrometry N=7 Unpaired t- 
test
mitral annulus diameter
Mean SD Mean SD
ED 30.30 2.67 AM-PM ED 27.94 2.70 0.44
ES 29.10 3.28 ES 26.44 4.07 0.05
T1-P1 ED 13.22 2.84 <0.05
ES 12.41 2.40 <0.05
T2-P2 ED 14.20 3.16 <0.05
ES 13.86 2.28 <0.05
T1-PM ED 28.16 4.75 0.66
ES 25.53 3.75 0.01
T2-PM ED 11.93 2.11 <0.05
ES 12.65 2.61 <0.05
AM-Pl ED 28.60 1.1 0.05
ES 26.8 1.2 0.07
AM-P2 ED 13.04 4.23 <0.05
ES 13.64 3.94 <0.05
Tricuspid annulus diameter
Mean SD Mean SD
ED 22.75 1.75 S-A ED 29.68 5.57 0.02
ES 22.02 1.73 ES 29.57 6.37 0.04
SAP ED 25.85 6.01 0.18
ES 25.97 6.42 0.28
S-P ED 20.46 5.84 0.55
ES 22.71 5.71 0.99
AS-P ED 28.73 6.24 0.07
ES 31.00 6.45 0.02
AS- AP ED 20.66 4.72 0.53
ES 20.59 5.72 0.41
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For the mitral valve, the TTE tethering distance (ED: 39.54 ± 5.24; ES: 40 ± 5.27) 
was not significantly different from the sono measurements of M2-AM (ED: 38.22 ± 
4.57,p=0.76; ES: 38.62 ± 5.2, p=0.99) and of M2-T1 (42.54 ± 4.97, p=0.14; ES: 41.62 ± 
5.12,p=0.17) but was significantly different from M2-T2 (ED: 30.17 ± 4.5, p<0.005; ES: 
30.6 ± 4.6, p<0.005). M2-posterior mitral annulus (ED: 25 ± 3.23 and ES: 25.7 ± 2.83) 
was not significantly different from M2-PI (ED: 41.01 ± 8.26, p=0.59; ES: 39.51 ± 7.47, 
p=0.6) M2-PM (ED: 32.34 ± 6.41, p=0.25; ES: 34.4 ± 5.7, p=0.54) but was significantly 
different from M2-P2 (ED: 26.7 ± 4.9, p<0.005; ES: 28.24 ± 4.8, p<0.005). These results 
are consistent with the previous results on the mitral annulus.
For the tricuspid valve, the TTE distance papillary muscle free wall-septal 
annulus (ED: 31.48 ± 6.04; ES: 36.08 ± 2.87, p=0.12) was not significantly different from 
the sono measurement of Apm-S (ED: 38.25 ± 2.86, p=0.14; ES: 36.08 ± 2.87, p=0.12) 
and of Apm-AS (ED: 35.85 ± 5.5,p=0.53; ES: 34.04 ± 4.8, p=0.38) but was significantly 
different from Apm-PS (ED: 39.33 ± 3.83, p=0.03; 38.33 ± 4.1,p=0.04). For papillary 
muscle free wall-free wall annulus, the TTE measurement was not significantly different 
from Apm-P (ED: 28.1 ± 5.92, p=0.97; ES: 27.73 ± 6.51, p=0.32), from Apm-AP (AD: 
21.22 ± 3.44, p=0.1; ES: 21.4±3.14, p=0.05) Apm-A (ED: 28.14 ± 2.36, p=0.98; ES: 
27.86 ± 2.6, p=0.22). These results were consistent with the previous results if we 
consider that Apm-P and Apm-A present the same dimension.
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3-2: Correlation of Trans-thoracle Echocardiography and Sonomicrometry 
Measurements:
Altogether, the 2-D picture acquired by the TTE corresponded to a longitudinal 
slice of the heart (Figure 25):
At the level of the LV :
- through the mitral annulus at the level of the segments AM-Tl and PM-P2, 
through the postero medial papillary muscle M2.
At the level of the RV :
- through the tricuspid annulus at the level of the segments S-AS and AP-P,
- through the septum between Spm and Ppm,
- through Apm
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Figure 25: Correlation in sheep between a slice of the sound waves at the level of the 
annuli (left) and the TTE picture (long axis view acquired trough the 4*'’ intercostal 
space).
AM: Anterior mitral annulus
PM: Posterior mitral annulus
T1 and T2: Left and right trigone
PI and P2: Left and right lateral mitral annulus
S, AS and PS: Septal, anteroseptal and postero septal tricuspid annulus
A, AP and P: Anterior, anteroposterior and posterior tricuspid annulus.
LV and RV: Left and right ventricle
Apm: Anterior papillary muscle of the right ventricle.
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4: Discussion
In experimental studies with sheep, different methods may be used to measure the 
geometrical variations of the heart. Sonomicrometry crystals were developed by Smith et 
al. [122]. Using sound waves and piezoelectric crystals, records of distances between 
crystals can be obtained 200 times per second. The sonomicrometry technology was used 
to study the mitral valve physiology [119], the importance of the stay chords [66] and the 
aortic valve during the cardiac cycle [130]. Another technology to measure the geometry 
of the heart is to implant radiopaque markers to silhouette the LV, annulus and papillary 
muscles. Using a biplane videofluoroscopic machine, two-dimensional images from the 
two X-ray views are acquired and analyzed through a computer at 60 Hz. With that 
technology in the research laboratory of cardiovascular sciences at Stanford University, 
geometrical changes of the LV after Ml or chordal cutting [65] were studied. These two 
technologies measure at high frequency and with great precision the variations of the 
distances between two crystals or between two radiopaque markers. However, a 
cardiopulmonary bypass is needed to implant crystals and radiopaque markers. The 
advantage of the sonomicrometry is the 200 Hz frequency of data acquisitions. However, 
sonomicrometric crystals have to be connected to the sono-computer to record the data.
In case of a survivor model, the chest of the animal has to be closed with the crystal wires 
under the skin and additional measurements must be performed by opening the skin 
again. The use of radiopaque markers allows researchers to study the sheep while 
anesthetized only. Thus, in a survivor model, two sets of measurements with these 
technologies can be “safely” recorded: After implantation, and at sacrifice. The surgeon 
places the crystals or the radiopaque markers under direct view. All the distances
118
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
measured are between anatomical places chosen and known by the surgeon. Because of 
the non-invasiveness of TTE image acquisition, the measures can be made repetitively 
and allows the follow-up of geometrical changes of the ventricle and the mitral valve in a 
survivor model. The TTE allows the measurement on 2-D pictures of distances between 
structures that have an assumed precise position on a 3-D heart. Further the 2-D 
echocardiography can be done with the sheep not anesthetized, restrained in a sling for 
example, and therefore, avoids the surgical implantation of sonomicrometry crystals or 
radiopaque markers thus reducing the morbidity and mortality associated with a survivor 
model. TTE technique in sheep is different from humans and no reference on TTE 
technique exists for the sheep. Due to the anatomy and the position of the transducer, 
traditional TTE views are not possible to acquire in sheep. As in humans, the heart is 
closer to the ribs in the left side of the chest in sheep. The acquisition of an image 
through the right part of the chest was not possible because of the presence of the right 
lung. The air in the lung does not transmit the sound waves of the crystal vibration and 
does not allow one to acquire reliable pictures. Therefore, the view of the heart was taken 
on the left side of the chest. A four to five centimeter space between the inferior and 
superior part of the lung, at the level of the sternum and the 4* and 5th intercostal space 
was used (Personal observation on 50 sheep). Through this space it was possible to 
acquire a long- and short-axis view of the heart. The short-axis view allows the 
acquisition of an image at the level of the papillary muscles of the mitral valve, but the 
view through the annulus was not possible. The measurements of the interpapillary 
muscle distance were comparable to the M l-M2 distance as measured by 
sonomicrometry. To analyze both atrioventricular valves, only a long-axis view through
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the 4*'’ intercostal space was available. We compared TTE distances available to 
sonomicrometry measurements. The comparison of our data showed that the long-axis 
view acquired by TTE in sheep corresponded to the analysis of the antero lateral part of 
the mitral annulus (around AM-Pl) and to the short-axis diameters (S-AP or S-P) of the 
tricuspid valve (Figure 25). The presence on the TTE image of a papillary muscle head in 
the LV close to the septum corresponded to the postero-medial papillary muscle, M2. The 
presence of a PM in the RV close to the free wall corresponded to the anterior papillary 
muscle Apm that we described as well isolated and constant (Experiment 1).
The TTE examination in sheep is not standardized and as in humans is iterative and 
largely determined by the anatomic characteristics of the sheep and manual manipulation 
of the transducer by the operator. The presence of a good “window” that enables the 
transmission of the ultrasound signal to the heart is not predictable. The same operator 
performed all the echocardiograms and the measurements to minimize any differences.
Conscious of the complexity and invasiveness of sonomicrometry, we undertook 
a study comparing sonomicrometry versus TTE measurements. In an attempt to study the 
geometry of both atrioventricular valves in sheep we compared sonomicrometry findings 
with TTE measurements obtained on anesthetized sheep and found that TTE 
measurements were comparable to sonomicrometry measurements. The long axis view 
acquired through the 4̂ ’’ left intercostal space in sheep provided the distance between the 
postero-lateral and anteromedial mitral annulus and between the septal and lateral part of 
the tricuspid annulus. This view allowed the analysis of both leaflets and postero-medial 
PM of the mitral valve and of the Apm of the tricuspid valve. These findings confirmed 
the possibility of performing chronic animal studies with TTE follow-up.
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Experiment 4: Percutaneous induction of a postero-lateral infarct by 
injection of 100% ethanol and analysis of LV and RV geometrical 
changes. 
1: Review of Existing Animal Models of Heart Failure:
The objectives of the animal model are to mimic the condition of human ischemic 
MR, which corresponds with a LV dysfunction associated with functional MR. The 
chronic experimental models have been directed towards inducing either global 
cardiomyopathy or a localized infarction. Ischemic heart failure can be studied with a 
large animal model to evaluate the effects and benefit-to risk ratio of new medical and 
surgical therapies.
1-1: Heart Failure Induced by Toxin:
Toxin administration to animals can mimic heart failure. The most commonly 
used toxin is doxorubicin, an anti-neoplastic drug, well known for its cardiac toxicity. 
Eighty-nine cases of heart transplantation in patients with doxorubicin -induced 
cardiomyopathy were reported by United Network for Organ Sharing between 1990 and 
1996. In animals, many experiments demonstrate a decrease in cardiac function after 
doxorubicin administration.
Tessier et al [131] associated the use of low dose doxorubicin (0.5-1 mg/kg) 
systemic infusion with the surgical creation of an arterio-venous (carotid-jugular vein) 
fistula. Evaluation of the heart dysfunction was done with 2-D echocardiography 
measuring the LVEDD, LVESD and LV shortening fraction. They showed in goats that 
0.5 mg/kg of doxorubicin injected weekly during 13 weeks created an increase in LVESD
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of 48 ± 12% and in LVEDD of 24 ± 4%. Also, shortening fraction decreased 
concomitantly by 32 ± 1%. When 1 mg/kg was injected, similar but more pronounced 
results were observed with a 38 ± 23% increase in LVESD and 10.3 ± 5.6% in LVEDD 
as well as a 41.7 ± 3.2% decrease in shortening fraction. All these results remain stable 
during three months after the 13* injection. The respective role of the doxorubicin 
infusion and the arterio-venous fistula could not be determined because of the absence of 
a control group. Chekanov et al. [132] used the same protocol with a daily injection of 
doxorubicin resulting in a creation of acute stable heart failure.
To avoid systemic toxicity, intracoronary injection of doxorubicin was reported 
by Shah et al. [133]. In 20 dogs, 1 mg/kg of doxorubicin was administrated through a 2"** 
diagonal catheter resulting in accelerated heart failure in 12 weeks. Results were assessed 
by 2-D echocardiography measurements. All measurements were significantly different 
through the follow-up (LVEDD: +17.5%, p<0.0001; EF: -  38.3% p<0.0001).
Histological changes in both ventricles included myocyte hypertophy, loss of myofibrillar 
material and vacuolization, which are comparable to findings in clinical human heart 
failure. However 60% survival rate were reported at 12 weeks with nine sudden cardiac 
deaths.
Reviewing the intracoronary doxorubicin administration as a chronic heart failure 
model in dogs, shows that this drug can be used effectively to produce heart failure 
without systemic complications [134-136]. However, LV depression and mortality rates 
are dose-dependent and vary from one study to the other (mortality reported from 0% to 
40-50 %[135]). This high mortality rate is likely unacceptable for most heart failure 
studies and result variations question the reproducibility of this method in dogs.
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LV intramyocardial injection of snake cardiotoxin induced a well-delineated 
transmural lesion. Rajnoch et al [137] reported the snake cardiotoxin Naja Mossambica 
Mossambica injected directly in the LV wall exposed through a LV thoracotomy in nine 
sheep. This method created a scar and was followed by remodeling of the LV. This 
original method was used to study LV wall motion after the implantation of satellite cells 
into the myocardium. All these techniques can create heart failure with LV dilatation. 
However, the presence of mitral or tricuspid insufficiency was not reported in these 
studies.
1-2: Heart Failure Induced by Rapid Pacing
Rapid ventricular pacing or tachycardia induced heart failure is the most common 
heart failure animal model associated with MR. Dogs were most commonly used [138] 
and to a lesser degree swine and sheep[139]. At 240 bpm during 3-4 weeks, dogs 
develop heart failure with many features of human end-stage heart failure, but rapid 
reversal of signs with profuse diuresis occurs at termination of pacing [140]. Byrne et al 
[139] created a pacing protocol which allowed a slower heart failure development. The 
pacing rate was modified through the study according to cardiac output and the clinical 
status of the animal. Therefore the authors were able to measure and study the distinct 
levels of heart failure. Patel showed also that increasing the duration of ventricular pacing 
to ten weeks created a long-term model of heart failure [141]. Results were assessed by 2- 
D echocardiography measuring a 155% increase in LV volume at 12 weeks.
Timek et al [142] studied the mechanism of the MR associated with an ovine 
model of tachycardia-induced cardiomyopathy. Timek showed that the mechanism of the
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MR was not associated with a tethering effect. LVES and LVED volumes, mitral annulus 
area (36 ± 14% and 46 ± 13% in end diastole systole respectively), interpapillary muscles 
distance (from 29.9 ± 4.2 to 35 ± 4.1 mm in end diastole and from 23.9 ± 3 mm to 30.4 ± 
3.7 mm in end systole) increasing significantly. However, impaired mitral leaflet 
coaptation was not due to a displacement toward the ventricle of the coaptation point of 
the anterior and posterior leaflet. Mitral leaflets were at the same position relative to the 
annulus in systole. Therefore, incomplete mitral coaptation and resulting MR were due to 
mitral annulus dilatation.
In this ovine model of tachycardia-induced cardiomyopathy, the annulus dilated 
more in the septal-lateral (+25+12 %) than in the commissure-commissure dimension 
(+9+5%). The saddle shape of the annulus was preserved but flattened [143]. 
Tachycardia-induced heart failure is effective for a stable LV dilatation and depression of 
EF if associated with a long and slow pacing protocol. Associated MR is mainly due to a 
dilatation of the mitral annulus in the septo-lateral dimension.
1-3: Heart Failure Indueed by Isehemia
Several animal models reproduced ischemic events in the animal heart to mimic 
the development of ischemic heart failure in humans. Gelatin sponge intracoronary 
embolization created LV failure in pigs [144]. In a controlled study, pigs underwent 
catheterization of the LAD using a 2.5Fr catheter, with the tip of the catheter placed 
between the first and the second diagonal branches. Small gelatin sponge particles 
homogenized and mixed with heparanized saline were then infused in the distal part of 
the LAD. Recanalization of the LAD occurred in all animals with poor run-off at 1 week.
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LVEDD and LVESD increased significantly at 4 and 8 weeks. Plasma BNP levels, 
reported to increase with the severity of congestive heart failure [145,146], were 
significantly higher in infarcted animals than in the control group.
Microembolization of microsphere was also used in dogs to create a model of 
heart failure [147]. The technique that used cardiac catheterization of the left coronary 
ostium followed by injections of microspheres was performed and discontinued when EF 
measured by 2-D echocardiography was between 30 and 40%. LVED and LVES volumes 
increased significantly at three months from 62 ± 4 to 78 ± 4 ml (p-0.001) and from 38 ± 
3 to 47 ± 3 ml (p=0.001), respectively.
Llaneras et al [35] described a model of coronary ligature in sheep. Ligation of 
the L* and 2"‘̂ marginal branches (group 1) infarcted 23 ± 3% of LV mass, did not infarct 
the posterior papillary muscle and increased significantly LV cavity size. Ligation of 
OM2 and 0M3 (group 2) infarcted 21.4 ± 4% of the LV and completely infarcted the 
PPM. Ligation of 0M2, 0M3 and PDA (group 3) infarcted 40.4 ± 7.2% of the LV mass 
and included PPM and the posterior one third of the ventricular septum. Group 1 and 2 
sheep were followed during 8 weeks and MR was measured by echocardiography. MR 
developed in group 2 (average MR: +2.7) and not in group 1. Severe MR developed 
immediately in group 3 and 83% of sheep died within 3 hours. Ventricular dilatation was 
assessed by angiography measuring LVED and LVES areas. LVED and LVES dilatation 
were significant in Group 2 at 8 weeks (p<0.01) and in group 3 one hour after the 
infarction (p<0.01).
Gorman et al [148] and Moainie et al [149] observed that ligation of the first two 
diagonal branches of the left descending artery in sheep produced massive dilatation of
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the LV within 8 weeks. Both groups reported that around 24% of the LV mass with 82% 
of the anterior PM mass were infarcted. LVED and LVES volumes increased 
significantly (+73.2% and +115.3% respectively) at 8 weeks after the procedure and the 
EF significantly decreased (p<0.05). Gorman et al also reported the acute ligation of the 
L* and 2"‘* diagonal and OMl which infarcted 33 % of the LV and the entire APM. 
LVESD and area increased by 12.5% and 34.2%, respectively. However no MR was 
reported when coronaries which supplied the anterior wall were ligated. Therefore 
according to Gorman et al [148], infarct size and location determined the development of 
MR in the ovine model.
2: Materials and Methods
2-1: Induction of the Myocardial Infarction
The sheep were heparinized with 10,000 Units i.v. plus an additional 5,000 
Units/hour. A catheter was introduced (6F Pinnacle, Terumo, Inc., Somerset, NJ, USA) 
via the left carotid by percutaneous puncture or cut down. An angiogram was performed 
using a C-arm (OEC 9400, GE Medical Systems, Inc., Waukesha, WI, USA) via a 
guiding catheter (LA6HS1, multipurpose hockey stick 1, Medtronic, Inc., Minneapolis, 
MN, USA) to identify the second (0M2) and third (0M3) obtuse marginal branches of 
the circumflex artery. A balloon catheter (D3S3020, Over-the-Wire Balloon Dilatation 
Catheter, Medtronic, Inc., Minneapolis, MN, USA) was positioned in the origin of 0M2 
and inflated beyond the first branch (4 bar). Therefore, the distal part of OM2 was 
isolated from the coronary circulation. Without deflating the balloon, 1 to 3 ml of 100% 
ethanol (EtOH) was injected into the distal part of 0M2. After 5 minutes, the balloon was
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deflated and the heart was allowed to recover for 30 minutes. The guide wire and the 
balloon catheter were then advanced into 0M3, inflated again distal to its origin (4 bar), 
and 2 to 3 ml of 100% EtOH was injected. We empirically decided to limit the total 
volume of EtOH injected to 5 ml. After 5 minutes, the balloon catheter was deflated. 
Aortic pressure was recorded through the angiocatheter. Cardiac output and pulmonary 
artery pressure were measured through the Swan-Ganz catheter before and after the 
procedure. During the entire procedure, amiodarone (40 mg/h) and lidocaine (4 mg/min) 
were infused to prevent arrhythmia. Before each EtOH injection, magnesium (Ig i.v.), 
lidocaine (60 mg i.v.) and bretylium (25 mg i.v.) were injected.
2-2: Data Acquisition and Follow-up
Transthoracic echocardiography was performed before the procedure (baseline), 
after the procedure, at weekly intervals, and at sacrifice. The sheep was positioned 
upright in a fenestrated sling for the TTEs. Left ventricular end-systolic (LVESD) and 
end-diastolic (LVEDD) dimensions and the interpapillary muscle tips distance at end- 
systole (M l-M2 ES) and end-diastole (M l-M2 ED) were recorded through a short axis 
view. The mitral valve annulus diameter was measured and the presence of IMR and/or 
ITR was evaluated in the long axis view. The severity of IMR and of ITR was determined 
by the length of the jet (1+ present; 2+ half the distance to the atrial walls; 3+ reaching 
the atrial wall, and 4+ for reverse pulmonary vein flow or if the jet reached the inferior 
vena cava) [150]. Displacement of the papillary muscles was calculated as the distance 
between their tips and to the contralateral mitral annulus (“tethering distance”). Valve 
coaptation height or “tenting distance” was measured as the distance between the leaflet’s
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coaptation point and the mitral annulus plane at end-diastole. The ejection fraction (EF) 
was calculated using the Teichhotz formula for the end-diastolic and systolic volumes 
[151]. The following RV dimensions were measured at baseline and at sacrifice in ES 
and ED on the long axis view: the tricuspid annulus diameter, Apm-free wall annulus, 
Apm-septal annulus and RV diameter at the level of the Apm.
After 6 to 10 weeks, the animals were again anesthetized. The chest was opened 
through the fourth intercostal space. An epicardial echocardiogram was performed to 
analyze LV and RV function and the degree of IMR and ITR. A Swan-Ganz catheter was 
placed via the left jugular vein to record pulmonary artery and RV pressures and cardiac 
output. After heparinization with 10,000 Units, the animal was euthanized with an 
injection of 60 mEq of KCl in the ascending aorta and the heart was excised.
2-3: Macroscopic and Histology Analysis
The hearts were cut into eight or nine 1-cm thick transverse slices. The slices 
were incubated in 2% triphenyl tétrazolium chloride (Sigma Chemical, St. Louis, MO, 
USA) for 30 minutes at room temperature [152]. The individual slices were weighed and 
photographed (Canon Powershot A70). The left ventricular and infarcted areas were 
quantified using planimetry software (AutoCAD Autodesk, San Rafael, CA) to determine 
the percentage of LV area infarcted, which was used to determine the LV mass infarcted. 
The slices were fixed in 10% formalin for histologic analysis. The fixed samples were 
dehydrated and embedded in PolyFin wax (Polyscience, Inc, Warrington, PA, USA), 
sectioned at 5 pm, and collected on Superfrost® plus slides (VWR Scientific, West
128
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chester, PA, USA). Representative sections were stained with hematoxylin and eosin 
(H&E) for general tissue and cellular morphology.
2-4: Statistical Analysis
Data were evaluated with repeated measures analysis of variance (ANOVA) 
explored by 3 paired student t-test comparing each time point (baseline versus immediate 
post-infarction, post-infarction versus sacrifice, and baseline versus sacrifice). A p-value 
<0.016 was defined as statistically significant (Bonferroni corrected).
3: Results
3-1: Percutaneous Induction of Myocardial Infarction
The EtOH ablation procedure was performed in six sheep with an average weight 
of 53.6 Kg (range 64.5 to 39.5 Kg). The left carotid introducer was placed percutaneously 
in 4 and with a cut-down in 2 sheep. The baseline coronary angiograms showed that the 
LV apex was supplied by the left anterior descending artery in five cases (type A) and by 
the circumflex branches in one case (type B). These findings were similar to those 
reported by Llaneras et al. [35]. In five cases, it was easy to visualize OMl and 0M 2 by 
videofluoroscopy. In four sheep, the coronary anatomy was similar. The origins of 0M2 
and 0M3 were well-individualized branches off the circumflex artery. In three of these 
cases, each branch had two EtOH injections (Figure 26). In one case, 0M 2 and 0M3 
were very small, and 0M 4 was injected followed by irreversible ventricular fibrillation 
that terminated the procedure. In two other cases (one type A and one type B), a large 
branch of the circumflex artery divided distally into 0M2 and 0M3. In these cases, a
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single bolus of EtOH was injected in the large branch (4 and 5 ml respectively). The 
mean volume of 100 % EtOH injected was 1.5 ml in 0M2 and 2.6 ml in 0M3 (for a total 
of 4 ml/animal). The hemodynamic and echocardiographic data at baseline and 
immediately after the procedure are shown in Table 14. In all cases, frequent multiform 
ventricular nonsustained tachycardia occurred at the time of injection, which stopped 
spontaneously, when the injection was terminated. In all animals the EKG, showed 
severe ST segment elevation after the EtOH injection (Figure 27).
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Figure 26: Coronary angiogram o f the left coronary before (left) and after (right) 100%
EtOH injection.
The distal part of the artery is no more apparent after the injection of contrast product in 
the coronaries. EtOH: ethanol, 0M2 & 0M3: Obtuse marginal arteries 2 and 3.
Figure 27: EKG at the end of the procedure showing S-T segment elevation.
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3-2: Development of Ischemic Cardiomyopathy
Five animals were followed for an average of 8 ± 1.3 weeks. The two animals 
with a single large OM that received only one injection of EtOH developed early clinical 
heart failure at 2 weeks post-procedure, requiring the administration of furosemide (20 
mg twice/week) followed by daily doses (20 mg) during the last week before sacrifice at 
6 and 7 weeks. The other three animals showed signs of clinical heart failure after the 
fourth week. They were sacrificed at weeks 8 and 9. At the time of sacrifice, all animals 
were in heart failure. They were breathing rapidly, had pale noses, stretched their hind 
legs, increased their water intake and retained fluid. The average weight increased by 
16% (p==0.043), from 56.4 ± 7.6 kg (range 44 to 64.5 kg) to 65.3 ± 3.9 kg (range 63.1 to 
71.2 kg). The hemodynamic and echocardiogram data at the end of the study are shown 
in Table 14. At sacrifice, the mean grade of IMR was 2.8 ± 0.45+ and ITR was 2.1 ± 
0.5+. The LVEDD increased from 43.9 ± 3.51 mm to 58.4 ± 5.94 mm (33.7 ± 17%, 
/?=0.009) and the LVESD increased from 31.7 ± 3.4 to 50.6 ± 8.47 mm (62 ± 40%, 
/?=0.015). The diastolic distance between papillary muscles increased from 28.2 ± 6.8 to 
36.4 ± 5.4 mm (32 ± 24%,/?=0.01). The systolic distance between papillary muscles 
increased from 21.3 ± 3.4 to 29.6 ± 6.2 mm (40.7 ± 32%). The tethering and tenting 
distances increased by 32.7 ± 28% and 108 ± 65% (p=0.036), respectively. The mitral 
annulus diameter had enlarged by 18.5 ± 15.3% in diastole and by 29.7 ± 41.3% in 
systole.
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Table 14: Hemodynamic and echo data, before and after EtOH injection and at sacrifice.
M l : antero-medial left papillary muscle 
M2: postero-lateral left papillary muscle
LVEDD & LVESD: Left Ventricular End-Diastolic/Systolic Dimensions in short axis 
view
MR&TR: Mitral and Tricuspid regurgitation, PAP; Pulmonary artery pressure 
0M2 & 0M3: Obtuse marginal arteries 2 & 3
*: Repeated measure analysis of variance, p<0.05 repeated measures ANOVA significant 
**: Comparison between baseline and sacrifice, p<0.016 (Bonferroni corrected)
***: Comparison between after injection and sacrifice, p<0.016 (Bonferroni corrected). 
The differences were not significant for the paired t-test between baseline and after 
injection. Significant dilatation of the left ventricle occurred during the follow-up after 
the EtoH injection.
Baseiine After injection OM2-OM3 Sacrifice
PAP mm Hg 25/18 28.6/22 28/13
Cardiac output L/min 3.18 2.87 3.92
Aortic pressure mmHg 87/66 86/67 72/55
EKG normal ST-segment elevation
EF%* 56.4+7 48+9 29.6±14** ***
M1-M2 ED mm* 28.2+6.8 32.4+4.64 36.4±5.4** ***
M1-M2 ES mm 21.3+3.36 25.4+2.25 29.6±6.23
MR* 0 0.2 2.8±0.45** ***
LVEDD short axis, mm* 43.9+3.51 48.8+5.08 58.4±5.94**
LVESD short axis, mm* 31.7+3.4 37.5±3.15 50.6±8.47**
TR* 0.2 0.5 2 i±0  5** ***
Tethering distance 37.1+6 37.5 ±6.59 47.2±3.76
Tenting distance mm* 4.7+1.3 6.6 ± 1.6 10.25±0.5**
Mitrai annuius ES 29.6+5.6 31 ±2.4 36.3±2
Mitrai annuius ED 31.5+5.4 33.2 ±4.7 37.3±2.9
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We also observed the development of a TR during the development of the MR. At 
sacrifice we observed a directional jet toward the atrial septum on epicardial 
echocardiography (figure 28). The dimension of the tricuspid annulus increased by 11 + 
7% (p=0.03) in ED, and by 8 ± 6% (p=0.04) in ES. The distance between the papillary 
muscle on the free wall (Apm) and the annulus at the level of the free wall increased by 5 
± 3% (p=0.05) in ED, and by 3 ± 7% (p=0.48) in ES. The distance between Apm and the 
annulus at the level of the septum increased by 8 ± 5% (0.03) in ED, and by 16 ± 24 
(p=0.26) in ES. The distance between the septum wall and the free wall increased by 21 ± 
17% (p=0.04) in ED, and by 0.35 ± 23% (p=0.01) in ES. The dimension of the RV and 
the tricuspid valve are reported in table 15. Figure 29 shows the progressive TTE changes 
during the follow-up.
Table 15: Variations of RV dimensions at baseline and at sacrifice.
FW: Free wall, Apm: Anterior papillary muscle of the RV, ED: End diastole, ES: End 
systole
Pre EtOH Sacrifice Paired t-test
Tricuspid annulus ED 21.1±1.2 23.6±2.2 0.03
ES 19.5±1.8 21±1.9 0.04
Apm-FW annulus ED 29 ±5.6 30.9±6.9 0.05
ES 28.8±11.3 28±7.9 0.87
Apm-septal annulus ED 28.2±1.2 30.6±1.3 0.03
ES 24.1 ±4.8 26.3±1.1 0.26
RV diameter at level of Apm ED 14±2.2 16.5±1.2 0.04
ES 9.6±1.9 12.7±2 0.01
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Figure 28: Directional jet o f the ITR at sacrifice.
The directional jet toward the atrial septum corresponded to a tethering of the septal 
leaflet.
RA: Right atrium,
RV : Right ventricle 
LV : left ventricle
L
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Figure 29: Mean variations o f all sheep in MR, TR, LVEDD, EF and M l-M2 ED (during
the follow-up).
MR & TR: Mitral and Tricuspid regurgitation 
EF: Ejection fraction
M l-M2 ED: Interpapillary muscle distance in end diastole 
LVEDD: Left ventricle end diastolic dimension
E
E
MR ITR EF% M1-M2 ED ■ LVEDD
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3-3: Histology Analysis
The infarct area was 22 ± 3.5% (range 19.1% to 24%) of the LV area and had a 
mean calculated weight of 48.2 ± 6.1g. Macro and microscopically, the posterior 
papillary muscle was not infarcted. Histology of the infarcted area showed marked 
thinning of the ventricular wall with no inflammatory response (Figures 30 A and 32B). 
Small bundles of eardiomyocytes were present in the subendocardial area (Figure 30C). 
The remainder of the wall consisted of bands of fibroblasts alternating with adipocytes 
within a finely fibrillar background. Ghost cells without residual nuclear material and 
with a waxy eosinophilic cytoplasm were occasionally observed (Figure 30D). Small 
vessels surrounded by occasional normal looking lymphocytes could be seen near the 
periphery of the infarct. No foreign body giant cell response was identified. These 
changes abruptly gave way to a normal appearing myocardium at the periphery of the 
induced lesion. No epicardial abnormalities were identified.
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Figure 30: Histologie sections o f the infarcted ventricular wall (H & E stained)
A : x4, Border zone. Normal cardiomyocytes: White arrow.
B : xlO, small bundles of cardiac myocytes present in a subendocardial location
C : x40, Border zone, bands of fibroblasts in a finely fibrillar background with bundles of
eardiomyocytes
D : x40, ghost cell (white arrow), collagen and fibroblastes
%
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4: Discussion
The incidence of functional IMR after acute myocardial infarction has been 
reported to be between 13% [18] and 39% [19]. Its presence doubles the long-term (5 
years) mortality [3], even in cases with mild or moderate regurgitation [22]. Although, 
IMR is known to be related to the location and extension of the infarct [23], successful 
early reperfusion does not reduce mortality [33]. Due to the high level of interest in this 
subject, it is obvious that far more questions than answers remain regarding the 
pathophysiology of IMR and, indeed, of the mechanisms involved in the remodeling of 
the well-perfused remote areas from the infarct [153]. In fact, it has been recently 
questioned whether IMR is the main cause for the poor prognosis of these patients or 
only a reflection of poor LV function secondary to remodeling [154]. These questions 
highlight the need for reproducible chronic experimental models. Furthermore, reduction 
annuloplasty, considered the standard surgical treatment for IMR, has been shown to 
have a 30% failure rate and no improvement in 5-year survival [59]. These unsatisfactory 
results have spurred interest in new surgical alternatives that need to be tested in large 
animals. Current chronic experimental models have been directed toward inducing either 
global cardiomyopathy or a localized infarction. Systemic or intracoronary injection of 
doxorubicin hydrochloride in dogs and goats [131,135], local transmural injection of 
snake cardiotoxin [137], and coronary micro-embolization [144,147] result in a variable 
degree of heart failure, but with absent or unmentioned IMR. The rapid pacing model of 
cardiomyopathy requires several weeks to create chronic heart failure but usually 
achieves only mild or moderate MR that is reversible when pacing is discontinued 
[139,143]. The mechanism responsible for the MR might be different according to the
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experimental method used. In the rapid pacing ovine model, Timek and associates [142] 
have described significant mitral annulus dilatation, particularly in the septolateral 
direction, without papillary muscle displacement and leaflet tethering.
In a seminal anatomic study of the coronary artery distribution in sheep, Llaneras 
et al. [35] demonstrated the absence of collaterals and, the very precise and localized 
effects of selective coronary ligature. This systematic approach revealed that IMR did not 
follow the selective ligature of OMl and 0M2 while occlusion of 0M 2 and 0M3 
induced a posterolateral infarct with development of significant IMR at about 8 weeks. 
When ligature of 0M4 was added, severe IMR appeared followed by death within hours. 
These models, extensively applied by Gorman and associates [148,155], have the 
disadvantage of needing a thoracotomy to access the selected arteries. Although a 
thoracotomy is often required to fully instrument the animal when radiopaque or 
ultrasound crystals are used, a previous or second thoracotomy is needed to either induce 
the infarction or to test a particular surgical procedure.
A previous review of the use of percutaneous alcohol injections in the 
interventricular septum for the treatment of hypertrophic cardiomyopathy suggested to us 
the possibility of applying it to induee IMR by infarcting the myocardium served by 0M2 
and 0M3 [156-159]. Our results confirm the findings of Llaneras and associates [35]. In 
both cases, ligature or EtOH injection of CM2 and 0M3 resulted in a localized and well- 
defined posterolateral infarct and significant IMR In the current study, a central IMR 
appeared in all five survivors between 2 and 4 weeks after the proeedure and evolved to 
2.8+ at 8 ± 3.1 weeks. The development of significant functional tricuspid regurgitation 
was seen in all cases. Beeause of the difficult imaging of the tricuspid valve in sheep, we
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could not evaluate the RV function when the animal was standing in a sling. Therefore 
we analyzed the geometry of the RV at baseline and sacrifice. A significant ITR appeared 
in all survivors between three and four weeks and its development followed the 
progression of the MR. This finding has not been previously reported in animals 
subjected to occlusion of the circumflex branches. It confirms its similar high incidence 
found in human cases with IMR [44].
The histology of the EtOH-induced infarct was similar to that described after 
alcohol septal ablation [160], i.e. an appearance typical of an old, well-defined infarct 
with signs of inflammation absent. Interestingly, contrary to Llaneras et al. [35], who 
reported the presence of an infarcted posterior papillary muscle in all cases, we found an 
intact posterior papillary muscle in all of ours independently of whether the LV apex was 
supplied by the left anterior or by the circumflex artery (type A or B heart). The infarct 
area and degree of IMR were similar in both the Llaneras report (21.4% and 3.18+ 
respectively) and in our model (22%.and 2.8+). These similar end results in spite of the 
different status of the papillary muscle might be explained by the LV remodeling that 
displaees a perfused posterior papillary muscle. Also, the reports of Messas and 
associates in sheep [28] and of Khankirawatana et al. in humans [161] deseribed 
paradoxical decrease in IMR severity in the presence of an ischemic papillary muscle. 
Recently, in a pig model of alcohol injection into the circumflex arteries, Li et al. [162] 
showed that the size of the infarct is related to the volume injected and not to the velocity 
of delivery [163]. In our study, the maximum volume was arbitrarily limited to 5 ml and 
the velocity of injection was controlled by hand and according to the arrhythmias that 
occurred during the injection.
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Transthoracic echocardiography allowed us to follow each animal weekly 
avoiding a thoracotomy before sacrifice. The echocardiographic findings in our series 
confirm those reported in patients [23] and in sheep [27,28]. The mitral annulus dilated 
by 32% in systole and by 13% in diastole and the interpapillary muscle distance increased 
by 32% in diastole and by 40% in systole, resulting in an increase in leaflet tethering 
(32%+) and coaptation (108%+) distances. The 3-D data at 8 weeks post infarction 
reported by Otsuji et al [27] are similar to our 2-D data (Table 14). However, while 
Messas et al. [28] and Otsuji and assoeiates have reported significant 3-D differences 
between pre and immediate post infarction, these differences obtained with 2-D 
echography did not reach statistical significance [148].
In the RV, between the baseline and sacrifice in our study, the annulus 
measurement increased by 11% in diastole and 8% in systole and the distance between 
the free wall and the septum increased by 21% in diastole and 35% in systole. As in our 
sheep, ITR has been associated with annulus dilatation [47,49] and RV enlargement [50]. 
Right ventricle enlargement may result in leaflet tethering [51,53]. Also, the distance 
between Apm and the septal annulus increased significantly in diastole by 8% in our 
sheep. However, the 16 ± 24% increase in systole was not significant. No significant 
increase was found for the distance between the Apm tip and the annulus at the level of 
the free wall (+5% in diastole and + 3% in systole).
According to experiment 3, the measured dilatation of the mitral annulus oecurred 
in an antero-posterior axis and the measured dilatation of the tricuspid annulus occurred 
in the short axis. The dilatation of the mitral armulus in case of IMR has been deseribed 
as homogeneous in the antero-posterior and septo-lateral dimensions [30]. The increase
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of the short-axis diameter of the tricuspid armulus on our sheep corresponds to the 
segmental free wall dilatation observed by Deloche et al. in human valves [49].
Following the EtOH infarction, we observed the development of IMR and ITR associated 
with annulus, LV and RV enlargement. These enlargements resulted in tethering of the 
anterior mitral leaflet (the tethering distance increased by 32.7 ± 28% between baseline 
and sacrifice in systole) and an increase of the Apm-annulus distance at the level of the 
septum (+16 ± 24% in systole) in the RV. All these variations resulted in geometrical 
distortion of the remarkable and very precise geometry of the annuli and their 
eorresponding subvalvular apparatus. The increased Apm-annulus distance at the level of 
the septum did not result in eventual tethering of the septal leaflet because no chord 
linked the Apm to the septal leaflet [93]. Tethering of the septal leaflet may have 
occurred by displacement of the Ppm and Spm that are linked by chords to the septal 
leaflets. The displacement of the papillary muscles inserted on the septum may be 
associated with LV enlargement. We showed in experiment 2 that both annuli and 
ventricles at the level of the papillary muscle were linked by the septum. According to the 
Laplace law, with the increasing dimensions of the LV, the pressure on the LV wall 
increased and resulted in significant bulging inside the RV. The bulging of the septum 
inside the RV had been described as associated with functional TR [164]. The increased 
bulging of the septum may have displaced the Spm and Apm enough to distort the 
geometry of the septo-anterior papillary muscle unit of the trieuspid valve. By minimal 
distortion of all the annulo-papillary units of the tricuspid valve, the moderate armulus 
and RV enlargement may have also facilitated the development of the ITR. The eccentrie
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jet described in human cases of septal bulging with ischemic LV dysfunction [164] was 
also observed at sacrifice on epicardial echocardiography in our sheep model (figure 28).
The small number of animals is obviously one major limitation of the studies. 
However, in the development of the animal model the fact that all but one reached the 
intended objective of inducing a significant IMR confirms the feasibility, simplicity and 
reproducibility of the method. Also, the results in sheep can not be applied uncritically to 
the human where, for instance, there is a diffuse eoronary vaseular inflammation, which 
has been associated with acute coronary syndrome. Whether our animal model of IMR 
following a postero-lateral infarct is similar to the clinical situation of an IMR secondary 
to an inferior infarct remains to be answered [23]
In conclusion, to study the functional tricuspid regurgitation from ischemic origin, 
we developed an original animal model of heart failure. The percutaneous seleetive 
injection of 100% EtOH in the second and third marginal coronary arteries of sheep heart 
resulted in a transmural LV infarction with no PM damage. During the eight weeks 
follow-up, remodeling of both ventricles was at the origin of ischemic mitral and 
tricuspid regurgitation. The non-invasiveness of this technique opens the field of chronic 
experimental ischemie cardiomyopathy to study the remodeling of the heart.
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Experiment 5; Change in eNOS and nNOS expression by distance from 
the infarct in an ovine ischemic heart failure model 
1: Nitric Oxide Synthase
1-1: Background
Nitric oxide (NO) is an endothelium derived relaxing factor synthesized from L- 
arginine by activation of NO synthase (NOS). Three isoforms of NOS are known: 
constitutive forms, discovered in neurons (NOSl = nNOS) and endothelial cells (N0S3 = 
eNOS), and the inducible isoform (N0S2 = iNOS) discovered in macrophages. The three 
NOS isoforms share 50 to 60% homology of their amino acid sequence and are encoded 
by three different genes (respectively NOSl, N0S2 and N0S3). All three isoforms 
combine two functionally complementary portions, a carboxyl-terminal reductase domain 
homologous to cytochrome P450 reductase and an amino-terminal oxygenase domain 
containing binding sites for heme, L-arginine, and tetrahydrobiopterin (THB4). A 
calmodulin-binding domain in the middle connects the two portions. The three isoforms 
function presumably as homodimers (Figure 31). Within each monomer, the chemical 
reaction is the following:
O 2  O 2
L-arginine -----------► N-hydroxy-L-arginine  ^  L-citrulline + NO
NADPH 1/2NADPH
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Figure 31 : Nitric Oxide Synthase principles.
Within each monomer, electrons provided by NADPH are transferred from the flavins 
(FAD or FMN) in the carboxyl-terminal portion of the molecule to the heme iron (Black 
arrows). This is activated to bind O2 and in presence of L-arginine, to catalyze the 
synthesis of NO and L-citrulline (Grey arrow). Calmodulin seems to be required to allow 
the transfer of the electron. THB4 appears to stabilize the homodimeric conformation of 
the enzyme (modified from Xu et al.. Nitric Oxide Website, www.wxumac.demon.co.uk).
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1-2: Nitric Oxide Synthase and the Heart
NO is a highly diffusible gas that permeates eell membranes and cannot be stored. 
Its theoretical diffusion is limited within the cardiac tissue by the abundance of 
superoxide anions produced by actively contracting myocytes, which combine with NO 
to produce nitrogen derivatives, and by the abundanee of cytoplasmic myoglobin, a 
heme-protein with a high affinity for NO. The autocrine effect is therefore predominant 
and may explain the multiple NOS synthases within the same tissue. The source of NO 
may be a predictor of its functional impact and thus the signaling specificity of NO is 
likely controlled at the level of its synthesis [94]. Both eNOS and nNOS are 
constitutively expressed in eardiomyocytes [94]. These isoforms are localized in key 
organelles that regulate cell function [165]. Endothelial NOS is localized in cell- 
membrane caveolae, which are organelles that link extracellular hormones with 
appropriate intracellular signaling effectors (eNOS is mostly associated with caveolin-3, 
the cardiomyocyte-specific structural protein of caveolae) [166]). It has been shown in 
endothelial cells that multiple protein interactions in caveolae regulate eNOS activity and 
its coupling to extracellular stimuli [167]. Endothelial NOS interacts with the major 
protein of caveolae, caveolin, which inhibits eNOS. In presence of Ca^^, calmodulin 
causes dissociation of eNOS from caveolin [168]. This is modified by heat shock protein 
90 (Hsp90), which binds to eNOS and facilitates the displacement of caveolin by 
calmodulin. Hsp90 belongs to a family of proteins that are synthetized by the cell in 
response to stress sueh as elevated temperature [167]. Among the NOS isoforms, nNOS 
is unique in containing a PDZ domain, a specific peptide sequence that allows it to 
recognize and bind to other proteins [169]. This PDZ domain may play a major role in
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targeting the nNOS to spécifié cellular membranes [167]. In eardiomyocytes, nNOS 
localizes to the sarcoplasmic reticulum, the organelle responsible for the intracellular 
caleium cyele that drives exeitation-eontraction coupling [170]. Endothelial NOS is also 
expressed in endothelial and endocardial cells and nNOS is present in adrenergic and 
cholinergic fibers.
2-3-1: Endothelial NOS, nNOS and Cardiac Function in the Normal Heart
Endothelial NOS is localized in sarcolemmal caveolae with ^-adrenergic 
receptors and L-type Ca^  ̂channels and nNOS is localized in the SR [170]. In the 
unstimulated heart, eNOS is not expressed at significant levels and has little impact on 
basal contractile [171] and relaxation [172] functions. In vivo studies showed an inerease 
of contractility in nNOS -/- mice compared to wild type (WT) controls and on isolated 
cardiomyoeytes, an increase of L-type calcium current and amplitude of contractile 
shortening were found [173]. When stimulating hearts or isolated LV myocytes from 
nNOS -/- mice, an attenuated positive force-frequency response in conjunction with 
impaired inerease in SR calcium load in comparison to WT mice were found [174].
These findings showed a role for nNOS in reducing calcium entry, facilitating SR load 
and, thus, promoting relaxation. A promoting effect of nNOS on SERCA activity remains 
under question [94]. Nitric oxide synthase isoforms affect the contractile response to IB- 
adrenergic stimulation. The P-adrenergic effect of isoproterenol was enhanced by L-NG- 
monomethyl-arginine (L-NMMA, a competitive inhibitor of all NOS isoforms) treatment 
in isolated rat eardiomyocytes. An in vivo study of eNOS -/- mice has shown a role for 
eNOS in limiting the inotropic effect of catecholamines [172]. However, no change was 
seen in normal subjects who received an intravenous dobutamine infusion and a
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concurrent intracoronary infusion of L-NMMA [175]. The significant impact of eNOS on 
the contractile response to P-adrenergic stimulation is due to the stimulation of a P3- 
adrenoreceptor isoform on cardiac myocytes. This receptor signals through G-protein 
coupling to eNOS activation and cGMP increases. Cyclic GMP was demonstrated to 
antagonize the effect of beta-adrenergic signaling in eardiomyocytes through degradation 
of cAMP, phosphorylation of calcium channel or ryanodine receptor or Troponin I 
(decreases myofilaments Ca^  ̂sensibility) (Figure 32) [94]. Neuronal NOS was also 
shown to decrease the inotropie response to p-adrenergic stimulation in isolated 
eardiomyocytes. In isolated LV myocytes from nNOS -/- mice, increased inotropic 
response was found after exposure to a low concentration of isoproterenol [176]. The 
limiting effect of nNOS-derived NO on L-type Ca^  ̂current may be implicated in the 
positive response to P-adrenergic stimulation. However, in nNOS -/- animals in vivo, this 
positive response was not seen and could even be reversed [170]. The profound alteration 
of Ca^^cycling in the stressed heart may be a major factor influencing the increase in 
sarcolemma Câ "̂  influx. Thus, nNOS may have a more important role in promoting 
SERCA funetion and SR calcium load to promote diastole in response to catecholamines 
in vivo. Endothelial NOS may act as a balance to prevent P-adrenergic overstimulation 
[94]. Spatial localization of eNOS and nNOS in proximity with effector signaling 
pathways allows NO to exert complex and precise autocrine regulation of cardiac 
contraction, relaxation and rate [172]. Endothelial NOS was also shown to facilitate 
excitation/contraetion coupling in response to sarcomere stretch. Petrof et al. showed that 
SR Ca^^release was proportional to length change of the sarcomere and was abrogated in 
cardiomyoeytes from eNOS -/- mice. The mechanism appeared to involve an activation
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of the ryanodine receptor facilitated by the localization of both proteins. Endothelial 
NOS-derived NO may serve as a local messenger that plays a role in the Anrep effect 
[177].
Figure 32: Endothelial and neuronal Nitric Oxide Synthase in the normal heart.
In the normal heart, eNOS promotes calcium increases in response to stretch (double 
black arrow) and protects the myocardium against excess catecholamine stimulation 
through the cGMP activation, that degrades cAMP, phosphorylates the calcium channel, 
ryanodin receptor and Troponin I (bold black arrow). Neuronal NOS limits the beta- 
adrenergic increase in calcium transient (bold grey arrows). This function may be less 
relevant in vivo compared with its activation of SERCA activity to sustain SR calcium 
load in response to inotropic interventions and promote cytosolic calcium removal and 
diastolic relaxation. These two isoforms would then cooperatively sustain 
excitation/contraction coupling and cardiac contraction. (Modified from Pelat et al. [94])
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2-3-2: Endothelial NOS, nNOS and Cardiac Function in the Diseased Heart
Nitric oxide synthase isoforms appear to have a role in cardiac remodeling.
Indeed, in a mouse model of an anterior myocardial infarct, the infarct size was 
unchanged in eNOS-/- mice in comparison with WT. However, the remodeling of the 
eNOS-/- mouse hearts presented decreased capillary density and greater myocyte width, 
as well as diastolic and systolic dysfunction in comparison with the WT at both day two 
and 28 after the MI [178].
Intracoronary L-NMMA infusion in moderate heart failure patients with an 
ethiology of dilated cardiomyopathy had no significant effect on basal function and the 
pacing of these patients was not altered either. Thus, NO may have little influence on 
cardiac basal function and force-frequency relationships in moderate heart failure patients 
[179]. However, Hare et al showed that NO inhibited the positive inotropic response to P- 
adrenergic stimulation in LV dysfunction patients using the same kind of protocol with 
dobutamine infusion [180]. This study supported the role of NO in modulation of cardiac 
function in heart failure patients.
In heart failure patients with idiopathic dilated cardiomyopathy, eNOS has been 
reported to be down-regulated [181,182]. Damy et al reported up-regulation of nNOS in 
these patients with a translocation of the enzyme from the SR to the sarcolemma 
membrane [182]. The decreased nNOS activity in the SR associated with the increased 
nNOS activity in the sarcolemma membrane may be a central pathological event that 
enhances the importance of the spatial confinement of NOS isoforms within the 
cardiomyocyte [169]. The role of nNOS as an adaptative mechanism to preserve diastolic 
Ca^  ̂levels and SR calcium load in the failing cardiomyocyte is not yet established.
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The failing dilated heart is limited in the amount it can increase stroke volume as 
any increase in diastolic volume greatly increases the filling pressure of the ventricle. The 
sarcomeres in the wall are at their maximal length and cannot adapt [83]. The eNOS 
down-regulation and nNOS up-regulation and translocation may participate in the altered 
Frank-Starling adaptation of the failing heart through defective stretch-dependent 
contractile reserve and altered relaxation [171].
Dynamic changes in expression of the enzymes, substrates and cofactors as well 
as change in repartition of NOSs in the different structures of the cardiomyocyte are 
probably associated with the heart failure [94].
2: Materials and Methods
The hearts from the animals who underwent a percutaneous injection of 100% 
EtOH in the 0M2 and OM3 (experiment 4) and five control hearts from age-matched 
animals obtained from a local abattoir (Lolo Locker, Lolo, MT, USA) were analyzed.
2-1: Preparation of Tissue
The right and left ventricles were cut into 8 to 9 transverse slices. On the 5* slices 
from the apex, samples, about 1cm wide, of myocardium from seven different areas were 
removed, snap frozen in liquid nitrogen and stored at -70°C until used. The areas were 
sampled from the LV anterior wall (Al), LV posterior wall (A2) RV posterior wall (A3), 
inferior septum (Bl), RV free lateral wall (B2), superior septum (Cl) and RV anterior 
wall (C2). The distances between the sampled areas and the Ml were also measured.
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2-2: Protein isolation, SDS-polyaciylamide gel electrophoresis (SDS-PAGE) and 
Western Blot Analysis
For protein isolation, the snap-frozen heart tissue was allowed to thaw on ice and 
then was weighed. The samples were homogenized using a Tissuemizer in 4 vol/wet 
weight of sample in Triton lysis Buffer [20mM Tris.HCl (pH 7.6), 0.5% Triton X-100, 
and 20% glycerol] supplemented with protease inhibitors (Leupeptin, Aprotinine and 
PMSF). Extracts were then clarified by centrifugation (14,000 X g for 20 min) and the 
supernatant was removed for protein determination, SDS-PAGE and Western blot 
analysis. Final protein concentration of the myocardial extracts was determined with a 
standardized colorimetric assay (Bio Rad Protein Microassay from Bio-Rad Laboratories, 
Hercules, California, USA) according to the package insert. Protein concentration was 
adjusted to the appropriate concentration with PBS-T followed by the addition of 
Laemmli denaturing buffer at the ratio of one volume/volume. The samples were then 
heated at 100°C for 20 minutes. The Laemmli denaturing buffer contains sodium 
dodecylsulfate (SDS) that denatures the proteins by wrapping around the polypeptide 
backbone. SDS also confers a negative charge to the polypeptides in proportion to their 
lengths, leaving the proteins with a constant charge-to-mass ratio. The protein extracts 
isolated from ovine heart samples were separated on a 6% denaturing polyacrylamide gel 
and electrophoretically transferred to Hybond-PVDF membrane (Amersham, Arlington 
Heights, IL, USA). The membranes were incubated with a blocking solution of 5% non­
fat dry milk in tris-buffered saline containing 0.1% Tween (TBS-T) to block all the non 
specific binding sites of the proteins. After blocking, the membranes were incubated for 
one hour at room temperature with a 1 ;250 dilution of the primary antibody either eNOS
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or nNOS antiserum (Transduction Laboratories, Lexington KY, USA). The primary 
antibody was followed by the secondary antibody at a 1:1000 dilution (goat anti-mouse 
horseradish peroxidase conjugated antibody. Pierce Inc, Rockford, IL, USA). All 
dilutions were made in 5% non-fat dry milk in TBS-T. The membranes were washed 
three times between each step with TBS-T. Immunoreactive bands were visualized by 
incubation with 5 ml of the luminol enhancer solution and 5ml of the stable peroxidase 
buffer provided in the kit for 1 minute (SuperSignal West Femto Maximum Sensitivity 
Substrate, Pierce Inc, Rockford, IL, USA). Bands were quantified with a computer-based 
imaging system (ID Image Analysis Software, Kodak Digital Science, Scientific Imaging 
System, Eastman Kodak Company, Rochester, NY, USA). To compare the optical 
density of the bands between the different gels, we used the lowest optical density for the 
area corresponding to a distance of 3 cm from the infarct as a reference value on each gel. 
The optical densities of the other bands were normalized according to the reference band 
density within the same gel.
2-3: Immunohistochemistry
The snap frozen heart tissues were used for immunohistochemistry. Representative slices 
from each area were placed in optimum cutting temperature compound, frozen on dry ice 
(-70“C) and cut in sections (6 pm) with a Cryotome (Thermo Electron Corporation, 
Milford, MA, USA) and transferred to aminoalkylsilane-treated slides (Superfrost Plus; 
Fisher Scientific, Santa Clara, CA). Cryostat sections were post fixed with 100% ethanol 
and stored at -80°C until used. The tissue sections were first incubated in PBS-T and 1% 
goat serum for 30 minutes, to eliminate non-specific binding of the primary antiserum to
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tissue sections and to block endogenous peroxidase activity. Then, the sections were 
incubated with the eNOS antiserum or nNOS antiserum (Transduction Laboratories, 
Lexington KY, USA) at a 1:250 dilution for 1 hour at room temperature. After washing 
with PBS-T, the sections were incubated with appropriate fluorescent secondary 
antibodies (Alexa Fluor 546, Molecular Probes™, Invitrogen Inc, Carlsbad, CA, USA) at 
a dilution of 1:1000 for one hour at room temperature in the dark. Sections were washed 
again with PBS-T and mounted. An Olympus 1X51 microscope (Olympus America Inc., 
Melville, NY, USA) equipped with epifluorescence optics was used to visualize the 
immunofluorescence. Immunostaining intensity was quantified at a magnification of 
200X for ten different layers per area using an image program analysis (Image Pro Plus, 
version 5.0.1, Media Cybernetics Inc., Silver Spring, MD, USA).
2-4: Statistical Analysis
Data are expressed as mean ± standard deviation. Statistical significance was 
determined by using the unpaired student-t test in case of comparison of two groups. 
ANOVA was used in case of comparison of more than two groups. p<0.05 was 
considered significant.
3: Results
Four hearts of the animals (53.3 ± 6.4 Kg body weight) that underwent the EtOH 
infarction procedure were available for this experiment.
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3-1: Development of Ischemic Cardiomyopathy
The left carotid introducer was placed percutaneously in three and with a cut- 
down in one sheep. The total volume of 100 % EtOH injected was 2.5 ±1.5 ml/animal. 
These four animals were followed for an average of 7.5 ±1.5 weeks and they all 
developed clinical heart failure after the fourth week. Their weight presented a 24% 
increase from 54.3 ± 5 kg to 67.4 ± 3, p=0.04. As reported previously in experiment 4, 
the hemodynamic characteristics were not significantly changed (cardiac output varied 
fi-om 3.3 ± 0.4 to 3.9 ± 1, p=0.2 and aortic systolic pressure did not change). The 
echocardiographic data showed, as previously described an increase in distance between 
baseline and before the sacrifice (Table 16). The infarct area was 21 ± 2% of the LV area 
and had a mean calculated weight of 44.6 ± 3.6 g.
Table 16: Geometric variations between baseline and sacrifice measured with 
Echocardiography in four sheep
EF: Ejection fraction, LVEDD & LVEES: Left ventricle end diastolic & end systolic 
dimension. M l-M2 ED & M l-M2 ES: Interpapillary muscle distance in end diastole and 
end systole, MR & TR: Mitral & tricuspid regurgitation
Baseiine At Sacrifice Variation Paired Student t-test: 
p vaiue
EF 54±5% 32±12% 40%- 0.04
LVEDD short axis 43.7±4 56±2.9 28%+ 0.06
LVEES short axis 32.3+3.8 47.2±4.6 46%+ 0.02
M1-M2 ED 25.7±6.7 34.2±2.9 33%+ 0.03
M1-M2 ES 21 +3 27+2.6 25%+ 0.03
TR 0 2.1 Yes <0.05
MR 0 2.7 Yes <0.05
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3-2: Expression of eNOS and nNOS
The expression of eNOS was barely detectable in normal hearts and was 
expressed in all areas of the diseased heart as shown by western blot analysis (Figure 33). 
Among the ICM group, no significant difference was found for eNOS expression in the 
LV, RV and septum according to the area sampled (ANOVA: p=0.712). However, 
relative expression of eNOS presented significant variations when samples where 
regrouped according to the distance from the MI (ANOVA, p=0.0I8). The relative 
optical density of eNOS expression appeared to be inversely correlated with the distance 
from the MI with an R-value of 0.723 (Figure 34). The immunohistochemical analysis 
(Figure 35) confirmed that eNOS was expressed in cardiomyoeytes and that the intensity 
of eNOS staining was greater in ICM tissue. The measure of optical density intensity was 
increased ten fold in ICM hearts compared to controls (grades: I ± 4.5 versus O.I I ± 0.32, 
p=0.002). The eNOS-staining pattern appeared to be peripheral. The staining did not 
appear to encompass the entire periphery of the majority of stained cells.
Neuronal NOS was not detected on Western blot analysis even with increased 
concentration of proteins loaded (25, 50 and 100 pg/lane) using a 1:250 dilution of nNOS 
antibody. Immunoreactivity for nNOS was also not seen on stained tissue sections (1:250 
dilution).
Immunoreactive bands at the level of 70Kda were seen by Western blot analysis for 
eNOS and nNOS. These bands may correspond to degradation products from eNOS. 
Cross-reaction with nNOS antibodies may explain their appearance on nNOS Western 
blots (Personnal communication from the technical service representative of 
Transduction Laboratories, BD Biosciences, Lexington, KY, USA)
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Figure 33: eNOS expression in sheep heart eight weeks after infarction.
A: eNOS band in ICM, expression in all areas (50 pg per lane);
B: eNOS bands in control hearts, expression detectable in A l, A2 and A3 areas and 
undetectable in other areas (50 pg per lane);
C: eNOS band in A2 area of the nine sheep, expression barely detectable in control hearts 
(20 pg per lane).
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Figure 34: Plot showing a significant correlation between relative expression of eNOS in 
the diseased heart samples and the distance from the Ml.
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Figure 35: Representatitive immunofluorescence micrographs of ovine heart sections of 
failing heart and controls, labelled with eNOS (200X magnification).
A l=  anterior LV wall, A 2- posterior LV wall, A3= posterior RV wall, B l= posterior 
septum, B2= RV free lateral wall, Cl = anterior septum, 02= anterior RV wall. 
Endothelial NOS was up-regulated in ischemic heart and seemed to be more expressed 
closer to the infarct.
ICM CanXxok
Controls
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4: Discussion
Our finding of weak cNGS expression in normal cardiomyocytes of sheep origin 
corresponds to previous studies in human hearts [182,183]. This insignificant level of 
cNGS expression in the cardiomyocyte may be due to the minor effect of cNGS-derived 
NG on the basal contractile function of the heart [94]. Gur study demonstrated increased 
expression of cNGS in ovine heart failure eight weeks after a postero lateral infarction. 
This result is consistent with a report by Baker et al. [184] who showed that chronic 
hypoxia increased eNGS expression in the immature rabbit heart. Fukuchi et al. [183] 
studied 28 failing human hearts with various etiologies and reported increased expression 
of eNGS irrespective of the underlying pathogenesis of heart failure. In dogs, Yamamoto 
et al [185] reported increased eNGS activity in isolated LV cardiomyocytes from 
tachycardia-induced heart failure. In our sheep model of early heart failure, the peripheral 
eNGS-staining pattern suggested the presence of eNGS in the sarcolemma. This result is 
consistent with previous studies that reported eNGS localizing to membranae caveolae 
where it can regulate the P-adrenergie stimulation [169]. With heart failure, the decrease 
in cardiac output stimulates the sympathetic nervous system with an increase in 
cireulating level of catecholamines [90,186]. Endothelial NGS has been reported to limit 
the inotropic effect of the catecholamines [172] and thus may be up-regulated in our 
sheep to counteract a P-adrenergic overstimulation of the heart. This finding is different 
from other studies where it was reported that eNGS is down regulated in human late heart 
failure [94,182]. However, the studies that reported eNGS down-regulation in heart 
failure were done on end-stage heart failure patients whose etiologies were mostly due to 
idiopathic dilated cardiomyopathy. In these studies, samples of patient hearts were
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obtained after death or during cardiac transplantation and the duration of end-stage heart 
failure of these patients was not reported [94,182]. In end-stage heart failure, a 
desensitization of the heart to catecholamines caused by a decrease in p-receptor density 
has been shown [187]. The mechanism that accounts for myocardial P-adrenergic- 
receptor down-regulation is presumably related to exposure to increased levels of 
catecholamines [90]. Taken together, these results suggested in our sheep a temporal 
“adaptative” up-regulation of eNOS to mitigate the excessive P-adrenergic stimulation of 
the heart in early heart failure. This might have been followed by a down-regulation of 
eNOS assoeiated with the decrease in the P-adrenergic-receptor density. The alteration of 
eNGS expression may be dynamic during the course of development of a specific disease 
thus participating in the altered Frank-Starling adaptation of the terminally failing heart 
[94].
The up-regulation of eNGS was observed in cardiomyocytes from sheep hearts 
eight weeks after an MI. Heart failure symptoms and evidence of geometrical remodeling 
of the hearts, such as a significant increased LV diameter and the presence of functional 
MR and TR, were observed in all sheep after the fourth week. Endothelial NGS was up- 
regulated in all areas of the heart and we found that the level of eNGS expression was 
correlated with the distance from the MI. This eorrelation has not been previously 
reported in the littérature. Fukuchi et al. reported increased eNGS expression mostly in 
the subendocardial area in failing human myoeardium irrespective of the site of infarction 
in ischemic cardiomyopathy [183]. The mechanism responsible for our finding may 
correspond to stretch since the quantitative loss of cardiomyocytes following an MI 
results in work overload. The reduced stroke volume is compensated by an inereased end-
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diastolic volume. Thus the filling pressure increases on cardiomyocytes that are already 
lengthened. During the progression toward heart failure, the cardiomyocyte stretch tends 
to remain at a high level with persistent reduced EF [90]. According to Wilson et al. [89], 
the remodeling of the heart results in differences in the level of stretch of the 
myocardium: the further from the MI, less stretch is applied. The stretch of the sarcomere 
has a faeilitatory effect on the Ca^  ̂release process resulting in an increased contraction 
[85]. In vitro, Petroff et al [177] showed that eNOS-derived NO enhanced the release of 
Ca^  ̂in response to sareomere stretch through a direct activation of the ryanodin receptor 
independently from eGM? [177]. Altogether, this suggested that in early heart failure the 
expression of eNOS might be up-regulated to potentiate the SR calcium release according 
to the amount of stretch exerted on the cardiomyocytes. Direct activation of signaling 
molecules or release of paracrine or autocrine signaling factors appears to be among the 
different pathways to adapt the cardiomyocyte to stretch [188]. The exact mechanisms 
underlying the production of eNOS-derived NO that modulates the excitation/contraction 
coupling, as observed by Petroff et al. [177] in the case of increased stretch, remain 
unknown and eNOS may be associated with or may act as a “stretch sensor”.
Endothelial NOS was assumed to be the only constitutive isoform expressed in 
the cardiomyocyte until the report of Xu et al in 1999, who showed that nNOS localized 
to the murine and human SR [189]. Damy et al [182] reported a weak expression of 
nNOS in the SR of normal human heart. Using the same antibody, we were unable to 
detect nNOS in our samples by western blot analysis or immunohistochemistry. After a 
review of the literature, no previous report was found on the detection of the different 
NOS isoforms in the sheep cardiomyocyte. A lack of nNOS expression in the sheep
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cardiomyocytes may explain the absence of detectable levels of nNOS in our samples. 
However, the presence of nNOS in many mammalian cardiomyocytes such as humans 
[182,189], mice [173,176,189] and rabbits [189] has been reported. The sheep 
cardiomyocytes may express a different isoform of nNOS, therefore the difference in 
species may be the reason for a potential lower cross reactivity between the nNOS 
antibody (mouse anti-rat antibody) that we used and the nNOS isoform in sheep 
myocardium.
It has been reported that nNOS derived NO regulates myocardial contraction by 
controlling Câ "̂  handling in cardiomyocytes [173]. In late human heart failure, eNOS 
expression that localizes to the sarcolemma is down-regulated [94,182] while greater 
expression and activity of nNOS and its translocation from the SR to the sarcolemma has 
been reported [182]. The defeet of eNOS-derived NO in the sarcolemma might be 
compensated by the translocation of nNOS from the SR to the cell membrane. This 
implicates an altered regulation of therole of nNOS in the autocrine control of cardiac 
contractility. The loss of NO in the SR and thus, the regulation on the Ca^  ̂load of this 
organelle, may be a central pathophysiological event [169]. In our failing heart, there was 
up-regulation of eNOS that appeared to be localized to the sarcolemma. The increase of 
NO in the sarcolemma may be related with an adaptative response to the increased 
systemie catecholamines in heart failure. The absence of deteetable nNOS in our model 
may be due not only to the reasons cited above (absence of expression or difference in 
species), but also its dynamic expression. The NOS isoforms may present a dynamic 
pattern of expression in the development of heart failure as postulated by Pelat et al. [94].
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Limitations of the study
We used a sheep model to study the expression of eNOS and nNOS in early 
ischemic heart failure. We did not find any report on the expression of eNOS and nNOS 
in sheep cardiomyocytes in the literature. The physiology of eNOS and nNOS expression 
in sheep cardiomyocytes might be different from the other species studied.
The controlled hearts in our study were obtained from a local abattoir from age- 
matched sheep. These sheep were assumed to be healthy and to present a normal 
expression of eNOS and nNOS.
The induction of an MI in our sheep model of heart failure was done by the 
percutaneous injection of 100% EtOH that created a MI of 21 ± 2% of the LV. The 
histology showed a well-defined MI surrounded by a fibrillar web. In humans, Raute- 
Kreinsen [160] studied the myocardial tissue from patients who underwent EtOH ablation 
of the septum in the case of hypertrophic cardiomyopathy. The myocardial tissue from 
patients who died minutes to two years following the EtOH ablation showed a preserved 
fixed necrotic area that was not infiltrated by leukocytes. After one month, a web of 
collagen was produced by the fibroblasts around the fixed myofibrils (ghost cells). The 
border zone of the damaged myocardium was, however, transformed to scar tissue by 
leukocytes. The pathophysiology of the transformation and stabilization of the 100% 
EtOH ablated area is not known and may have its own signaling characteristics that may 
have influenced the eNOS and nNOS expression level. In our model, the MI was also 
induced acutely in a sheep model that did not present any evidence of coronary disease.
In humans, the progressive evolution of atherosclerotic lesions and inflammation that
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plays a key role in coronary disease [2] may influence the NOS expression in the 
infarcted heart.
Furthermore, the pathophysiology of the different diseases that lead to heart 
failure may also be different. The heart failure syndrome can be defined as a constellation 
of signs and symptoms caused by inadequate performance of the heart, but the subject of 
heart failure requires a number of definitions to denote hemodynamic alterations, clinical 
symptoms and pathology. More precise analysis and classification might be based on 
differences in pathology and biochemistry [90].
Mechanisms of Functional Ischemic Tricuspid 
Regurgitation
1: Heart Remodeling and Stretch
The analysis of the normal geometry of the tricuspid valve in isolated pig hearts 
(Experiment 1) and the study of the normal geometrical variations of the mitral and 
tricuspid valves during the cardiac cycle (Experiment 2) allowed us to understand the 
remarkable geometry of both valves that are linked by the septum. In Experiment 4, we 
demonstrated that, following an MI, both mitral and tricuspid valve regurgitations were 
due to ventrieular enlargement that altered the geometry of the mitral and tricuspid 
valves. More precisely, these valve distortions oeeurred at the level of the annulo- 
papillary musele apparatus. These geometrical alterations were consistent with the 
ventricular remodeling observed in human cases of heart failure [2]. According to the 
Laplace Law, the ventricular enlargement increases the mechanical stress exerted on the
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ventricular wall, thus the stretch on the cardiomyocytes [90]. The macroseopic 
remodeling of the myocardium is associated with alterations of the cardiomyocytes and 
the extra-cellular matrix [90]. During the remodeling process, the stretched 
cardiomyocytes change their phenotype with marked enlargement in size associated with 
deterioration in contractile function [1]. In heart-failure patients with an apparently 
normal mitral valve, it has been shown that the mitral valve leaflets had significant 
alterations in both cellularity and extracellular matrix [190]. These findings suggest that 
not only the myocardium, but also the mitral leaflets, thus, the entire heart, remodel as an 
adaptative response to overload [191]. The cardiomyocyte hypertrophy with the laying 
down of new sarcomeres in parallel is accomplished with biochemical alterations in both 
the contraetile proteins and activating membrane systems [1]. It has been shown that the 
stretch of cultured cardiomyocytes results in gene transcription and protein synthesis that 
mimics the load-induced hypertrophic response in vivo [192]. The activation of a large 
number of cellular signal transduction pathways follows an ischemic event [188]. These 
signals may compensate for the increased wall stress on the surviving myocardium. 
Within the myoeardium, the biochemical alterations include dysregulation of myosin 
gene expression [91], loss of myofilament and alterations of cytoskeletal proteins [193], 
alterations in excitation/contraction coupling [90,194] and desensitization of P-adrenergic 
signaling [187]. The dynamic equilibrium of the extracellular matrix, regulated by the 
metalloproteinases (MMPs) and their inhibitors (tissue inhibitors of metalloproteinases or 
TIMPs) changes also in the myocardium of failing hearts [195,196] and the proliferation 
and increased secretory activity of fibroblasts increase also fibrosis and collagen 
remodeling of the myoeardium [197]. We demonstrated in our study, that the ventricular
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remodeling was associated with an up-regulation of eNOS that was correlated with the 
distance from the infarct (Experiment 5). According to Wilson et ah, the further from the 
MI, the less streteh is applied to the cardiomyoeytes [89]. Thus, the up-regulation of 
eNOS expression associated with the geometrical alterations of the ventricle appears to 
be correlated with the degree of stretch. This finding corresponds to a previous study on 
regional changes of MMPs and TIMPs that were also correlated with the distance from an 
anterior MI [89]. This eorrelation between protein expression and distance from the MI 
suggests that the direct hemodynamic forces may be the drivers of protein expression and 
extraeellular matrix changes. The initial stimulus that starts the remodeling proeess is 
almost invariably stretching of the myocardium [1]. The remodeling process seems to not 
be unidirectional and, according to some authors, might undergo a “reverse remodeling” 
process [198,199]. It has been observed in some end-stage heart failure patients, that 
unloading the left ventricle with a left ventricular assist device induces reverse 
remodeling. Reduction of the mechanical stress on the myocytes through the reduction in 
intraventricular volume appears to play an important role in reverse remodeling [200]. 
However, unloading on its own seems to be inadequate [1]. The explanation for the 
cellular and extracellular ehanges observed in heart failure is probably more complex. 
Indeed, heart failure involves many compensatory systems to adjust to the reduced 
cardiac output [2,90]. These compensatory mechanisms have been shown to have 
potential harmful effects on the myocytes, fibroblasts and endothelial cells and may also 
participate in the development of contractile dysfunction [2,91,92]. For example, it has 
been reported that the increased circulating level of catecholamines following an MI [90] 
may produce apoptosis of cardiomyoeytes [1]. In our early heart failure model, the up-
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regulation of eNOS may be an ’’adaptative process” to counteract the excess of p- 
adrenergic stimulation and protect the cardiomyoeytes. Heart failure may be viewed as a 
“neurohormonal model”, in which heart failure progresses as a result of the 
overexpression of active molecules exerting deleterious effects on the heart and 
circulation [2]. However, the neurohormonal model fails to explain the disease 
progression in heart failure [91]. During the remodeling process, not only the ehanges 
that occur in the biology of the failing myocardium but also the geometric alterations of 
the LV contribute to the development of the LV dilatation and dysfunction [1,2]. 
Therefore, the remodeling process appears to be the consequence of both stretehing and 
activated compensatory mechanisms. The interrelationship between contractile 
dysfunction and cardiac remodeling is responsible for disease progression in heart failure 
[91]. The progressive cardiomyocyte hypertrophy considered as a physiological 
adaptative response to increased load may eventually become maladaptative resulting in a 
self perpetuating pathological process of continuous remodeling leading to irreversible 
heart failure [1].
2: Clinical Application
Surgical therapies that directly affect cardiac remodeling should improve eardiac 
function and the natural history of heart failure. Restoration of the LV and RV geometry 
aims at decreasing myocardial stress and may initiate a reverse remodeling proeess. For 
this geometric restoration, mitral annuloplasty is being performed in nearly 80% of 
patients with ischemic mitral regurgitation [56]. An undersized mitral ring is the standard 
technique that by reducing the mitral orifice increases leaflet eoaptation and consequently
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reduces the IMR [54]. However, mitral annuloplasty is sometimes inadequate, following 
annuloplasty for ischemic MR a rate of 30% for recurrent MR has been reported [58,59]. 
Papillary muscle displacement as well as LV dysfunction and enlargement are 
responsible for the reeurrent MR [60]. Chordal cutting was described as a new surgical 
approach for the treatment of ischemic MR [201]. However, experimentation on sheep 
showed the importance of these chords as essential for the valvular-LV geometry. 
Transection of these chords did not prevent acute isehemic mitral regurgitation and 
resulted in LV systolic dysfunction in sheep [64,65] and also narrowed the aorto-mitral 
angle and inereased the papillary muscles-fibrous trigones distances [66]. To relocate the 
postero-lateral papillary muscle, Kron et al. added a suture between the left trigone and 
the papillary muscle in patients with previous inferior myocardial infarction and ischemic 
MR [56]. In case of papillary muscle displacement, to reestablish constant distances 
between the tip of the papillary muscles and the corresponding hemi-mitral annulus could 
lead to better outcomes due to the restoration of the geometry of the annulo-papillary 
muscle unit. The importance of the annulo-papillary muscle continuity and therefore of 
the annulo-papillary unit geometry for global LV function in prosthetic valve 
replacement has also been widely recognized. The preservation of papillary muscles- 
annulus continuity is either restored by conservation of chords [126] or by use of 
polytetrafluoroethylene to create new chords [124]. In cases of mitral homograft 
implantation, conservation of the recipient’s papillary muscles and suturing of the 
allograft to their tips preserves the constant distance between the tip of the papillary 
muscles and the mitral annulus plane [120].
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For the restoration of the RV, the annuloplasty in the case of ITR has poor results 
with a high incidenee of recurrence [79] that may be predicted by tricuspid valve 
tethering after annuloplasty [202]. The mechanism of functional TR is not only the result 
of tricuspid annulus dilatation, but also the result of a bulging septum [164]. The annulus 
dilatation, the RV enlargement and the presence of the septum bulging in the RV resulted 
in annulo-papillary muscle apparatus distortion. This finding in a sheep model of heart 
failure may explain the recurrence and the persistence of the apical displacement of the 
tricuspid lealfets [51]. It is hoped that a better knowledge of the dynamic relationship 
between the septum and the RV will promote new surgical techniques.
As previously seen, stretch of the myocardium appears to not be the only factor 
involved in the remodeling process. Both eNOS and nNOS appear to regulate 
cardiomyocyte functions [169]. The up-regulation of eNOS expression in early heart 
failure may be an important step in the pathophysiology of ischemic heart failure. The 
correlation of eNOS expression with the distance from the infarct suggested a correlation 
with the degree of stretch. A better understanding of the signaling pathway of the NOS 
isoforms in the heart may lead to new pharmacologic therapy.
3: Limitations of the Study
Given the many aspects of the present work, a discussion has followed each 
experiment. The following limitations are of a general nature that applies to the overall 
characteristics of all experiments. To study the normal geometry of the atrioventricular 
valves, we based our study on animal hearts, which may present different anatomieal 
characteristics compared to human hearts. The remarkable geometry of the mitral and
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tricuspid valves of the sheep may not be exactly the same in the human. However, our 
findings about the mitral geometry are consistent with the anatomical finding of Sakai et 
al. [124] on human hearts. The small number of animals also involved in all our 
experiments is obviously one major limitation. Our findings about the geometrical 
changes of the LV and RV that lead to IMR and ITR corresponded to the remodeling of a 
sheep heart following a postero-lateral infarction. In sheep, the localization of the infarct 
may play a role in the remodeling process. Our original method to induce the infarction 
with the percutaneous injection of 100% ethanol may have also its own signaling 
characteristics [160] that may have influenced the mieroscopie and macroscopic 
remodeling. We also compared the expression of eNOS in our infarcted sheep’s heart to 
the expression in normal sheep hearts obtained from an abattoir. These age-matched 
sheep were assumed to be healthy without any pathology that may have influenced our 
results.
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Conclusion
Patients in heart failure from ischemic origin may present mitral and tricuspid 
functional regurgitation. Ischemic mitral regurgitation doubles the mortality at five years 
[21] and when tricuspid functional regurgitation is associated, the one-year mortality 
doubles [42]. Remodeling of the whole heart results in geometrical distortion of both 
atrioventricular valves, ereating valve incompetences. We studied the geometrical 
variations of the ventricles in an original sheep model of heart failure. For the mitral 
valve, annulus dilatation, LV enlargement and a tethering effect on the anterior mitral 
leaflet were at the origin of a eentral regurgitation by lack of coaptation of the leaflets.
For the tricuspid valve, annulus dilatation, chamber enlargement and lateral bulging of 
the septum toward the RV were associated with the functional TR. Alteration of the 
geometry of the annulo-papillary muscle apparatus were at the origin of the regurgitation 
of both valves. These findings may lead to new surgical approaches.
The geometrical distortions are associated with molecular changes in the heart 
wall. Seven areas that represented the whole heart - the anterior, LV, RV and septum, the 
lateral RV, the middle of the septum, the posterior RV and LV wall were studied eight 
weeks following a EtOFl-induced lateral MI in four sheep and compared to five control 
hearts from a local abattoir. In the ischemic heart eNOS was increased ten-fold compared 
to the controls. The expression of eNOS was correlated with the distance from the MI and 
thus the amount of stress. Because eNOS is known to play a role in stretch adaptation, the 
up-regulation of eNOS may be correlated with an adapatative process of the stretched 
cardiomyocyte. However, we did not find evidence of the presence of nNOS in the
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samples. These, according to our knowledge, previously unreported findings, eight weeks 
after a MI resulting in an ovine model of heart failure, may enhance the dynamic 
response of eNOS to the resulting stretch.
Whether these findings are applicable to the ischemic human heart is unknown 
and further studies are warranted.
References:
1. Yacoub MH. A novel strategy to maximize the efficacy of left ventricular assist 
devices as a bridge to reeovery. Eur Heart J 2001;22(7):534-40.
2. Jessup M ,Brozena S. Heart failure. N Engl J Med 2003;348(20):2007-18.
3. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR ,Tajik AJ. Ischemic mitral 
regurgitation: long-term outcome and prognostic implications with quantitative Doppler 
assessment. Circulation 2001 ;103(13): 1759-64.
4. Givertz MM. Underlying causes and survival in patients with heart failure. N Engl J 
Med 2000;342(15): 1120-2.
5. Selke B, Brunot A ,Lebrun T. [Economic repercussions of cardiac insufficiency in 
France]. Arch Mai Coeur Vaiss 2003;96(3):191-6.
6. Konstam MA. Progress in heart failure Management? Lessons from the real world. 
Circulation 2000;102(10):1076-8.
7. Khand A, Gemmel I, Clark AL ,Cleland JG. Is the prognosis of heart failure 
improving? J Am Coll Cardiol 2000;36(7):2284-6.
174
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
8. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the 
community: a study of all incident cases in Olmsted County, Minnesota, in 1991. 
Circulation 1998;98(21):2282-9.
9. Sutton MG ,Sharpe N. Left ventricular remodeling after myocardial infarction: 
pathophysiology and therapy. Circulation 2000;101(25):2981-8.
10. Eichhom EJ ,Bristow MR. Medical therapy can improve the biological properties of 
the chronically failing heart. A new era in the treatment of heart failure. Circulation 
1996;94(9):2285-96.
11. Dujardin JJ, Hanania G, Mialet G, Bounhoure JP ,Gallois H. [Registry of heart failure 
patients hospitalized in 2000. Data from the National College of Cardiology and General 
Hospital]. Areh Mai Coeur Vaiss 2002;95 Spec 4(5 Spec 4):7-10.
12. Bart BA, Shaw LK, McCants CB, Jr., et al. Clinical determinants of mortality in 
patients with angiographically diagnosed ischemic or nonischemic cardiomyopathy. J Am 
Coll Cardiol 1997;30(4): 1002-8.
13. McGovern PG, Pankow JS, Shahar E, et al. Recent trends in acute coronary heart 
disease—mortality, morbidity, medieal care, and risk factors. The Minnesota Heart Survey 
Investigators. N Engl J Med 1996;334(14):884-90.
14. Beaglehole R. International trends in coronary heart disease mortality, morbidity, and 
risk factors. Epidemiol Rev 1990;12(1-15.
15. Humphries JO, Kuller L, Ross RS, Friesinger GC ,Page EE. Natural history of 
ischemic heart disease in relation to artériographie findings: a twelve year study of 224 
patients. Circulation 1974;49(3):489-97.
16. Enriquez-Sarano M, Klodas E, Garratt KN, Bailey KR, Tajik AJ ,Holmes DR, Jr. 
Secular trends in coronary atherosclerosis—analysis in patients with valvular 
regurgitation. N Engl J Med 1996;335(5):316-22.
17. Carpentier A. Cardiac valve surgery—the "French correction". J Thorac Cardiovasc 
Surg 1983;86(3):323-37.
18. Lehmann KG, Francis CK ,Dodge HT. Mitral regurgitation in early myocardial 
infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group. 
Ann Intern Med 1992;117(l):10-7.
19. Barzilai B, Gessler C, Jr., Perez JE, Schaab C ,Jaffe AS. Significance of Doppler- 
detected mitral regurgitation in acute myocardial infarction. Am J Cardiol 
1988;61(4):220-3.
175
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
20. Barzilai B, Davis VG, Stone PH ,Jaffe AS. Prognostic significance of mitral 
regurgitation in acute myocardial infarction. The MILIS Study Group. Am J Cardiol 
1990;65(18):1169-75.
21. Hickey MS, Smith LR, Muhlbaier LH, et al. Current prognosis of ischemic mitral 
regurgitation. Implications for future management. Circulation 1988;78(3 Pt 2):I51-9.
22. Hills G MJ, Pellikka P, Oh J. Prognostic Significance of Mitral Regurgitation 
Identified Using Color Doppler Echocardiography Early after Acute Myocardial 
infarction. J Am Coll Cardiol 2004;43(Suppl A): 347.
23. Kumanohoso T, Otsuji Y, Yoshifuku S, et al. Mechanism of higher incidence of 
ischemic mitral regurgitation in patients with inferior myocardial infarction: quantitative 
analysis of left ventrieular and mitral valve geometry in 103 patients with prior 
myocardial infarction. J Thorac Cardiovasc Surg 2003;125(1): 135-43.
24. Kono T, Sabbah HN, Rosman H, Alam M, Jafri S ,Goldstein S. Left ventricular shape 
is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll 
Cardiol 1992;20(7): 1594-8.
25. Lamas GA, Mitchell GF, Flaker GC, et al. Clinical significance of mitral 
regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement 
Investigators. Circulation 1997;96(3):827-33.
26. Gorman RC, McCaughan JS, Ratcliffe MB, et al. Pathogenesis of acute ischemic 
mitral regurgitation in three dimensions. J Thorac Cardiovasc Surg 1995;109(4):684-93.
27. Otsuji Y, Handschumacher MD, Liel-Cohen N, et al. Mechanism of ischemic mitral 
regurgitation with segmental left ventricular dysfunction: three-dimensional 
echocardiographic studies in models of acute and chronic progressive regurgitation. J Am 
Coll Cardiol 2001;37(2):641-8.
28. Messas E, Guerrero JL, Handschumacher MD, et al. Paradoxic decrease in ischemic 
mitral regurgitation with papillary muscle dysfunction: insights from three-dimensional 
and contrast echocardiography with strain rate measurement. Circulation 
2001;104(16):1952-7.
29. Gorman JH, 3rd, Gorman RC, Jackson BM, Enomoto Y, St John-Sutton MG 
,Edmunds LH, Jr. Annuloplasty ring selection for chronic ischemic mitral regurgitation: 
lessons from the ovine model. Ann Thorac Surg 2003 ;76(5): 1556-63.
30. Tibayan FA, Rodriguez F, Langer F, et al. Annular remodeling in chronic ischemic 
mitral regurgitation: ring selection implications. Ann Thorac Surg 2003;76(5): 1549-54; 
discussion 1554-5.
176
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
31. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB ,Tajik AJ. Determinants of the 
degree of functional mitral regurgitation in patients with systolie left ventricular 
dysfunction: A quantitative clinical study. Circulation 2000;102(12): 1400-6.
32. Yu HY, Su MY, Liao TY, Peng HH, Lin FY ,Tseng WY. Functional mitral 
regurgitation in chronic ischemic coronary artery disease: analysis of geometric 
alterations of mitral apparatus with magnetic resonance imaging. J Thorac Cardiovasc 
Surg 2004; 128(4):543-51.
33. Tcheng JE, Jackman JD, Jr., Nelson CL, et al. Outeome of patients sustaining acute 
ischemic mitral regurgitation during myocardial infarction. Ann Intern Med 
1992;117(I):I8-24.
34. Llaneras MR, Nance ML, Streicher JT, et al. Pathogenesis of ischemic mitral 
insufficiency. J Thorac Cardiovasc Surg 1993; 105(3):439-42; discussion 442-3.
35. Llaneras MR, Nance ML, Streicher JT, et al. Large animal model of ischemic mitral 
regurgitation. Ann Thorac Surg 1994;57(2):432-9.
36. Torrent-Guasp F, Ballester M, Buckberg GD, et al. Spatial orientation of the 
ventrieular musele band: physiologic contribution and surgical implications. J Thorac 
Cardiovasc Surg 2001 ; 122(2) :3 89-92.
37. Levine RA. Dynamic mitral regurgitation—more than meets the eye. N Engl J Med 
2004;351(16):1681-4.
38. Marzilli M, Sabbah HN, Goldstein S ,Stein PD. Assessment of papillary muscle 
function in the intact heart. Cireulation 1985;71(5):1017-22.
39. Burch GE, De Pasquale NP ,Phillips JH. Clinical manifestations of papillary musele 
dysfunction. Arch Intern Med 1963;112(112-7.
40. Pierard LA ,Lancellotti P. The role of ischemic mitral regurgitation in the 
pathogenesis of acute pulmonary edema. N Engl J Med 2004;351(16): 1627-34.
4L Hiro ME, Jouan J, Pagel MR, et al. Sonometric study of the normal tricuspid valve 
annulus in sheep. J Heart Valve Dis 2004;13(3):452-60.
42. Hung J, Koelling T, Semigran MJ, Dec GW, Levine RA ,Di Salvo TG. Usefulness of 
echocardiographic determined tricuspid regurgitation in predieting event-free survival in 
severe heart failure secondary to idiopathic-dilated cardiomyopathy or to ischemic 
cardiomyopathy. Am J Cardiol 1998;82(10):1301-3, AlO.
43. Di Salvo TG, Mathier M, Semigran MJ ,Dec GW. Preserved right ventricular ejection 
fraction predicts exercise capacity and survival in advanced heart failure. J Am Coll 
Cardiol 1995;25(5): 1143-53.
177
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
44. Koelling TM, Aaronson KD, Cody RJ, Bach DS ,Armstrong WF. Prognostic 
significance of mitral regurgitation and tricuspid regurgitation in patients with left 
ventricular systolic dysfunction. Am Heart J 2002;144(3):524-9.
45. Polak JF, Holman BL, Wynne J ,Colucci WS. Right ventricular ejection fraction: an 
indicator of increased mortality in patients with congestive heart failure associated with 
coronary artery disease. J Am Coll Cardiol 1983;2(2):217-24.
46. Behm CZ, Nath J ,Foster E. Clinieal correlates and mortality of hemodynamically 
significant tricuspid regurgitation. J Heart Valve Dis 2004;13(5):784-9.
47. Waller BF, Moriarty AT, Eble JN, Davey DM, Hawley DA ,Pless JE. Etiology of 
pure tricuspid regurgitation based on anular circumference and leaflet area: analysis of 45 
necropsy patients with clinical and morphologic evidence of pure tricuspid regurgitation.
J Am Coll Cardiol 1986;7(5): 1063-74.
48. Ubago JL, Figueroa A, Ochoteco A, Colman T, Duran RM ,Duran CG. Analysis of 
the amount of tricuspid valve anular dilatation required to produce functional tricuspid 
regurgitation. Am J Cardiol 1983;52(l):155-8.
49. Deloche A, Guerinon J, Fabiani JN, et al. [Anatomical study of rheumatic tricuspid 
valve diseases: Application to the study of various valvuloplasties]. Ann Chir Thorac 
Cardiovasc 1973;12(4):343-9.
50. Carpentier A, Deloehe A, Hanania G, et al. Surgical management of acquired 
trieuspid valve disease. J Thorac Cardiovasc Surg 1974;67(l):53-65.
51. Mikami T, Kudo T, Sakurai N, Sakamoto S, Tanabe Y ,Yasuda H. Mechanisms for 
development of functional tricuspid regurgitation determined by pulsed Doppler and two- 
dimensional echocardiography. Am J Cardiol 1984;53(1): 160-3.
52. Come PC ,Riley MF. Tricuspid anular dilatation and failure of tricuspid leaflet 
coaptation in tricuspid regurgitation. Am J Cardiol 1985;55(5):599-601.
53. Sagie A, Schwammenthal E, Radial LR, Vazquez de Prada JA, Weyman AE ,Levine 
RA. Determinants of functional tricuspid regurgitation in incomplete tricuspid valve 
closure: Doppler color flow study of 109 patients. J Am Coll Cardiol 1994;24(2):446-53.
54. Adams DH, Filsoufi F ,Aklog L. Surgical treatment o f the isehemic mitral valve. J 
Heart Valve Dis 2002; 11 Suppl l(S21-5).
55. Aklog L, Filsoufi F, Flores KQ, et al. Does coronary artery bypass grafting alone 
correct moderate ischemic mitral regurgitation? Circulation 2001;104(12 Suppl 1):I68-
75.
178
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
56. Kron IL, Green GR ,Cope JT. Surgical relocation of the posterior papillary muscle in 
ehronic ischemie mitral regurgitation. Ann Thorac Surg 2002;74(2):600-l.
57. J. Swanson FWSPJdNS. Surgery of the ehest. Philadelphia: Elsevier Inc, 2005: 1335- 
54
58. McGee EC, Gillinov AM, Blackstone EH, et al. Recurrent mitral regurgitation after 
annuloplasty for functional ischemic mitral regurgitation. J Thorac Cardiovasc Surg 
2004; 128(6):916-24.
59. Tahta SA, Oury JH, Maxwell JM, Hiro SP ,Duran CM. Outcome after mitral valve 
repair for functional ischemic mitral regurgitation. J Heart Valve Dis 2002;11(1): 11-8; 
diseussion 18-9.
60. Matsunaga A, Tahta SA ,Duran CM. Failure of reduction annuloplasty for functional 
ischemic mitral regurgitation. J Heart Valve Dis 2004;13(3):390-7; discussion 397-8.
61. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K ,Koelling TM. Impact of 
mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left 
ventricular systolic dysfunction. J Am Coll Cardiol 2005;45(3):381-7.
62. Messas E, Pouzet B, Touchot B, et al. Efficacy of chordal cutting to relieve chronic 
persistent ischemic mitral regurgitation. Circulation 2003; 108 Suppl 1(11111-5).
63. Wakiyama H, Okada Y, Kitamura A, et al. [Chordal cutting for the treatment of 
ischemic mitral regurgitation: two case reports]. J Cardiol 2004;44(3): 113-7.
64. Rodriguez F, Langer F, Harrington KB, et al. Cutting second-order chords does not 
prevent acute ischemic mitral regurgitation. Circulation 2004; 110(11 Suppl l):1191-7.
65. Rodriguez F, Langer F, Harrington KB, et al. Importance of mitral valve seeond-order 
chordae for left ventricular geometry, wall thickening meehanics, and global systolic 
function. Circulation 2004; 110(11 Suppl 1):11115-22.
66. Goetz WA, Lim HS, Lansac E, Weber PA, Birnbaum DE ,Duran CM. The 
aortomitral angle is suspended by the anterior mitral basal "stay" chords. Thorac 
Cardiovasc Surg 2003;51(4):190-5.
67. Ranganathan N, Lam JH, Wigle ED ,Silver MD. Morphology of the human mitral 
valve. II. The value leaflets. Circulation I970;41(3):459-67.
68. Lam JH, Ranganathan N, Wigle ED ,Silver MD. Morphology of the human mitral 
valve. 1. Chordae tendineae: anew classification. Circulation 1970;4I(3):449-58.
69. Dor V, Sabatier M, Di Donato M, Montiglio F, Toso A ,Maioli M. Efficacy of 
endoventricular patch plasty in large postinfarction akinetic scar and severe left
179
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
ventricular dysfunction: comparison with a series of large dyskinetic scars. J Thorac 
Cardiovasc Surg 1998;116(l):50-9.
70. Dor V. Left ventricular reconstruction: the aim and the reality after twenty years. J 
Thorac Cardiovasc Surg 2004; 128(1): 17-20.
71. Hvass U, Tapia M, Baron F, Pouzet B ,Shafy A. Papillary muscle sling: a new 
functional approach to mitral repair in patients with ischemic left ventrieular dysfunction 
and functional mitral regurgitation. Ann Thorac Surg 2003;75(3):809-l 1.
72. Grossi EA, Goldberg JD, LaPietra A, et al. Ischemic mitral valve reconstruction and 
replacement: comparison of long-term survival and complications. J Thorac Cardiovasc 
Surg2001;122(6):1107-24.
73. Gillinov AM, Wierup PN, Blackstone EH, et al. Is repair preferable to replacement 
for ischemic mitral regurgitation? J Thorac Cardiovasc Surg 2001 ;122(6): 1125-41.
74. Miller DC. Ischemic mitral regurgitation redux—to repair or to replace? J Thorac 
Cardiovasc Surg 2001 ; 122(6): 1059-62.
75. Goldman ME, Guarino T, Fuster V ,Mindich B. The necessity for tricuspid valve 
repair can be determined intraoperatively by two-dimensional echocardiography. J 
Thorac Cardiovasc Surg 1987;94(4):542-50.
76. Kay JH, Maselli-Campagna G ,Tsuji KK. Surgical Treatment of Tricuspid 
Insufficiency. Ann Surg 1965; 162(53-8).
77. Cabrol C. [Valvular annuloplasty. A new method]. Nouv Presse Med 
1972; 1(20): 1366.
78. Duran CG ,Ubago JL. Clinical and hemodynamic performance of a totally flexible 
prosthetie ring for atrioventricular valve reconstruction. Ann Thorac Surg 
1976;22(5):458-63.
79. McCarthy PM, Bhudia SK, Rajeswaran J, et al. Tricuspid valve repair: durability and 
risk factors for failure. J Thorac Cardiovasc Surg 2004;127(3):674-85.
80. Poveda JJ, Bernal JM, Matorras P, et al. Tricuspid valve replacement in rheumatic 
disease: preoperative predictors of hospital mortality. J Heart Valve Dis 1996;5(l):26-30.
81. Homick P, Harris PA ,Taylor KM. Tricuspid valve replacement subsequent to 
previous open heart surgery. J Heart Valve Dis 1996;5(l):20-5.
82. Hurt, ultrastructure of the myocardium. New York. McGraw-Hill, 1994: 73-80
180
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
83. Hurt. Normal physiology of the cardiovascular system. New York. MaGraw Hill, 
1994:81-124
84. Lakatta EG. Starling's law of the heart is explained by an intimate interaction of 
muscle length and myofilament calcium activation. J Am Coll Cardiol 1987; 10(5): 1157-
64.
85. Babu A, Sonnenblick E ,Gulati J. Molecular basis for the influence of muscle length 
on myocardial performance. Science 1988;240(4848):74-6.
86. Sonnenblick EH, Ross J, Jr., Covell JW, Spotnitz HM ,Spiro D. The ultrastrueture of 
the heart in systole and diastole. Changes in sarcomere length. Circ Res 1967;21(4):423-
31.
87. Ross J, Jr., Sonnenblick EH, Taylor RR, Spotnitz HM ,Covell JW. Diastolic geometry 
and sarcomere lengths in the chronically dilated canine left ventricle. Circ Res 
1971;28(1):49-61.
88. LeJemtel T, Sonnenblick, EH. Heart Failure and Maladaptative processes: 
Introduction. Circulation 1993;87(suppl VII):VII1-VII4.
89. Wilson EM, Moainie SL, Baskin JM, et al. Region- and type-specific induction of 
matrix metalloproteinases in post-myocardial infarction remodeling. Circulation 
2003;107(22):2857-63.
90. Hurt. Pathophysiology of heart failure. New York. McGraw Hill, 1994: 687-726
91. Mann DL ,Bristow MR. Mechanisms and models in heart failure: the biomechanieal 
model and beyond. Circulation 2005;111(21):2837-49.
92. Davies CH, Davia K, Bennett JG, Pepper JR, Poole-Wilson PA ,Harding SE.
Reduced contraction and altered frequency response of isolated ventricular myocytes 
from patients with heart failure. Circulation 1995;92(9):2540-9.
93. Victor S ,Nayak VM. The trieuspid valve is bicuspid. J Heart Valve Dis 
1994;3(l):27-36.
94. Pelat M, Massion PB ,Balligand JL. Nitric oxide "at heart": emerging paradigms after 
a decade. Arch Mai Coeur Vaiss 2005;98(3):242-8.
95. Gray. The Blood-Vascular System, the Heart. Gray's anatomy. Philadelphia: Running 
Press, 1974: 463-464
96. Tamers WH, Viragh S, Wessels A, Moorman AF , Anderson RH. Formation of the 
trieuspid valve in the human heart. Circulation 1995;91(1):111-21.
181
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
97. Kumar N, Kumar M ,Duran CM. A revised terminology for recording surgical 
findings of the mitral valve. J Heart Valve Dis 1995;4(l):70-5; discussion 76-7.
98. Zimmerman J BP. The surgical significance of the fibrous skeleton of the heart. J 
Thorac Cardiovasc Surg 1962;44(6):701-12.
99. Tsakiris AG, Von Bemuth G, Rastelli GC, Bourgeois MJ, Titus JL ,Wood EH. Size 
and motion of the mitral valve annulus in anesthetized intact dogs. J Appl Physiol 
1971;30(5):611-8.
100. Ormiston JA, Shah PM, Tei C ,Wong M. Size and motion of the mitral valve 
annulus in man. I. A two-dimensional echocardiographic method and findings in normal 
subjects. Circulation 1981;64(1):113-20.
101. Salgo IS, Gorman JH, 3rd, Gorman RC, et al. Effect of annular shape on leaflet 
curvature in reducing mitral leaflet stress. Circulation 2002; 106(6):711-7.
102. Levine RA, Handschumacher MD, Sanfilippo AJ, et al. Three-dimensional 
echocardiographic reconstruction of the mitral valve, with implications for the diagnosis 
of mitral valve prolapse. Circulation 1989;80(3):589-98.
103. Lomholt M, Nielsen SL, Hansen SB, Andersen NT ,Hasenkam JM. Differential 
tension between secondary and primary mitral chordae in an acute in-vivo porcine model. 
J Heart Valve Dis 2002;11(3):337-45.
104. Ranganathan N ,Burch GE. Gross morphology and arterial supply of the papillary 
muscles of the left ventriele of man. Am Heart J 1969;77(4):506-16.
105. Ramsheyi SA, Pargaonkar S, Lassau JP ,Acar C. Morphologic classification of the 
mitral papillary muscles. J Heart Valve Dis 1996;5(5):472-6.
106. Voci P, Bilotta F, Caretta Q, Mercanti C ,Marino B. Papillary muscle perfusion 
pattern. A hypothesis for ischemic papillary muscle dysfunction. Circulation 
1995;91(6):1714-8.
107. Tei C, Pilgrim JP, Shah PM, Ormiston JA ,Wong M. The tricuspid valve annulus: 
study of size and motion in normal subjects and in patients with tricuspid regurgitation. 
Circulation 1982;66(3):665-71.
108. Deloche A, Guerinon J, Fabiani JN, et al. [Anatomical study of rheumatic tricuspid 
valvulopathies. Applications to the critical study of various methods of annuloplasty]. 
Arch Mai Coeur Vaiss 1974;67(5):497-505.
109. Frater RW. The right-sided atrioventricular valve. J Heart Valve Dis 1994;3(l):25-6.
182
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
110. Higashidate M, Tamiya K, Kurosawa H ,Imai Y. Role of the septal leaflet in 
tricuspid valve closure. Consideration for treatment of complete atrioventricular canal. J 
Thorac Cardiovasc Surg 1992;104(5):1212-7.
111. Carpentier AF, Lessana A, Relland JY, et al. The "physio-ring": an advanced 
concept in mitral valve annuloplasty. Ann Thorac Surg 1995;60(5):1177-85; discussion 
1185-6.
112. Duran CG. Acquired disease of the tricuspid valve. Philadelphia. Anne Lenhan,
2004:1335-54
113. Chen CC, Morganroth J, Mardelli TJ ,Naito M. Tricuspid regurgitation in tricuspid 
valve prolapse demonstrated with contrast cross-sectional echocardiography. Am J 
Cardiol 1980;46(6):983-7.
114. Pomar JL ,Mestres CA. Tricuspid valve replacement using a mitral homograft. 
Surgical technique and initial results. J Heart Valve Dis 1993;2(2):125-8.
115. van Son JA, Danielson GK, Sehaff HV ,Miller FA, Jr. Traumatic tricuspid valve 
insufficiency. Experience in thirteen patients. J Thorae Cardiovase Surg 
1994;108(5):893-8.
116. Yankah AC, Musci M, Weng Y, et al. Tricuspid valve dysfunction and surgery after 
orthotopic cardiac transplantation. Eur J Cardiothorac Surg 2000;17(4):343-8.
117. Hvass U, Chatel D, Caliani J ,Oroudji M. Mitral valve repairs using the posterior 
tricuspid leaflet and chordae. Technique and results. Eur J Cardiothorac Surg 
1996;10(10):874-8.
118. Hvass U, Juliard JM, Assayag P, Laperche T, Pansard Y ,Chatel D. Tricuspid 
autograft for mitral-valve repair. Lancet 1996;347(9002):659-61.
119. Gorman JH, 3rd, Gupta KB, Streicher JT, et al. Dynamic three-dimensional imaging 
of the mitral valve and left ventricle by rapid sonomicrometry array localization. J Thorac 
Cardiovasc Surg 1996;112(3):712-26.
120. Komeda M, Glasson JR, Bolger AF, Daughters GT, 2nd, Ingels NB, Jr. ,Miller DC. 
Papillary musele-left ventricular wall "complex". J Thorac Cardiovasc Surg 
1997;113(2):292-300; discussion 300-1.
121. Lansac E, Lim KH, Shomura Y, et al. Dynamic balance of the aortomitral junction. J 
Thorac Cardiovasc Surg 2002;123(5):911-8.
122. Three dimensional ultrasonic micrometer for use in cardiovascular research. 
Proceedings of the 13th Conferenee of the lEEE-EMBS 1991
183
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
123. Tsakiris AG, Mair DD, Seki S, Titus JL ,Wood EH. Motion of the tricuspid valve 
annulus in anesthetized intaet dogs. Circ Res 1975;36(l);43-8.
124. Sakai T, Okita Y, Ueda Y, et al. Distance between mitral anulus and papillary 
muscles: anatomie study in normal human hearts. J Thorae Cardiovasc Surg 
1999;118(4):636-41.
125. Axel L. Papillary muscles do not attach directly to the solid heart wall. Cireulation 
2004;109(25):3145-8.
126. David TE. Mitral valve replacement with preservation of chordae tendinae: rationale 
and technical considerations. Ann Thorac Surg 1986;41(6):680-2.
127. Buckberg GD, Coghlan HC ,Torrent-Guasp F. The structure and function of the 
helical heart and its buttress wrapping. V. Anatomic and physiologic considerations in the 
healthy and failing heart. Semin Thorac Cardiovasc Surg 2001 ;13(4):358-85.
128. Henry WL, DeMaria A, Gramiak R, et al. Report of the American Society of 
Echocardiography Committee on Nomenclature and Standards in Two-dimensional 
Echocardiography. Circulation 1980;62(2):212-7.
129. Hurt. The echocardiogram. New York. McGraw-Hill, 1994: 415-517
130. Lansac E, Lim HS, Shomura Y, et al. Aortic and pulmonary root: are their dynamics 
similar? Eur J Cardiothorac Surg 2002;21(2):268-75.
131. Tessier D, Lajos P, Braunberger E, et al. Induction of chronic cardiac insufficiency 
by arteriovenous fistula and doxorubicin administration. J Card Surg 2003;18(4):307-11.
132. Chekanov VS. A stable model of chronic bilateral ventricular insufficiency (dilated 
cardiomyopathy) induced by arteriovenous anastomosis and doxorubicin administration 
in sheep. J Thorac Cardiovasc Surg 1999;117(l):198-9.
133. Shah HR, Vaynblat M, Ramdev G, Cunningham JN, Jr. ,Chiavarelli M.
Experimental cardiomyopathy as a model of chronic heart failure. J Invest Surg 
1997;10(6):387-96.
134. Monnet E ,Orton EC. A canine model of heart failure by intracoronary adriamycin 
injection: hemodynamic and energetic results. J Card Fail 1999;5(3):255-64.
135. Astra LI, Hammond R, Tarakji K ,Stephenson LW. Doxorubicin-induced canine 
CHF: advantages and disadvantages. J Card Surg 2003;18(4):301-6.
184
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
136. Toyoda Y, Okada M ,Kashem MA. A canine model of dilated cardiomyopathy 
induced by repetitive intraeoronary doxorubicin administration. J Thorac Cardiovasc 
Surg 1998;115(6):1367-73.
137. Rajnoch C, Chachques JC, Berrebi A, Bruneval P, Benoit MO ,Carpentier A. 
Cellular therapy reverses myocardial dysfunction. J Thorac Cardiovasc Surg 
2001;121(5):871-8.
138. O'Brien PJ, lanuzzo CD, Moe GW, Stopps TP ,Armstrong PW. Rapid ventricular 
pacing of dogs to heart failure: biochemical and physiological studies. Can J Physiol 
Pharmacol 1990;68(l):34-9.
139. Byrne MJ, Raman JS, Alfemess CA, Esler MD, Kaye DM ,Power JM. An ovine 
model of taehycardia-induced degenerative dilated cardiomyopathy and heart failure with 
prolonged onset. J Card Fail 2002;8(2):108-15.
140. Howard RJ, Stopps TP, Moe GW, Gotlieb A ,Armstrong PW. Recovery from heart 
failure: structural and functional analysis in a canine model. Can J Physiol Pharmacol 
1988;66(12):1505-12.
141. Patel HJ, Pilla JJ, Polidori DJ, et al. Ten weeks of rapid ventrieular pacing creates a 
long-term model of left ventricular dysfunction. J Thorac Cardiovasc Surg 2000; 119(4 Pt 
1):834-41.
142. Timek TA, Dagum P, Lai DT, et al. Pathogenesis of mitral regurgitation in 
tachycardia-induced cardiomyopathy. Circulation 2001; 104(12 Suppl l):I47-53.
143. Timek TA, Dagum P, Lai DT, et al. Tachycardia-induced cardiomyopathy in the 
ovine heart: mitral annular dynamic three-dimensional geometry. J Thorae Cardiovasc 
Surg 2003; 125(2):315-24.
144. Sakaguchi G, Sakakibara Y, Tambara K, et al. A pig model of chronic heart failure 
by intraeoronary embolization with gelatin sponge. Ann Thorac Surg 2003;75(6): 1942-7.
145. de Lemos JA, McGuire DK ,Drazner MH. B-type natriuretic peptide in 
cardiovaseular disease. Lancet 2003;362(9380):316-22.
146. Grantham JA, Borgeson DD ,Bumett JC, Jr. BNP: pathophysiological and potential 
therapeutic roles in acute eongestive heart failure. Am J Physiol 1997;272(4 Pt 2):R1077-
83.
147. Suzuki G, Morita H, Mishima T, et al. Effects of long-term monotherapy with 
eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction 
and remodeling in dogs with heart failure. Circulation 2002; 106(23):2967-72.
185
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
148. Gorman JH, 3rd, Gorman RC, Plappert T, et al. Infarct size and location determine 
development of mitral regurgitation in the sheep model. J Thorac Cardiovasc Surg 
1998;115(3):615-22.
149. Moainie SL, Gorman JH, 3rd, Guy TS, et al. An ovine model of postinfarction 
dilated cardiomyopathy. Ann Thorac Surg 2002;74(3):753-60.
150. Helmcke F, Nanda NC, Hsiung MC, et al. Color Doppler assessment of mitral 
regurgitation with orthogonal planes. Cireulation 1987;75(1): 175-83.
151. Teichholz LE, Kreulen T, Herman MV ,Gorlin R. Problems in echocardiographic 
volume determinations: echocardiographic-angiographic correlations in the presence of 
absence of asynergy. Am J Cardiol 1976;37(1):7-11.
152. Markovitz LJ, Savage EB, Ratcliffe MB, et al. Large animal model of left 
ventricular aneurysm. Ann Thorac Surg 1989;48(6):838-45.
153. Abbate A, Bonanno E, Mauriello A, et al. Widespread myoeardial inflammation and 
infarct-related artery pateney. Circulation 2004;110(l):46-50.
154. Gorman RC ,Gorman JH, 3rd. Does repair of ischemic mitral regurgitation help? 
Ann Thorac Surg 2003;76(5):1775-6; author reply 1776-7.
155. Jackson BM, Gorman JH, Moainie SL, et al. Extension of borderzone myocardium 
in postinfarction dilated cardiomyopathy. J Am Coll Cardiol 2002;40(6):1160-7; 
discussion 1168-71.
156. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive 
cardiomyopathy. Lancet 1995;346(8969):211-4.
157. Lakkis NM, Nagueh SF, Dunn JK, Killip D ,Spencer WH, 3rd. Nonsurgical septal 
reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up. J 
Am Coll Cardiol 2000;36(3):852-5.
158. Knight C, Kurbaan AS, Seggewiss H, et al. Nonsurgical septal reduction for 
hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. 
Circulation 1997;95(8):2075-81.
159. Gietzen FH, Leuner CJ, Raute-Kreinsen U, et al. Acute and long-term results after 
transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment 
for hypertrophic obstructive cardiomyopathy. Eur Heart J 1999;20(18): 1342-54.
160. Raute-Kreinsen U. Morphology of necrosis and repair after transcoronary ethanol 
ablation of septal hypertrophy. Pathol Res Tract 2003;199(3): 121-7.
186
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
161. Khankirawatana B, Khankirawatana S, Mahrous H ,Porter TR. Assessment of 
papillary muscle function using myocardial velocity gradient derived from tissue Doppler 
echocardiography. Am J Cardiol 2004;94(l):45-9.
162. Li ZQ, Cheng TO, Liu L, et al. Experimental study of relationship between 
intracoronary alcohol injection and the size of resultant myocardial infarct. Int J Cardiol 
2003;91(l):93-6.
163. Cheng TO. In percutaneous transluminal septal myocardial ablation for hypertrophic 
obstructive cardiomyopathy, it is not the speed of intracoronary alcohol injection but the 
amount of alcohol injected that determines the resultant infarct size. Cireulation 
2004;110(3):e23; author reply e23.
164. Mordehay Vaturi JH, Robert A. Levien. News concepts in the diagnosis and therapy 
of patients with valvular regurgitation. J Am Coll Cardiol 2004;Mareh 03(440A).
165. Hare JM. Nitric oxide and excitation-contraetion coupling. J Mol Cell Cardiol 
2003;35(7):719-29.
166. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA ,Michel T. Endothelial nitrie 
oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in 
cardiac myocytes and endothelial cells. J Biol Chem 1996;271(37):22810-4.
167. Bredt DS. Nitric oxide signaling specificity—the heart of the problem. J Cell Sci 
2003;116(Ptl):9-15.
168. Michel T ,Feron O. Nitric oxide synthases: which, where, how, and why? J Clin 
Invest 1997;100(9):2146-52.
169. Hare JM. Spatial confinement of isoforms of cardiac nitric-oxide synthase: 
unravelling the complexities of nitric oxide's cardiobiology. Lancet 
2004;363(9418):1338-9.
170. Barouch LA, Harrison RW, Skaf MW, et al. Nitric oxide regulates the heart by 
spatial confinement of nitric oxide synthase isoforms. Nature 2002;416(6878):337-9.
171. Massion PB, Feron O, Dessy C ,Balligand JL. Nitric oxide and cardiac function: ten 
years after, and continuing. Circ Res 2003;93(5):388-98.
172. Massion PB ,Balligand JL. Modulation of cardiac contraction, relaxation and rate by 
the endothelial nitric oxide synthase (eNOS): lessons from genetically modified mice. J 
Physiol 2003;546(Pt l):63-75.
173. Sears CE, Bryant SM, Ashley EA, et al. Cardiac neuronal nitric oxide synthase 
isoform regulates myocardial contraction and calcium handling. Circ Res 
2003;92(5):e52-9.
187
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
174. Khan SA, Skaf MW, Harrison RW, et al. Nitric oxide regulation of myocardial 
contractility and calcium cycling: independent impact of neuronal and endothelial nitric 
oxide synthases. Circ Res 2003;92(12):1322-9.
175. Hare JM, Givertz MM, Creager MA ,Colucei WS. Increased sensitivity to nitric 
oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic 
inotropic responsiveness. Circulation 1998;97(2):161-6.
176. Ashley EA, Sears CE, Bryant SM, Watkins HC ,Casadei B. Cardiac nitric oxide 
synthase 1 regulates basal and beta-adrenergic contractility in murine ventricular 
myocytes. Circulation 2002;105(25):3011-6.
177. Petroff MG, Kim SH, Pepe S, et al. Endogenous nitric oxide mechanisms mediate 
the stretch dependence of Ca2+ release in cardiomyocytes. Nat Cell Biol 2001;3(10):867-
73.
178. Scherrer-Crosbie M, Ullrich R, Bloch KD, et al. Endothelial nitric oxide synthase 
limits left ventricular remodeling after myocardial infarction in mice. Circulation 
2001;104(11):1286-91.
179. Cotton JM, Kearney MT, MacCarthy PA, et al. Effects of nitric oxide synthase 
inhibition on Basal function and the force-frequency relationship in the normal and 
failing human heart in vivo. Circulation 2001 ;104(19):2318-23.
180. Hare JM, Loh E, Creager MA ,Colucci WS. Nitric oxide inhibits the positive 
inotropic response to beta-adrenergic stimulation in humans with left ventricular 
dysfunction. Circulation 1995;92(8):2198-203.
181. de Beider AJ, Radomski MW, Why HJ, et al. Nitric oxide synthase activities in 
human myocardium. Lancet 1993;341(8837):84-5.
182. Damy T, Ratajczak P, Shah AM, et al. Increased neuronal nitric oxide synthase- 
derived NO production in the failing human heart. Lancet 2004;363(9418): 1365-7.
183. Fukuchi M, Hussain SN ,Giaid A. Heterogeneous expression and activity of 
endothelial and inducible nitric oxide synthases in end-stage human heart failure: their 
relation to lesion site and beta-adrenergie receptor therapy. Circulation 1998;98(2):132-9.
184. Baker JE HP, Kalyanaraman b, Pritchard KA. Chronic myocardial hypoxia increases 
eNOS expression to produce elevated levels of nitric oxide for cardioprotection. 
Circulation 1996;94(suppl 1)1-468 Abstract.
185. Yamamoto S, Tsutsui H, Tagawa H, et al. Role of myocyte nitric oxide in beta- 
adrenergic hyporesponsiveness in heart failure. Circulation 1997;95(5):1111-4.
188
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
186. Schrier RW ,Abraham WT. Hormones and hemodynamics in heart failure. N Engl J 
Med 1999;341(8):577-85.
187. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and 
beta-adrenergic-reeeptor density in failing human hearts. N Engl J Med 1982;307(4):205- 
11.
188. Force T, Miehael A, Kilter H ,Haq S. Stretch-activated pathways and left ventricular 
remodeling. J Card Fail 2002;8(6 Suppl):S351-8.
189. Xu KY, Huso DL, Dawson TM, Bredt DS ,Becker EC. Nitric oxide synthase in 
cardiac sarcoplasmic reticulum. Proc Natl Acad Sci U S A 1999;96(2):657-62.
190. Grande-Allen KJ, Borowski AG, Troughton RW, et al. Apparently normal mitral 
valves in patients with heart failure demonstrate biochemical and structural 
derangements: an extracellular matrix and echocardiographic study. J Am Coll Cardiol 
2005;45(1):54-61.
191. O'Brien KD ,Fishbein DP. Mitral valve abnormalities in congestive heart failure: an 
interplay between form and function? J Am Coll Cardiol 2005;45(l):62-4.
192. Ruwhof C ,van der Laarse A. Mechanical stress-induced cardiac hypertrophy: 
mechanisms and signal transduction pathways. Cardiovasc Res 2000;47(l):23-37.
193. Schaper J, Froede R, Hein S, et al. Impairment of the myocardial ultrastructure and 
changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991;83(2):504-14.
194. Beuckelmann DJ, Nabauer M ,Erdmann E. Intracellular calcium handling in isolated 
ventricular myocytes from patients with terminal heart failure. Circulation 
1992;85(3):1046-55.
195. Spinale FG. Matrix metalloproteinases: regulation and dysregulation in the failing 
heart. Circ Res 2002;90(5):520-30.
196. Mann DL ,Spinale FG. Activation of matrix metalloproteinases in the failing human 
heart: breaking the tie that binds. Circulation 1998;98(17):1699-702.
197. Weber KT. Targeting pathological remodeling: concepts of cardioprotection and 
reparation. Circulation 2000;102(12): 1342-5.
198. Pfeffer MA ,Braunwald E. Ventricular enlargement following infarction is a 
modifiable process. Am J Cardiol 1991;68(14):127D-131D.
199. Tamura T, Said S, Harris J, Lu W ,Gerdes AM. Reverse remodeling of cardiac 
myocyte hypertrophy in hypertension and failure by targeting of the renin-angiotensin 
system. Circulation 2000;102(2):253-9.
189
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
200. Zafeiridis A, Jeevanandam V, Houser SR ,Margulies KB. Regression of cellular 
hypertrophy after left ventricular assist device support. Circulation 1998;98(7);656-62.
201. Messas E, Guerrero JL, Handschumacher MD, et al. Chordal cutting: a new 
therapeutic approach for ischemic mitral regurgitation. Circulation 2001 ;104(16): 1958-
63.
202. Fukuda S, Song JM, Gillinov AM, et al. Tricuspid valve tethering predicts residual 
tricuspid regurgitation after tricuspid armuloplasty. Circulation 2005;111(8):975-9.
190
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
